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ABSTRACT OF THE DISSERTATION 
Cell Cultures of Genetic Variation 
by 
Joshua Turner Witten 
Doctor of Philosophy in Biology and Biomedical Sciences (Molecular Cell Biology) 
Washington University in St. Louis, 2010 
Professor Barak Cohen, Chairperson 
 Studying genetic variation presents a dilemma. While the genetic variation of 
greatest interest is that causing variation in traits and disease risk in natural populations, 
natural populations have characteristics that make them challenging to study. In this 
work, I have assessed the use of cell culture methods as a solution to some of these 
challenges. In particular, I studied genetic variation in the budding yeast Saccharomyces 
cerevisiae that was generated by selection in the lab as a model for natural genetic 
variation. I have found that even simplistic selection programs in the laboratory, 
including the use of chemical mutagenesis to introduce genetic variation, can be used to 
rapidly generate genetic variation with the same characteristics as that observed in natural 
populations of budding yeast. 
I also explored the use of human-derived lymphoblastoid cell lines as source of 
genetic variation that eliminates some of the most challenging problems that arise from 
the use of humans as research subjects. In addition to the ethical limitations, there are 
also severe technical limitations to the study of human subjects, not least of which is the 
difficulty of direct experimentation to confirm hypotheses. 
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 I found that lymphoblastoid cell lines are a reliable experimental system in which 
phenotypic variation, at the cellular level, primarily represents differences between lines, 
a significant portion of which is due to additive genetic variation. Due to the growth of 
publicly available genotype data, these lines can be used to locate genetic variants with 
phenotypic effects by linkage-association mapping. In addition to the shared database 
resources, cell lines are amenable to distribution from central repositories, suggesting that 
cell culture could form the basis of a community resource for the study of human genetic 
variation.     
While cell culture methods have share weaknesses with traditional genetic model 
systems, the use of a variety of cell culture approaches, including microorganisms and 
human-derived cell lines, represents an important, complementary approach to the 
investigation of genetic variation both for basic, mechanistic questions and for 
understanding the genetic causes of diversity in human phenotypes.   
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CHAPTER ONE: GENERAL INTRODUCTION 
INTRODUCTION 
 Gregor Mendel’s discovery of the Laws of Inheritance was, to a degree, 
serendipitous. The choice of model system (peas) and phenotype (round/wrinkled seeds, 
among others) was essential. That system presented Mendel with a situation ideally 
suited for the discovery of his Laws of Inheritance – a phenotype controlled by a single 
gene with two alleles, one of which was completely dominant (the round allele) over the 
other. It would, however, been very easy for Mendel to pick a system that did not have 
the necessary characteristics for the discovery of the Laws of Inheritance, because most 
of the traits he could have chosen (e.g., height, yield, drought resistance, etc.) are 
complex. This discussion serves not to downplay Mendel’s brilliance, but to highlight the 
fact that no amount of genius would have given the world his Laws of Inheritance 
without the right phenotype in the right model system. The right system is integral to 
address any question in science. The main goal of the work in this thesis was to 
investigate cell culture methods as systems to address questions about genetic variation. 
 Genetics is the study of how DNA polymorphism determines phenotypic 
variation. In classical genetics phenotypes are connected to single large effect mutations, 
which often identify key genes in biological pathways. In quantitative genetics 
phenotypes are modeled as being the output of alleles at multiple segregating loci. 
Population genetics is the study of how these alleles are distributed within and between 
populations.     
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 As the ability to determine genotype becomes simpler, the study of genetic 
variation could be augmented by model systems that can represent natural genetic 
variation, are amenable to high-throughput approaches, and allow methods to 
experimental test genotype-phenotype association hypotheses. A particularly challenging 
area that might benefit from model systems to complement traditional practices is 
research of natural genetic variaton. In this work, I have assessed the utility of studying 
selection in the laboratory using the budding yeast Saccharomyces cerevisiae as a model 
system for natural variation. I have also examined the utility of lymphoblastoid cell lines 
(LCLs) as a model system for the study of human genetic variation. Background specific 
to each model system follows below   
A description of my research on selection in S. cerevisiae as a model for natural 
genetic variation appears in Chapter Two. A description of my research on LCLs as a 
model for human genetic variation appears in Chapter Three. General conclusions and 
discussion appear in Chapter Four. 
CELL CULTURE AS A MODEL FOR NATURAL GENETIC VARIATION 
 The fundamental distinction between studies of laboratory and naturally occurring 
strains of a model organism is the degree to which the environment can be controlled. 
The variables affecting phenotype in laboratory strains can be limited and controlled by 
the researcher. This allows variables (e.g., genotype, environment, etc.) to be manipulated 
individually, which is ideal for the study of mechanism. Naturally occurring strains, on 
the other hand, are the product of multivariate processes, which have not been observed, 
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resulting in multifactor differences between strains. The variables affecting phenotype 
between natural strains are complex and have not been controlled. 
There are, however, reasons why laboratory researchers might wish to step away 
from pristine laboratory strains to examine variation in natural strains. Most phenotypic 
variation observed in nature is continuous, genetically complex, and dependent on the 
environment. The progressive goal of genetics is to build models that predict phenotype 
from knowledge of genotype and environment with increasing accuracy. While these 
models require a mechanistic basis, they also require an understanding of the 
consequences of small variation in their parameters that are frequently below the 
resolution of mechanistic studies. Variation in natural strains provides examples of this 
type of variation (GERKE et al. 2009; GERKE et al. 2006). The study of natural variation 
complements mechanistic study of laboratory strains.   
In addition, naturally occurring strains are reservoirs of variation and novelty in 
potentially useful traits. The search for useful variation in nature is a major component of 
agricultural science and pharmaceutical research.      
 One weakness in studying natural strains is that they are inherently anecdotal. 
These studies tend to assume that the experimental tools and accumulated knowledge 
base from the laboratory strain of the species (or closely related species) are directly 
applicable to the natural strains. Because each example of natural variation occurs in an 
uncontrolled, multivariate environment and is determined by chance events, it can be 
very difficult to identify the environmental variables driving that variation and to re-
examine the history of that variation in detail.  The multivariate, contingent evolutionary 
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history of natural strains makes it difficult, if not impossible, to systematically explore 
the effects of individual variables on phenotype.  
Laboratory selection as a model system: Can the systematic control of variables in 
laboratory strains be brought together with the continuous, complex variation of natural 
strains in a model system for the study of naturally occurring genetic variation? The use 
of selection in the laboratory to generate variation with the characteristics of natural 
variation is a potential solution.     
 Artificial selection (breeding determined by phenotype of interest) has a long and 
successful history in the agricultural breeding of plants and animals. William Ernst 
Castle, one of the earliest geneticists, used directional selection in hooded rats to 
demonstrate transgressive segregation and disproved the generality of the pure line 
genetic concept (CASTLE 1951). Since then, laboratory selection has been used to study a 
wide variety of areas of interest in genetics and evolutionary biology, such as the fitness 
effects of mutation (DE VISSER and LENSKI 2002; DE VISSER and ROZEN 2006; ESTES et 
al. 2004; HEGRENESS et al. 2006; KASSEN and BATAILLON 2006; LENSKI and TRAVISANO 
1994; OSTROWSKI et al. 2005a; SILANDER et al. 2007), the role of genome 
rearrangements (DUNHAM et al. 2002), the effects of haploidy and diploidy (PAQUIN and 
ADAMS 1983a; ZEYL et al. 2003), the frequency of parallelism versus convergence 
(BUCKLING et al. 2003; COHAN and HOFFMANN 1986; COOPER et al. 2003; HERRING et 
al. 2006; LENSKI and TRAVISANO 1994), the effects of asexual and sexual lifestyles (DE 
VISSER and ROZEN 2006; GRIMBERG and ZEYL 2005a), and evolutionary change in gene 
expression (COOPER et al. 2003; FEREA et al. 1999; PELOSI et al. 2006; RIEHLE et al. 
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2003; RIFKIN et al. 2005). Selection in the laboratory has also been used extensively to 
investigate questions in evolutionary theory and quantitative genetics. 
Laboratory selection of microorganisms as a model system: Microorganism cell 
culture is particularly advantageous for selection experiments in the laboratory. Cell 
culture systems using microorganisms generally have the following advantages: large 
population size, short generation time, amenability to high-throughput techniques, long-
term storage, environmental control, experimental tractability, and small genome size.  
Microorganisms routinely achieve extremely large population sizes under 
standard cell culture conditions (
! 
n >109 individuals/mL of culture for E. coli and 
! 
n >107 
individuals/mL of culture for S. cerevisiae) than those achievable for multicellular 
organisms. Large population sizes increase the efficiency of selection relative to drift 
(FALCONER 1989) making it tractable to detect small changes in fitness.  
The short generation time of microorganisms increases the number of generations 
that can be observed. The observation of evolutionary dynamics over long periods of the 
relevant time scale (i.e., generations) allows the detection of small fitness changes and a 
thorough exploration of the the genotype-phenotype landscape.  
Large population size and short generation time makes microorganisms suitable 
for culturing and assaying using high-throughput methods, including growth in 96-, 384-, 
and 1024-well plates. Because each well is an isolated environment, dense cell culture on 
plates increases sample sizes and the number of variables that may be tested.  
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In addition, standard, laboratory microorganism model systems can be maintained 
in long-term frozen storage, allowing samples from different generational time points 
during the evolution experiment to be directly compared.  
The environment of microorganisms - the variables determining the nature and 
intensity of selection - can be strictly controlled in the laboratory. The use of defined 
media allows the researcher to control resource availability and the presence of chemical 
challenges. The availability of both liquid and solid phase media allows the researcher to 
control the spatial structure of the environment. The use of incubators allows the 
researcher to control temperature, humidity, and gas mixture. Strict, well documented cell 
culture protocols have the additional advantage of controlling variables that have not 
been formally considered by the researcher. Environmental control removes uncertainty 
about the variables driving selection and explicit testing of evolutionary questions.  
Microorganims are also experimentally tractable. Depending on the species of 
microorganism, extensive experimental options for both phenotyping assays and direct 
hypothesis testing exist. For example, allelic conversion via homologous recombination 
in yeast can be used to test the phenotypic effect of a single nucleotide polymorphism 
(SNP) (GERKE et al. 2009). The experimental tools available for data collection and 
hypothesis testing in microorganisms are more extensive and more easily applied to large 
sample sets than those available in multicellular organisms. Among those experimental 
tools is the expansion of sequencing capacity with “next-generation” sequencing 
technology, which makes sequencing entire genomes to identify genetic variation 
between lines possible, especially for microorganisms due their small genome sizes. The 
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ability to experimentally confirm hypotheses, such as identifying the phenotypic effects 
of a SNP, is critical for understanding the molecular basis of genetic variation.     
  The paradigmatic laboratory selection experiment using microorganisms is 
Richard Lenski’s long-term experimental evolution in Escherichia coli. At last report, 
twelve lines of E. coli split from a single clone (i.e., all lines had the same genotype at the 
beginning of the experiment with variation introduced by mutation accumulation) were 
passaged through over 40,000 generations of asexual growth in glucose-limited medium 
for nearly twenty years (BARRICK et al. 2009).  
By way of comparison, a similar long-term selection in a multicelluar organism 
(Zea mays) has been operated at the University of Illinois since 1896. In that time, the 
divergent selection for kernel oil concentration on two lines has progressed through 
approximately 100 generations (LAURIE 2004). The Lenski selection experiment using E. 
coli has passed six times as many lines through 400 times as many generations in one-
fifth the time of a long-term selection in multicellular organisms (BARRICK et al. 2009; 
LAURIE 2004).   
The Lenski selection experiment, which has dominated both the literature and 
intellectual space of experimental evolution, illustrates the advantages of microorganism 
cell culture as a model system for laboratory selection experiments. The large population 
sizes and number of generations allowed very small fitness effects to be detected (DE 
VISSER and LENSKI 2002; OSTROWSKI et al. 2008). The number of generations allowed 
the dynamics of the evolutionary process to be observed, such as the slowing of the 
response to selection due to the number and effect size of available, potentially adaptive 
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mutations decreasing as the fitness landscape becomes more completely explored over 
evolutionary time (ARJAN et al. 1999; DE VISSER and LENSKI 2002). Samples from each 
line were taken and stored periodically, allowing samples from different generational 
time points in the evolutionary timeline to be directly compared (BLOUNT et al. 2008; DE 
VISSER and LENSKI 2002) and questions of historical contingency to be investigated 
(BLOUNT et al. 2008). This experiment has used the ability to control the E. coli 
environment to maintain constant cell culture conditions for nearly 20 years (BARRICK 
and LENSKI 2009) and to make defined changes in individual nutrients to examine the 
pleiotropic effects of adaptive mutations (OSTROWSKI et al. 2005b; OSTROWSKI et al. 
2008). The experimental tractability of E. coli has permitted the identification of 
molecular difference between the lines(WOODS et al. 2006), and the testing of those 
differences for their effects on fitness (OSTROWSKI et al. 2008). Most recently, the newest 
generation of high-throughput sequencing technology has begun to be applied to these 
lines to detect sequence changes during the evolutionary process (BARRICK and LENSKI 
2009; BARRICK et al. 2009; JEONG et al. 2009; OSTROWSKI et al. 2008; STUDIER et al. 
2009). The Lenski selection experiment has exploited many of the advantages of 
microorganisms for selection experiments to make wide-ranging contributions to the 
study of evolution. 
 Beyond the contributions of the literature devoted to this resource, the Lenski 
selection experiment stands as a rigorous, documented, empirical example of 
microevolution (i.e., changes in gene frequency due to selection, drift, mutation, and 
migration) in action, which alone has tremendous epistemological and rhetorical value.  
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The choice of E. coli as the model system and the design of the Lenski selection 
experiment impose certain constraints on the question that it can address. E. coli is an 
asexual, haploid making E. coli an unsuitable model system for the investigation of some 
of the most difficult issues in evolutionary biology. As an asexual organism, E. coli is not 
accommodated within the traditional textbook definition of speciation (FRASER et al. 
2009) proposed by Ernst Mayr, “groups of actually or potentially interbreeding natural 
populations, which are reproductively isolated from other such groups” (MAYR 1942), 
although others have argued that the definitional species concept problem is not 
significant (DE QUEIROZ 2007). E. coli is not a suitable model system to investigate 
macroevolution (i.e., speciation) under the most widely accepted species concepts.  
Asexuality also makes E. coli an unsuitable model system for the investigation of 
the relative advantages of asexual and sexual reproduction. Similarly, the fact that E. coli 
is a facultative haploid throughout its life cycle (except in the interval between 
completion of DNA replication and cytokinesis in mitosis) makes it an unsuitable model 
system to compare haploidy to diploidy – a distinct question from asexual/sexual 
comparisons as reproductive strategy does not necessarily constrain ploidy. The 
simplicity of E. coli is a strength, but it also prohibits the study these issues.      
 An interesting feature of the Lenski selection experiment is that no variables are 
manipulated in the selection. All twelve lines had the same ancestral genotype and were 
cultured in the same environment. Random effects, like mutation and experimental error, 
have introduced all variation between the lines. In this context, the number of lines under 
study is a limitation. In order to rigorously study the effects of such random processes, 
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one would prefer far more than twelve samples. Because this long-term evolution 
experiment did not use high-throughput cell culture methods, the number of samples that 
could be studied was limited by practical considerations. The decision to passage these 
lines through as many generations as possible dedicated experimental resources, which 
might have been used to explore environmental variables or expand the number of lines, 
to maximizing the number of generations that might have been used to explore 
environmental variables or expand the number of lines. In addition, using mutation 
accumulation to introduce genetic variation increases the time required for beneficial 
mutations to occur. The use of a chemical mutagen to introduce variation at the beginning 
of the experiment could reduce the time required for beneficial variant to arise in the 
population as well as permit the study of the evolutionary dynamics of highly variable 
populations. The Lenski selection experiment has been extremely productive, but has also 
been limited by the choice of model organism and the study design.  
Saccharomyces cerevisiae as a model system for natural genetic variation: As an 
alternative to the E. coli model system used in the Lenski selection experiment, the 
budding yeast S. cerevisiae is a potential model system for natural genetic variation that 
has the standard advantages of microorganism cell culture as well as a number of 
additional characteristics that are useful for the study of genetic variation.  
S. cerevisiae is a eukaryote making it a relevant model system for natural genetic 
variation in eukaryotes, due to the presence of eukaryotic specific features (e.g., 
mitochondria, etc.) that might be affected by genetic variation. S. cerevisiae can 
reproduce asexually or sexually, allowing the effects of reproductive strategy to be 
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investigated. S. cerevisiae, in the laboratory, can be maintained in either a haploid or a 
diploid state, allowing the effects of ploidy to be investigated independent of 
reproductive strategy. While questions regarding reproductive strategy (GRIMBERG and 
ZEYL 2005b; ZEYL et al. 2005a; ZEYL and BELL 1997), ploidy (PAQUIN and ADAMS 
1983a; PAQUIN and ADAMS 1983b; ZEYL 2004; ZEYL 2005; ZEYL et al. 2003), and 
eukaryotic features (TAYLOR et al. 2002; ZEYL et al. 2005a) were inaccessible in E. coli, 
they are active areas of research in S. cerevisiae.  
In addition, S. cerevisiae have many advantages that are relatively specific to 
yeast. Homologous recombination is efficient, which allows the phenotypic effects of 
SNPs to be tested by direct experimentation (DEUTSCHBAUER and DAVIS 2005; GERKE et 
al. 2009; GERKE et al. 2006). S. cerevisiae also enjoys extensive resource sharing in the 
research community. In addition to the reference genome (GOFFEAU et al. 1996), 
genomic sequences are available for several closely related species (CLIFTEN et al. 2003) 
and the phylogenetic relationships between species and strains have been described (LITI 
et al. 2009). Furthermore, resources like the yeast deletion collection, in which all non-
essential genes have been knocked-out (GIAEVER et al. 2002), has simplified discovery 
and genetic manipulation. The ability to identify causal molecular variation is combined 
with the community resources to allow that molecular variation to be understood in the 
context of the organism.   
Like E. coli, S. cerevisiae has been proposed as model system to investigate 
genetic variation and evolutionary dynamics (ZEYL 2000; ZEYL 2006). It has been used to 
study the effects of reproductive strategy (GRIMBERG and ZEYL 2005b; ZEYL and BELL 
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1997; ZEYL et al. 2005b), mutation effect size and frequency (ADAMS et al. 1985; 
GRIMBERG and ZEYL 2005b; TAYLOR et al. 2002; ZEYL and DEVISSER 2001; ZEYL et al. 
2001), ploidy(PAQUIN and ADAMS 1983a; PAQUIN and ADAMS 1983b; ZEYL 2004; ZEYL 
2005; ZEYL et al. 2003), mitochondrial defects (TAYLOR et al. 2002; ZEYL et al. 2005b), 
environment (GRIMBERG and ZEYL 2005b), and epistasis (PAQUIN and ADAMS 1983b; 
ZEYL et al. 2005b).  
In order to determine if laboratory selection of S. cerevisiae can be used as a 
model system for natural genetic variation, the characteristics of natural genetic variation 
in S. cerevisiae require description. The genetic basis of variation in sporulation 
efficiency in S. cerevisiae has been determined at the resolution of single nucleotides for 
several strains (DEUTSCHBAUER and DAVIS 2005; GERKE et al. 2009; GERKE et al. 2006), 
including a natural isolates (GERKE et al. 2009; GERKE et al. 2006). These studies have 
concluded that variation in sporulation efficiency is due to a small number of variants 
(three (DEUTSCHBAUER and DAVIS 2005) and four (GERKE et al. 2009)) at a small 
number of loci (five in total (DEUTSCHBAUER and DAVIS 2005; GERKE et al. 2009; 
GERKE et al. 2006)) with large additive effects (DEUTSCHBAUER and DAVIS 2005; GERKE 
et al. 2009; GERKE et al. 2006) and a smaller, but significant, contribution from epistatic 
interactions between loci (GERKE et al. 2009). Based on this single, well researched trait, 
natural genetic variation in S. cerevisiae can be described as being controlled by a few 
loci with large additive effects and some epistatic interactions between loci. 
One study estimated that a small number (n=2) of S. cerevisiae strains produced 
by 2000 generations of selection for growth in low-glucose media produced strains with 
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similar characteristics to the genetic variation seen in natural strains. They estimated that 
growth rate in the derived strains was controlled by only a few loci of large effect (ZEYL 
2005); supporting the use of S. cerevisiae strains derived from laboratory selection as a 
model system for the study of natural genetic variation. The small number of strains 
tested in this study (ZEYL 2005) underscores the need for cell culture and phenotyping 
techniques with increased throughput.   
Laboratory selection experiments with microorganisms generally use the 
spontaneous accumulation of mutations to introduce genetic variation, which is generally 
viewed as more natural than using mutagens. As mentioned above, this increases the 
number of generations needed for beneficial mutations to arise in the experimental 
population. An alternative method is to use chemical or radiation mutagenesis to 
introduce genetic variation, which would reduce the time needed to observe the 
phenotypic effects of introduced genetic variation in the experimental population, as well 
as allow the study of both isogenic and genetically variable populations. Although there 
may be concern that the known biases of different mutagens – it should be noted that 
naturally occurring mechanisms of mutation are also biased – may affect the distribution 
of mutation effect sizes, there is no theoretical reason to expect that mutagens have a 
different distribution of mutation effect sizes compared to normal sources of variation, 
only a greatly increased rate of mutation.   
Is the approach of artificially produced variation a viable method for the study of 
how genetic variation controls the complex phenotypic variation observed outside the 
laboratory? Does variation produced in the laboratory have similar genetic characteristics 
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to that observed outside the laboratory? Is the phenotype is controlled by a few genes of 
relatively large, not completely additive effects with evidence of many, small modifying 
variants? In experiments described in Chapter Two, I have used lines of the budding 
yeast S. cerevisiae derived by selection in the laboratory to address these questions and 
develop a quantitative, high-throughput phenotyping assay that should be applicable to 
most yeast cell culture environmental conditions.  A quantitative, high-throughput cell 
culture model of genetic variation would be an important tool in the addressing the 
complex relationship between genotype and phenotype in complex traits. 
MODEL SYSTEMS FOR THE STUDY OF HUMAN GENETIC VARIATION 
     Studying basic genetic mechanisms allows the researcher the freedom to select 
a model system ideally suited to the question. When the question is not a basic research 
one – how does genetic variation control phenotypic variation, but is directed toward 
understanding the causes of specific phenotypic variation in a specific organism – which 
genetic variants control the phenotypic variation of a specific trait, the researcher is 
generally restricted to pursuing the question in that organism. Understanding variation in 
maize crop qualities requires research in maize (LAURIE et al. 2004). Understanding 
variation in pig carcass quality requires research in pigs (HEUVEN et al. 2009). 
Understanding the genetic variation that affects both normal human variation and disease 
risk requires research using human subjects.  
While humans are the species of greatest practical interest to human researchers, 
they are a difficult experimental subject. Complementary approaches to the use of human 
subjects could be a useful in moving the field forward. Below, I will first discuss some of 
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the challenges in human genetics and how cell culture, and LCLs in particular, addresses 
these challenges, and then I will discuss considerations in the use of LCLs as a model 
system in the context of the existing literature.   
Challenges in human genetics: Homo sapiens is, at the same time, an extremely 
challenging species to research and the species in which we are most interested in 
studying. The difficulties with human studies have come under renewed focus recently as 
the results of genome-wide association studies continue to accumulate, but have so far 
failed to explain the majority of the genetic variation in common human diseases and 
traits. 
 Efforts to connect genetic variation with quantitative variation in phenotype via 
associations date back to at least 1953 (AIRD et al. 1953) – less than a decade after the 
discovery that DNA is the genetic molecule (AVERY et al. 1944) and the same year as the 
discovery of the structure of DNA (WATSON and CRICK 1953). The goal is to associate 
molecular variation in DNA with quantitative phenotypic variation. With the completion 
of the Human Genome Project in combination with high-density microarray technology, 
it became possible to genotype millions of SNPs simultaneously allowing the search for 
phenotype associated genetic variants across the entire genome without making any prior 
assumptions (BODMER and BONILLA 2008). The identification of molecular variation has 
become increasingly accessible, but associating it with phenotypic variation remains a 
significant challenge.  
 The technology allows an individual to be genotyped for millions of common 
SNPs (2007) (usually SNPs with a minor allele frequency > 5% (BODMER and BONILLA 
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2008)) rapidly and for relatively little cost. It is an ideal system for testing the common 
disease-common variant (CDCV) hypothesis. The CDCV hypothesis, as originally 
described by Reich and Lander, postulates that the genetic variation controlling the 
common versions of diseases, like diabetes, consists of common genetic variants at 
multiple loci, whose combined effects determine disease risk (REICH and LANDER 2001), 
and can be extended to other, non-disease quantitative traits. The Genome Wide 
Association Study (GWAS) design is an approach to genome-phenotype association 
studies based on this concept. 
 While genome-phenotype association studies have been enormously successful in 
identifying quantitative trait loci (QTL), they have not produced significant ability to 
predict phenotype from genotype for disease risk or any other human trait. At the level of 
the individual, the associated variants appear to have very small effects on phenotype 
(i.e., low penetrance). The odds ratios for most genome-phenotype association identified 
QTL are between 1.2 and 1.5 (BODMER and BONILLA 2008). As a result, the number of 
variants identified has, to some degree, supplanted predictive power as the metric by 
which success is measured. The largest genotype-phenotype association study group, the 
Wellcome Trust Case-Control Consortium (WTCCC) reports: 
The WTCCC has substantially increased the number of genes known to 
play a role in the development of some of our most common diseases and 
has to date identified approximately 90 new variants across all of the 
diseases analyzed. As well as confirming many of the known associations, 
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some 28 in total, the WTCCC has also identified many novel variants that 
affect susceptibility to disease. (CONSORTIUM 2010) 
It is this low predictive power that has precipitated the controversy over private 
genotyping services and slowed the progress toward personalized medicine. 
 Does the lack of predictive power accurately reflect the relationship of genetic 
variation in humans? The results of genome-phenotype association studies suggest that 
quantitative traits in humans are controlled by many variants of small effect. This, 
however, does not agree with experimentally confirmed quantitative trait nucleotides 
(QTN) in budding yeast, where the sporulation efficiency is controlled by a few QTN of 
relatively large effect (GERKE et al. 2009; GERKE et al. 2006). The dramatic differences 
may reflect real differences in the types of genetic variants that contribute to phenotypic 
variation between microorganims and multicellular organisms. On the other hand, the 
difference may reflect technical characteristics of the system under study. The 
complications inherent in research using human subjects make it difficult to clearly 
understand these issues.  
There are numerous human characteristics that make the species a difficult 
genetic system in which to work, such as the long developmental period (sexual maturity 
at 10-15 years of age depending on sex), long gestation period (38 weeks after 
conception), small generation size (one child per mother per generation), and inability to 
conduct directed crosses are either obvious or trivial and will not be discussed in detail. 
More significant complications for the study of human genetic variation include ethics, 
sample size, environmental variation, population stratification, and limited options for 
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direct experimentation. Below, I discuss each of these issues, before discussing the 
benefits  a complementary cell culture approach might provide. 
Ethics: In the United States of America’s National Institutes of Health Grants Policy 
Statement (Part II, Subpart A), the institutional review board evaluation of a human 
subject research program must meet ethical standards: 
The procedures to be used will minimize risks to subjects . . . Risks to 
subjects are reasonable in relation to expected benefits, if any, to subjects 
and the importance of the knowledge that may reasonably be expected to 
result. (HEALTH 2003) 
Researchers are required to both minimize the risk to human subjects and those risks 
must be relative to the expected benefit by both professional standards of ethics and 
funding agencies. 
Ethical standards complicate experiments in human subjects. The identification of 
diagnostic, genetic variants could beneficially inform treatment and prophylaxis. To use 
the example of personalized chemotherapeutic treatment of cancers, studying genetic 
variation in therapy response in human subjects would necessitate giving 
chemotherapeutics to otherwise healthy human subjects (MEUCCI et al. 2005; SHUKLA 
and DOLAN 2005; THOMAS et al. 2004). The requirement to balance potential benefit with 
risk poses a potentially severe, but necessary restriction on the number and extent of 
speculative and research programs that might be pursued, due to the potential for harm, 
relative to the probability of benefit.   
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 Similarly, understanding variation in susceptibility to infectious disease has the 
potential to impact the approaches taken to disease prevention and response. This 
information could inspire new approaches to infectious agents, like human 
immunodefiency virus (HIV), that have proven difficult targets for prophylaxis and 
treatment. 
 Cell culture methods are a potential solution to these ethical limitations. 
Dangerous treatments and conditions can ethically be tested in renewable cell culture 
(SHUKLA and DOLAN 2005), without a high expectation of beneficial outcome to balance 
the perceived risks. As opposed to the concern for subject safety in human studies, the 
major ethical consideration with cell culture is the handling of information. Individuals 
require protection from having the results of testing, phenotyping, and genotyping of their 
derivative cell lines being associated with their personal identity. Major collections of 
LCLs (such as the International HapMap Project collection at the Coriell Institute of 
Medical Research) are completely deidentified (THE INTERNATIONAL HAPMAP 2005).  
Thus, the ethical limitations restricting exposure of these cell lines to potentially 
dangerous chemicals or infectious agents, and association of their genotypes with 
observed phenotypic responses are not constrained to the same degree as human 
subjects.. 
Sample size: Sample size is a critical issue in quantitative genetics because it is the 
sample size that directly determines the power of the study to identify the locations of 
causal genetic variants.  There are two aspects of sample size – the number of individuals 
sampled (N) and the number of times an individual is sampled (n) – that affect studies of 
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genetic variation. Repeated sampling of an individual gives a more accurate 
quantification of the individual’s phenotype. Sampling more individuals gives a more 
accurate estimate of the distribution of phenotypic variation (FALCONER 1989). The 
increase in accuracy from more sampling allows smaller effects to be detected (BODMER 
and BONILLA 2008). Limited resources generally require any experimental design to 
balance these aspects of sample size against each other. The total number of assays 
available must be apportioned between the number of individuals included in the study 
and the number of times those individuals are assayed (the “N vs. n Problem”) in order to 
best support the goals of the research. The substantial costs and difficulties associated 
with recruiting and assaying human subjects (e.g., specialists required for phenotyping 
and limited supplies of willing subjects) imposes practical limitations on the amount of 
sampling that can be done.      
The International HapMap Project has provided a list of 3.1 million SNPs at 
which human subjects may easily be genotyped (2007). Microarrays are used routinely to 
genotype individuals at hundreds of thousands of SNPs. While these resources have 
fueled the enormous output of genotype-phenotype association studies, they have also 
fueled a need for ever-larger sample sizes. Genotype-phenotype association studies in 
humans have identified many QTL, but virtually all are of very small effect (odds ratios 
typically between 1.2 and 1.5 (BODMER and BONILLA 2008)). Novel QTL are likely to be 
within this range or below it, as a common variant with a significantly larger effect than 
these is unlikely to have escaped detection. Identifying QTL of decreasing effect size will 
require increasing sample sizes.  
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Additionally, the large number of hypotheses to be tested (each potential SNP-
phenotype association is tested as an independent hypothesis) imposes a substantial 
multiple testing penalty if large numbers of false positives are to be avoided. The P-
values required for genome-wide significance can approach 10-7 (BODMER and BONILLA 
2008). Increasing numbers of SNP-phenotype associations to test require increasing 
sample sizes. Therefore, the use of next-generation sequencing to identify all SNPs in 
individuals will actually exacerbate this problem.    
 While no system can eliminate the fundamental trade-off between more 
individuals and more replication, cell culture does address both problematic aspects of 
sample size. Renewable cell culture allows the same individuals to be resampled 
repeatedly for the same phenotype. In addition, the study of new phenotypes does not 
require collection of a new cohort, or obtaining informed consent for a new assay.  Cell 
lines can be maintained in long-term frozen storage and easily distributed from 
centralized repositories. This allows the number of individuals sampled to be 
cumulatively increased over time as cell lines are added, while allowing the same 
individual to be tested repeatedly.  
Environmental variation: A major complication of almost all research using human 
subjects is the lack of control over environmental variables. Control over life history prior 
to a study is non-existent and environmental control during a study is limited by 
practicality and the rate of subject compliance with study protocols, making it difficult to 
explicitly control environmental variables or to explicitly quantify their effects.  
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Stated simply, the total phenotypic variance for a trait in a population is composed 
of genetic variance and environmental variance: 
! 
"P
2 ="G
2 +"E
2 , 
where 
! 
"P
2  is the total phenotypic variance, 
! 
"G
2  is the genetic variance, and 
! 
"E
2  is the 
environmental variance (FALCONER 1989). In most studies of human genetic variation, 
only the phenotypic variance can be measured. Control over environmental variables is 
necessary to make comparisons between individuals that primarily reflect genetic 
differences. In the absence of control over environmental variables, statistical corrections 
are used to remove the effects of environmental covariates. Quantification of 
environmental variance allows the amount of phenotypic variance that can be explained 
by genetic variance to be defined. Monozygotic/dizygotic twins can be used to separate 
the genetic and environmental components, but are not frequent enough in the population 
to replace the use of non-twin individuals. Lack of control of environmental variables 
decreases a study’s power to detect genotype-phenotype associations.  
 In contrast to human subjects, the use of their derivative cell lines is subject to 
tight control of environmental variables. Different genotypes can be exposed to exactly 
the same conditions (e.g., media, incubator, and culturing practices). As a result, the 
contribution of environmental variance to the phenotypic differences between lines is 
expected to be small. The ability to control environmental variables and resample 
individuals allows the genetic and environmental components of the total phenotypic 
variance to be separated. Data on this topic, however, are generally not reported in the 
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literature, unless individual experiences do not conform to this expectation (CHOY et al. 
2008).  
Population structure: Population structure is the difference in allele frequencies between 
populations, due to deviation from the Hardy-Weinberg assumption of random mating, 
and is a potentially serious complication for any genotype-phenotype association study in 
natural populations. In case-control studies, unequal representation of populations in the 
case and control groups can cause spurious associations with the alleles at different 
frequencies in the two populations. The association is not genotype-phenotype, but 
genotype-population. Alternatively, the causal variant may be at lower frequency or be 
more poorly linked to a marker variant in one population, which could cause 
underestimation of the effect size associated with that marker and the failure to identify a 
true genotype-phenotype association. Population structure can cause both false positives 
and false negatives in these studies. 
In human studies, population structure takes on additional importance beyond its 
impact on the ability to correctly identify genotype-phenotype associations. When 
population structure is minimized, there is risk that research benefits may be population 
specific - depriving less studied populations of potential advances in diagnosis or 
treatment. In addition, there are potential sociopolitical implications of any discussion of 
human population differences. Population structure is both a technical complication and a 
heated topic in the public sphere.  
Because validation of genotype-phenotype associations is technically difficult 
(further discussion below), one practical standard for validation of a genotype-phenotype 
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association is replication between populations (CHANOCK et al. 2007). This practice 
increases the confidence that the observed association was not due to the specific 
population structure of the samples in the original study. Failure to replicate, however, 
does not necessarily indicate that a genotype-phenotype association is a false positive. 
The causal variant may be poorly linked to the marker in the second population. The 
causal variant may not be present in the second population. The success or failure of a 
genotype-phenotype association replication is not entirely dependent on the accuracy of 
that association.     
 Unlike many problems, increasing sample size does not resolve population 
structure issues. Current research suggests that genetic divergence between human 
populations is primarily dependent on geographic distance between individuals 
(NOVEMBRE et al. 2008). As a result, larger samples will have greater population 
structure. Larger sample sizes allow associations with smaller effects to be detected, but 
also increase the probability of spurious associations due to population structure.    
 Large association studies generally attempt to compensate for population 
structure. Cell culture methods have no specific, methodological advantages over human 
subjects when it comes to population structure. The ability to store lines do allow sample 
collections to be cumulatively built by adding samples over time from a constrained 
population. The accumulation of community knowledge, particularly genotypes, would 
allow the population structure of cell line samples to become progressively better defined 
over time.   
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Limited options for direct experimentation: Given an identified genotype-phenotype 
association, there are, currently, almost no options available to confirm the association by 
direct experimentation. A hypothetical case where the association leads to an effective 
disease prophylaxis or treatment may be considered practical evidence for the causal 
hypothesis, but it does not constitute a direct test. The lack of options for experimental 
confirmation has led to replication of genotype-phenotype associations between 
populations becoming the standard for genotype-phenotype association validation in 
humans (CHANOCK et al. 2007). This method of validation is not only susceptible to 
population structure (as discussed above), but is also vulnerable to the effects of 
statistical false negatives.   
The small effect size of genotype-phenotype associations places many of these 
associations just over the threshold of statistical significance. Therefore, it would be 
expected that a number of these associations, even if true positives would not be 
replicated as significant by chance even if the same population, but not the same 
individuals, was sampled again. True positives in one test may be false negatives in 
another test. While replication between populations is an accessible and useful approach 
to validation, direct, experimental confirmation is necessary to rigorously distinguish true 
associations from false positives without generating an excessive number of false 
negatives. 
In contrast to human subjects, cell culture does have options available for 
experimental confirmation of genotype-phenotype associations. LCLs can be 
transformed, permitting experiments using plasmids or short interfering RNA (siRNA). 
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Recently, Shukla et al. used siRNA in LCLs to confirm the hypothesis that CD44 
expression affects sensitivity to carboplatin, a hypothesis generated from genome-wide 
genotype-phenotype associations (SHUKLA et al. 2009). Although this experimental 
methodology may not be applicable to all phenotypes, this study demonstrates that 
experimental confirmation is practical in cell culture.   
It is also theoretically possible, due to the nature of cell culture phenotypes, to 
separate an untested set of samples to be used to confirm phenotypic predictions based on 
significant genotype-phenotype associations. Given the small average effect size and low 
predictive power of human QTL, this approach may not be practical and I am currently 
unaware of any applications of this method.      
Because cell culture is not constrained by the same ethical limits as human 
subjects, it is reasonable to suggest that methods to directly test genotype-phenotype 
associations will develop more rapidly for cell culture than human subjects in the future. 
Conclusion: The complications addressed above are common to natural populations, 
although not necessarily of the same degree (ethical limitations vary depending on the 
species, with humans being among the most restrictive), especially when compared to 
idealized model organisms in the laboratory, or domesticated organisms in controlled 
settings. The inescapable fact is that genetic variation of greatest interest to humans is 
human genetic variation. Regardless of the difficulty of the system, the study of human 
genetic variation will continue to be a high priority and essential avenue of research. Due 
to these limitations, however, the study of human genetic variation would benefit from 
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complementary cell culture systems models that might address some of the most serious 
limitations of human cohort studies. 
Cell culture as a model system for human genetic variation: The choice of cell lines 
to study and phenotypes to measure is of central importance to any study using cell 
culture to study human genetic variation. There are many available cell lines and 
collections with characteristics making each suitable for different applications. While the 
number of phenotypes that might conceivably be measured is effectively infinite, the 
number suited for measurement in cell culture is more limited. The applicability of the 
phenotypes chosen for measurement to cell culture may influence the reliability and 
applicability of experimental results. 
One of the major, perceived advantages of the use of cell culture for the study of 
human genetic variation is the ability to control environmental variables. This factor is a 
substantial balancing factor to counteract the weaknesses of cell culture as a human 
analog. Understanding the components of non-genetic variation in phenotype in cell 
culture is critical to investigating the sources of genetic variation in phenotype.  
First, we will discuss the available cell line collections that are available as 
experimental resources for the study of human genetic variation. Then, we will discuss 
phenotyping of these collections in other studies. Finally, we will discuss non-genetic 
variation in these cell lines.  
Available cell line collections: LCLs are a particularly attractive cell line for the study of 
human genetic variation. LCLs are derived from human B cells that have been 
immortalized by infection with Epstein-Barr Virus (EBV). LCLs grow as non-adherent 
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cell lines in liquid media making LCLs particularly easy to culture and manpulate. 
Because EBV immortalization of B cells is a relatively standard and straightforward 
procedure, LCLs have been routinely isolated from humans across many categories, such 
as ethnicity and disease, as a source of DNA and for phenotypic characterization. An 
LCL accurately represents the genotype of the individual from which it was derived. The 
LCL collections, therefore, represent the genetic variation in the human populations from 
which they are drawn, making LCL collections a compelling resource for the use of cell 
culture to investigate human genetic variation.    
Due to the presence of shared genotype data, LCL sets for the study of human 
genetic variation have primarily been drawn from two large, partially overlapping 
collections: the Foundation Jean Dausset-Centre d’Etude du Polymorphisme Humain 
(CEPH) (DAUSSET et al. 1990) and the International HapMap Project (2003; 2007). The 
LCLs in both were not collected to test genotype-phenotype associations, but to create a 
standard, renewable supply of genetic material for the identification and mapping of 
genetic variation in human populations (2003; 2007; DAUSSET et al. 1990; THE 
INTERNATIONAL HAPMAP 2005). The goal of the International HapMap Project (2003; 
THE INTERNATIONAL HAPMAP 2005) was to:  
…determine the common patterns of DNA sequence variation in the 
human genome, by characterizing sequence variants, their frequencies, 
and correlations between them, in DNA samples from populations with 
ancestry from parts of Africa, Asia and Europe. The project will thus 
provide tools that will allow the indirect association approach to be 
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applied readily to any functional candidate gene in the genome, to any 
region suggested by family-based linkage analysis, or ultimately to the 
whole genome for scans for disease risk factors. (2003) 
It must be noted that the utility of this goal has been questioned (BODMER and BONILLA 
2008; TERWILLIGER and HIEKKALINNA 2006). These collections were designed to 
represent diversity of human genomic sequence variation.  
Because the current use, testing genotype-phenotype associations, was not the 
original purpose of these collections, the suitability of these collections for this 
application should be assessed. Their utility will be strongly influenced by the collection 
design.    
Despite similar goals, these collections have different designs (2003; 2007; 
DAUSSET et al. 1990; THE INTERNATIONAL HAPMAP 2005), reflecting the technology 
available at the time the projects were implemented. The overall CEPH collection is an 
extremely diverse set of cell lines that includes all 1050 individuals from 51 populations 
comprising the Human Genome Diversity Cell Line Panel of the Human Genome 
Diversity Project (CANN et al. 2002). A subset of the larger CEPH collection, however, is 
generally used for testing genotype-phenotype associations. This subset normally consists 
of LCLs derived from complete, or nearly complete, three-generation pedigrees of Utah 
residents with large sibships in the final generation (CEPH-UT). These individuals are 
considered to representative of Americans of European-origin populations (MEUCCI et al. 
2005), as well as Northern (BAUCHET et al. 2007; LAO et al. 2008; MEUCCI et al. 2005; 
SMITH et al. 2006) and Western European populations (BAUCHET et al. 2007; HE et al. 
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2009; LAO et al. 2008; MEUCCI et al. 2005). At the time of collection (circa 1980 
(DAUSSET et al. 1990)), neither the human reference genome nor modern genotyping 
technologies were available. Mapping genetic variation required linkage. Linkage 
required pedigrees; hence, the pedigree structure of the collection. Publicly available 
genotypes exist for many CEPH-UT LCLs, but, because most of these data were 
generated by individual research groups, there is a great deal of variation in the type of 
data (e.g., microsatellite, SNP, etc.), quality, density, and number of polymorphisms. 
 A subset of the CEPH-UT LCLs are central to the International HapMap Project 
collection, but with a different structure. The International HapMap Project collection 
contains 270 individuals. Ninety individuals, representing 30 father-mother-adult child 
trios, come from the CEPH-UT collection (CEU). The International HapMap Project 
collection also contains LCLs from individuals in other world populations including 90 
Yoruban in Ibadan, Nigeria (YRI) individuals (30 father-mother-adult child trios), 45 
unrelated Han Chinese in Beijing, China (CHB) individuals, and 45 Japanese in Tokyo, 
Japan (JPT) individuals (2003; 2007; THE INTERNATIONAL HAPMAP 2005). Using 
microarray-based genotyping, these 270 individuals have been uniformly genotyped to 
generate a map of 3.1 million single nucleotide polymorphisms (SNPs). The density of 
SNPs genotypes increases the resolution of QTL mapping and the probability that a 
marker SNP will be tightly linked to a causal variant (limit case is the marker SNP being 
the causal variant) increasing the marker’s associated effect size and with it the 
probability of detection. The number of potential genotype-phenotype associations 
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available for testing, however, imposes substantial multiple hypothesis testing penalties 
(BODMER and BONILLA 2008).   
An estimate of the proportion of the total phenotypic variance that can be 
explained by genetic variance is critical for interpreting the results of GWA studies. The 
additive component of the genetic variance is of particular interest, as GWA studies must 
assume additive genetic models for genotype-phenotype associations (i.e., how much of 
the additive genetic variance is explained by significant QTL?). Genome-wide testing of 
interactions between pairs of loci is not possible for any reasonable sample size.  
The additive genetic component of phenotypic variance is estimated by the 
narrow-sense heritability (h2) of the phenotype within a population (FALCONER 1989). 
Methods for estimating narrow-sense heritability are based on estimating how well the 
mean progeny phenotypic value is predicted by the parental phenotype (FALCONER 1989; 
LYNCH and WALSH 1998), for example by regressing the mean progeny phenotypic 
values on the mid-parent phenotypic values (the mean phenotypic value of the two 
parents). The mean progeny phenotypic value will be estimated more accurately as the 
number of progeny measurements increase, increasing the confidence in narrow-sense 
heritability estimates.  
The three-generation pedigree structure of the CEPH-UT collection is informative 
for narrow-sense heritability analysis. Each pedigree contains up to three midparent-mean 
progeny comparisons (not all grandparents are present in every pedigree), two first 
generation-second generation comparisons and one second generation-third generation 
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comparison. In addition, the large sibships in the third generation allow the mean progeny 
phenotypic value for that generation to be estimated with increased accuracy. 
In the International HapMap Project collection, the narrow-sense heritability of a 
phenotype is estimated from thirty CEU and thirty YRI father-mother-adult child trios, 
which are useful for SNP quality control via Mendelian inheritance. The mean progeny 
phenotypic value is estimated from the phenotypic value of a single individual. The error 
inherent in the individual estimates of means, is accommodated by the number of trios 
assayed; but, in general, the narrow-sense heritability estimates from trios have more 
associated error and less confidence than those from large sibships (LYNCH and WALSH 
1998).  
The CEPH-UT collection minimizes complications due to population structure by 
sampling from a single population (BAUCHET et al. 2007; HE et al. 2009; LAO et al. 2008; 
MEUCCI et al. 2005; SMITH et al. 2006). In contrast, the International HapMap Project 
collection contains samples from four identified populations (2003; 2007; THE 
INTERNATIONAL HAPMAP 2005). Population structure is a potential, major complication 
if all samples are pooled in order to increase sample size. On the other hand, the 
population substructure in the International HapMap Project collection is explicitly 
defined and can be included in all analyses. Furthermore, inter-population comparisons 
are possible within the International HapMap Project collection, although the individual 
population sample sizes are rather small (
! 
45 " n " 90) (2003; 2007; THE INTERNATIONAL 
HAPMAP 2005). 
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The selection of a sample set will strongly influence the limitations of a research 
study. Based on the above characteristics, the CEPH-UT collection is suited for studies 
attempting to define the components of phenotypic variance (e.g., narrow-sense 
heritability estimates) or testing genotype-phenotype associations for a limited number of 
phenotypes of great interest (e.g., chemotherapeutic cytotoxicity). The International 
HapMap Project collection is suited for studies requiring higher resolution QTL (e.g., 
distinguishing cis- and trans-expression QTL [eQTL]) or testing a large number of 
phenotypes simultaneously (e.g., genome-wide transcript abundance) where a substantial 
per phenotype false negative rate can be tolerated, in order to reasonably constrain the 
false positive rate.  
A 2008 study by Choy et al. that examined genetic variation in the International 
HapMap Project LCL lines for transcript abundance and drug response (CHOY et al. 
2008) provides an example of the importance of sample selection. This study reported 
poor repeatability between replicate samples (discussed further below) and failed to 
identify any drug response QTL (CHOY et al. 2008). In particular, they failed to replicate 
the genotype-phenotype association from a 2004 study by Watters et al. (WATTERS et al. 
2004) for 5-fluorouracil cytotoxicity (5-FOA) (CHOY et al. 2008; WATTERS et al. 2004).  
The failure to replicate may be explained by the poor repeatability and the 
different number of replicates samples in Choy et al. (n=2) (CHOY et al. 2008) and 
Watters et al. (n=12) (WATTERS et al. 2004). The two studies used different sets of LCLs. 
Choy et al. used the International HapMap Project collection, with all populations 
combined (CHOY et al. 2008). The LCL panel of Watters et al. was primarily drawn from 
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the CEPH-UT collection (WATTERS et al. 2004). Population structure may have 
contributed to the discrepancy. Furthermore, Choy et al. lacked the power to detect 
significant narrow-sense heritability for cell physiology phenotypes when the additive 
genetic variance accounted for less than half of the total phenotypic variance (significant 
h2>0.5) (CHOY et al. 2008). Watters et al. could detect significant narrow-sense 
heritabilities down to h2=0.21 (WATTERS et al. 2004). While Choy et al. are pessimistic 
about the use of LCLs as an experimental system for the study of human genetics (CHOY 
et al. 2008), their results were substantially affected by technical difficulties and the 
choice of a sample set that was not suited to their research goals. 
Not only does type of cell line chosen affect the utility of cell culture as a model 
system for human genetic variation, but the design of the sample set is also critical.  
Phenotypes studied in lymphoblastoid cell lines: Based on paper publications, the use of 
LCLs as a model system for human genetic variation is increasing (2 papers in 2003, 9 in 
2009), likely due to the International HapMap Project. The phenotypes most frequently 
tested for genotype-phenotype association are transcript abundance (BERGEN et al. 2007; 
CHEUNG et al. 2003; CHEUNG and EWENS 2006; CHEUNG et al. 2005; CHOY et al. 2008; 
CORREA and CHEUNG 2004; DEUTSCH 2005; DUAN et al. 2007; DUAN et al. 2009; FORD 
et al. 2001; HUANG et al. 2007a; HUANG et al. 2008b; JEN and CHEUNG 2003; LI et al. 
2008; LI et al. 2009; MONKS et al. 2004; MORLEY et al. 2004; PRICE et al. 2008; 
SMIRNOV et al. 2009; SPIELMAN et al. 2007; STRANGER et al. 2007; WANG et al. 2009; 
ZHANG et al. 2009), response to chemotherapeutics (BLEIBEL et al. 2009; CHOY et al. 
2008; CLOOS et al. 1999; DOLAN et al. 2004; DUAN et al. 2007; HARTFORD et al. 2009; 
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HUANG et al. 2007a; HUANG et al. 2008a; HUANG et al. 2008b; HUANG et al. 2007b; 
HUANG et al. 2007c; LI et al. 2008; LI et al. 2009; SHUKLA et al. 2008; SHUKLA et al. 
2009; WATTERS et al. 2004; WEI et al. 1996), and response to ionizing radiation (CORREA 
and CHEUNG 2004; FORD et al. 2001; HARRIS et al. 2005; JEN and CHEUNG 2003; 
SMIRNOV et al. 2009); but LCLs have also been used to study a variety of phenotypes 
including alternative splicing (DUAN et al. 2009; KWAN et al. 2007; ZHANG et al. 2009), 
infection susceptibility (LOEUILLET et al. 2008), ion transport (SCHORK et al. 2002), 
metabolism (ATLAS et al. 1976; DUAN et al. 2009; SCHORK et al. 2002), and micro RNAs 
(WANG et al. 2009). These studies draw on both the CEPH-UT and HapMap collections.  
This history does not necessarily indicate widespread community interest in LCLs 
as a model system. Only a few research groups produce many of the studies (e.g., Cheung 
(CHEUNG et al. 2003; CHEUNG and EWENS 2006; CHEUNG et al. 2005; CORREA and 
CHEUNG 2004; JEN and CHEUNG 2003; MORLEY et al. 2004; PRICE et al. 2008; SMIRNOV 
et al. 2009; SPIELMAN et al. 2007), Dolan (BLEIBEL et al. 2009; DOLAN et al. 2004; 
DUAN et al. 2007; DUAN et al. 2009; HARTFORD et al. 2009; HUANG et al. 2007a; HUANG 
et al. 2008a; HUANG et al. 2008b; HUANG et al. 2007b; HUANG et al. 2007c; SHUKLA et 
al. 2008; SHUKLA et al. 2009; ZHANG et al. 2009), and the Mayo Clinic (HARRIS et al. 
2005; LI et al. 2008; LI et al. 2009; WANG et al. 2009)). In addition, multiple publications 
from a group may exploit overlapping data sets. For example, 111 of 143 samples in a 
2006 study from the Cheung group overlap (CHEUNG and EWENS 2006) with the 355 
samples of a 2004 study (MORLEY et al. 2004) and 56 samples overlap with the 100 
samples of a 2005 study (CHEUNG et al. 2005) and the 208 samples of a 2007 study 
 36 
(SPIELMAN et al. 2007); the 2005 study (CHEUNG et al. 2005) shares 71 of 100 samples 
with the 2007 study (SPIELMAN et al. 2007). Paper publication rates are not necessarily 
indicative of the amount of community interest or of the amount of work that has been 
done.   
 Because LCLs represent a single cell type and have been immortalized, it is 
relevant to question the applicability of LCL phenotypes to studies of human phenotypes 
(SHUKLA and DOLAN 2005). For studies interested in understanding the relationship of 
genetic variation to phenotypic variation, a relevant phenotype is one where genetic 
variance was a major component of the total phenotypic variance (discussed in detail 
below). For studies primarily interested in extracting clinically useful biomedical 
information from genetic variation, phenotypic relevance is defined by how well LCL 
phenotypes, and associated genotypes, translate to human phenotypes. 
 While primary tissue disease models are certainly more specific to the condition 
of interest (GRUNDBERG et al. 2009), LCLs are significantly more accessible. Current 
research indicates that eQTL identified in LCLs often co-occur in primary tissue samples 
(BULLAUGHEY et al. 2009). A 2008 study examining genetic variation in HIV-1 
susceptibility found that the LCL genotype-phenotype association was also associated 
with disease progression in one of two cohorts of HIV-1 infected human subjects 
(LOEUILLET et al. 2008). Although LCL phenotypes may not translate directly to human 
phenotypes, the variety and number of LCL phenotypes available for study suggests that 
LCLs are a useful complement to human subjects, especially as a platform for discovery 
and hypothesis development.    
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 An under-explored class of phenotypes is localized protein expression levels. 
Despite proteins being the primary functional unit of the cell and the ready access to 
monoclonal antibodies specific to B cell surface antigens, few LCL studies of human 
genetic variation have quantitated protein expression (CHOY et al. 2008; LOEUILLET et al. 
2008). Instead of being treated as a quantitative trait, immunological markers have been 
used to assess variation in B cell sub-type between lines (CHOY et al. 2008). While not as 
amenable to high-throughput analysis as transcript abundance, localized protein 
expression levels may integrate multiple sources of variation during localized expression 
(e.g., transcription, translation, post-translational modification, transport, etc.) with the 
potential to better represent how genetic variation generates phenotypic variation in 
humans.        
Non-Genetic variance in lymphoblastoid cell lines: The contribution of non-genetic 
variance to the total phenotypic variance in LCLs is relevant to the study of genotype-
phenotype associations, regardless of the biomedical importance of the phenotype. This 
topic, however, is not commonly addressed in the literature, and, then, only when results 
do not appear to conform to the expected strict control of environmental variance (CHOY 
et al. 2008).  
There are a number of potential sources of non-genetic variance during the 
phenotyping of LCLs. Although some sources will be specific to individual phenotyping 
assays, the general points at which non-genetic variation might be introduced are 
constrained by the cell culture process. The LCL specific components of non-genetic 
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variance, discussed in greater detail below, are the sampling/immortalization variance, 
freeze/thaw variance, cell culture variance, and assay variance.     
Sampling/Immortalization Variance: The sampling and immortalization process that 
establishes defined LCL stocks is not only the source of genetic variation between LCLs 
(samples are taken from different subjects with different genotypes), but it is also a 
potential source of non-genetic variation. Some sources are non-random in respect to that 
individual subject, such as life history and age. The CEPH collection, however, has 
limited information (only age at sampling, sex, and pedigree position) that would allow 
the impact of these variables on phenotypic variation to be understood. 
Sampling/immortalizaton variation will cause non-genetic differences between lines that 
cannot be distinguished from the genetic component of variation without samples that can 
be used to quantify the contribution of sampling/immortalizaton variance to phenotypic 
differences between lines.   
Unlike additional sources of variation discussed below, both the non-random and 
random variation introduced during the sampling and immortalization processes become 
fixed variation between lines during this process. While the non-genetic variation 
introduced during the collection and immortalization process will contribute to 
phenotypic variation between lines, it does not contribute to variation within a line. 
Random variation within a sample is converted into systematic variation between lines. 
 Because this variation is non-genetic, it will reduce the power of a study to 
identify genotype-phenotype associations.  
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Freezing, thawing, and cell culture variance: Following the establishment of LCLs, there 
are additional sources of variation, once the LCLs have entered the individual research 
lab. To reduce costs and insure consistency within samples by avoiding repeatedly 
ordering LCLs from a cell line repository, standard procedure is to freeze multiple 
aliquots from individual LCLs that can be stored and thawed individually as experiments 
require. The steps of freezing, thawing, and cell culture that necessarily fill the 
methodological space between the sampling and immortalization process and the 
phenotyping assay are all potential sources of non-genetic variation. 
Non-genetic variation within lines will affect the reliability of any phenotypic 
measurements made. There has, however only been one study, to date, that has attempted 
explicitly examined this question. The authors of this study concluded that LCLs are an 
unreliable experimental resource (CHOY et al. 2008). The reported correlation between 
two independent aliquots for drug response to three drugs and RNA transcript abundance 
was both low and inconsistent (ρ=0.39-0.82). Variation in response between aliquots was 
equal to the variation between drug treatments (CHOY et al. 2008). The methods used in 
this study, however, make it unclear whether the low correlation between aliquots was 
due to inherent variability in LCLs or the particular methods used. 
Non-genetic variation between and within LCLs will obscure the relationship 
between genetic variation and phenotypic variation by reducing the accuracy of 
phenotypic measurements.  
Assay variance: The final source of non-genetic variation in LCLs is variation in the 
phenotype assays. Random and non-random effects can affect the precision of the assays. 
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Random effects include sampling variance in the assay and variation introduced by the 
experimentalist. Non-random effects include one-time errors, systematic differences 
between equipment used at different locations, and tendencies of different 
experimentalists conducting the same assay. 
Although assay variation in phenotyping assays is not a major contributor to 
phenotypic variation, this variation is independent of sources of variation discussed above 
and will further reduce the ability to associate genetic variation with phenotypic variation 
by reducing the accuracy of phenotypic measurements. Sufficient sampling can control 
the random effects. Experimental consistency, including use of the same reagents, single 
experimentalists, and the same equipment, can control the non-random effects. A recent 
study suggests that variation between technical replicates is not a major contributor to 
overall phenotypic variation (CHOY et al. 2008). 
Conclusion: The numerous challenges facing human genetics require the use of multiple, 
complementary approaches, and that those approaches represent real human genetic 
variation. Cell culture as a model system for human genetic variation has obvious 
weakness, but also has strengths that address some of the challenges of studying human 
subjects. LCLs are a particularly attractive model system for the study of human genetic 
variation because they represent human genetic variation, can have a large sample sizes, 
are easy to use, and are publicly available. My efforts to test the utility of LCLs as a 
complementary resource for the study of human genetic variation are described in 
Chapter Three.  
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CHAPTER TWO: COMPLEX GENETIC CHANGES IN STRAINS OF 
SACCHAROMYCES CEREVISIAE DERIVED BY SELECTION IN THE 
LABORATORY 
STATEMENT OF EFFORT AND ATTRIBUTION 
 The work presented in this chapter was originally published in the July 2007 issue 
of Genetics (177:1) as “Complex genetic changes in strains of Saccharomyces cerevisiae 
derived by selection in the laboratory” authored by Joshua T. Witten, Christina T.L. 
Chen, and Barak A. Cohen (WITTEN et al. 2007). Witten and Cohen designed the 
experiments, analyzed the data, and wrote the paper. Witten conducted the experiments. 
Chen conducted the analysis of variance on transcript abundance data.   
Copyright for this article is held by Genetics. Per Genetics copyright policy, this 
article may be reprinted in this dissertation, in its entirety, by the first author without 
written permission from Genetics.  
ABSTRACT 
Selection of model organisms in the laboratory has the potential to generate useful 
substrates for testing evolutionary theories.  These studies generally employ relatively 
long term selections with weak selective pressures to allow the accumulation of multiple 
adaptations. In contrast to this approach, we analyzed two strains of Saccharomyces 
cerevisiae that were selected for resistance to multiple stress challenges by a rapid 
selection scheme to test whether the variation between rapidly selected strains might also 
be useful in evolutionary studies.  We found that resistance to oxidative stress is a 
multigene trait in these strains.  Both derived strains possess the same major effect 
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adaptations to oxidative stress, but have distinct modifiers of the phenotype.  Similarly, 
both derived strains have altered their global transcriptional responses to oxidative stress 
in similar ways, but do have at least some distinct differences in transcriptional 
regulation.  We conclude that short term laboratory selections can generate complex 
genetic variation that may be a useful substrate for testing evolutionary theories. 
INTRODUCTION 
 Selections of model organisms in the laboratory are a useful complement to the 
study of natural variation in wild populations aimed at understanding principles of 
adaptive evolution.  Indeed, selections in the laboratory have previously been used to 
address important questions in evolutionary biology such as the existence of transgressive 
segregation (CASTLE 1951), the fitness effects of mutation (DE VISSER and LENSKI 2002; 
DE VISSER and ROZEN 2006; ESTES et al. 2004; HEGRENESS et al. 2006; KASSEN and 
BATAILLON 2006; LENSKI and TRAVISANO 1994; OSTROWSKI et al. 2005; SILANDER et al. 
2007), the role of genome rearrangements (DUNHAM et al. 2002), the effects of haploidy 
and diploidy (PAQUIN and ADAMS 1983a; ZEYL et al. 2003), the frequency of parallelism 
versus convergence (BUCKLING et al. 2003; COHAN and HOFFMANN 1986; COOPER et al. 
2003; HERRING et al. 2006; LENSKI and TRAVISANO 1994), the effects of asexual and 
sexual lifestyles (DE VISSER and ROZEN 2006; GRIMBERG and ZEYL 2005), and 
evolutionary change in gene expression (COOPER et al. 2003; FEREA et al. 1999; PELOSI 
et al. 2006; RIEHLE et al. 2003; RIFKIN et al. 2005).  Microorganisms are particularly 
attractive for these kinds of experiments due to the ease of culturing, control of 
environment, short generation time, and genetic tractability (ESTES et al. 2004; ZEYL 
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2000). Several studies have employed the yeast, Saccharomyces cerevisiae as a model for 
natural selection (DUNHAM et al. 2002; FEREA et al. 1999; GRIMBERG and ZEYL 2005; 
PAQUIN and ADAMS 1983a; PAQUIN and ADAMS 1983b; ZEYL et al. 2005; ZEYL et al. 
2001; ZEYL et al. 2003).  
One goal of these studies is to generate diversity that resembles, in some respects, 
the diversity found in natural populations.  Most phenotypic variation in nature is 
continuous and results from the segregation of alleles at multiple genetic loci, as well as 
from environmental effects. Beneficial alleles that confer a fitness advantage tend to 
increase in frequency and eventually fix in natural populations.  One major question is 
how many different combinations of alleles can be beneficial when a continuously 
varying trait comes under selection.  The relative contribution of structural and regulatory 
changes to adaptive evolution is also unknown. Genetic diversity generated from 
selections in the laboratory could be a useful tool for addressing these questions. 
 Genetic diversity generated from selections in the laboratory must be sufficiently 
complex in order to serve as a useful model of natural variation.  Intuitively, strong 
selections applied over short intervals are expected to produce single genetic changes of 
large effect that show simple monogenic inheritance, while weak selections applied over 
long periods of time are expected to produce multiple genetic changes of smaller effect 
that show complex inheritance (ELENA and LENSKI 2003). Empirically, weak selection 
regimes applied over long periods of time do allow the accumulation of multiple genetic 
changes with smaller effect sizes (DE VISSER and LENSKI 2002; LENSKI and TRAVISANO 
1994), and may better mimic natural variation.  The practical difficulty, however, of 
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continually and accurately maintaining multiple lines over the course of long term 
selections presents a barrier to performing certain types of experiments.  For example, to 
address mechanisms of convergence, it is necessary to maintain a very large number of 
independent lines over a long period of time, an experiment that is not currently practical 
in many systems (CASTLE 1951; LAURIE et al. 2004; LENSKI and TRAVISANO 1994; 
PAQUIN and ADAMS 1983a; PAQUIN and ADAMS 1983b).  This barrier might be overcome 
if stronger selections conducted over shorter periods of time can generate comparable 
genetic variation. 
As a complement to existing studies on yeast selections, we analyzed two strains 
from a selection in the laboratory designed to produce stress resistant clones for industrial 
purposes (CAKAR et al. 2005).  We sought to determine whether the relatively short 
duration of selection, the stringency of selection, and the use of a mutagen would bias the 
selection toward less genetically complex phenotypes, or whether such selections could 
produce strains with genetically complex traits that can be used to study adaptive 
evolution. 
 MATERIALS AND METHODS 
Strains, plasmids, and primers: Strains were cultured on solid yeast extract-peptone-
dextrose (YPD) medium or in liquid synthetic complete (SC) medium unless otherwise 
noted.   
The haploid S. cerevisiae strain CEN.PK 113-14A (MATa, MAL2-8c, SUC2) was 
used as the ancestor for the selections performed.  JWY100 is a clonal isolate of the 
MATα CEN.PK 113-14A haploid with the MET14 locus replaced by the kanamycin 
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resistance cassette (KanMX4) (GOLDSTEIN and MCCUSKER 1999) (amplified using 
primers 5’-ACGACGCCTTGGCAATGTAGCA-3’ and 5’-
GCAAAGCACGCCTCAAAATCTGGT-3’) from the met14Δ0 homozygous diploid 
from the systematic deletion collection (GIAEVER et al. 2002).  All transformations were 
performed as described in (GIETZ and WOODS 2002). 
Strain JWY101 is a clonal isolate of population H1T2N3 that has been transformed 
with a plasmid containing a nourseothricin (Nat) resistance cassette (GOLDSTEIN and 
MCCUSKER 1999) (Mark Johnston, Washington University School of Medicine, St. 
Louis, MO).  Strain JWY102 is a clonal isolate of population H1H2 that has been 
transformed with a plasmid containing a Nat resistance cassette.  In order to cross 
JWY101 and JWY102 we transformed the same clonal isolate of H1H2 as JWY102 with a 
plasmid containing both a Kan resistance cassette and the HO locus (John McCusker, 
Duke University, Durham, NC).  We used dual selection (geneticin and Nat) to select 
hybrid diploids from all crosses.   
Quantitative 96-well growth assay: We arrayed samples in 96-well plate format.  Two 
days prior to the assay, frozen samples were pinned onto solid YPD and incubated 
overnight at 30°C.  One day prior to the assay, single colonies were suspended in 500µL 
SC medium and incubated overnight at 30°C with shaking at 325rpm in deep-well 96-
well plates (Corning #3960).  We diluted 10µL of each sample in 490µL fresh SC 
medium and incubated at 30°C for 5 hours with shaking at 325rpm. 
After incubation, all samples were diluted in SC medium to 5.26x106 cells /mL in 
190µL total volume.  We divided each dilute culture into two 95µL samples in adjacent 
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wells of a 96-well microtiter plate (Corning #3595).  We added 5µL of either SC medium 
or 20mM H2O2 in SC (1mM H2O2 final) to each well.  Samples were incubated on a 
BioTek Synergy HT plate reader (Winooski, VT) for 20 hours at 30°C with shaking at 
approximately 1200rpm (level 3) for 20 seconds every four minutes.  The reader 
measured the cell density (absorbance at 600 nm: A600) immediately after every shaking 
period (299 total measurements). 
In order to calculate the growth constant for a sample, we Log2 transformed the 
A600 measurements and analytically determined the best fit least squares linear regression 
through all time points where -2.5 < Log2(A600) < -2.  The best fit least squares linear 
regression assumes the form bmxy += , where y is Log2(A600), x is time in seconds, b is 
the intercept, and m is the growth constant in log2(OD600)•s-1 units. 
Biometric analysis of tetrads: Spores were identified as having the phenotype of either 
the ancestral parent (JWY100), the derived parent (JWY101 or JWY102), or neither 
using the z-test (α=0.05) to determine from which phenotypic distribution an individual 
spore measurement was drawn.  Tetrads with two spores with the ancestral phenotype 
and two with the derived phenotype were identified as having 2:2 segregation.  The 
probability of a false positive (a tetrad with 2:2 segregation identified as not having 2:2 
segregation due to mislabeling of a spore), if the phenotype is monogenic and all tetrads 
segregate 2:2, can be determined from the binomial distribution 
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where p=0.05 is the probability of incorrectly calling a spore derived from a parental 
distribution as being distinct, q=0.95 is the probability of correctly calling the spore, and 
N=4 is the number of spores in the tetrad.  This analysis assumes that the parental 
distributions are Gaussian and the probability of sampling one parent sample from the 
other parental distribution is infinitesimal (JWY100 vs. JWY101: P=1.83x10-44; JWY100 
vs. JWY102: P=6.38x10-48; two-tailed student’s t-test).  If any one of the four spores is 
incorrectly labeled, then the tetrad will also be incorrectly labeled.  Therefore, the 
probability, PI, of incorrectly labeling a tetrad that segregates 2:2 is  
 )0(1 =!= xPPI , 
 where P(x=0) is the probability of making no incorrect calls on the spores in a tetrad.  
The expected number of incorrect calls, if every tetrad is segregating 2:2, is  
 nPnE I=)( , 
where n is the number of tetrads assayed. 
 Additionally, we determined the distribution of growth constants in H2O2 for eight 
replicates of each spore from a single tetrad from the JWY100 x JWY101 and JWY100 x 
JWY102 crosses as above.  We ranked the spores in a tetrad by their average growth 
constant in H2O2 and defined 2:2 segregation as the null hypotheses where 
 !" µµµ ==DH :0  
 !" µµµ ==AH :
'
0 , 
where µ  is the mean growth constant (A, ancestral parent; D, derived parent; α, highest 
ranked spore; β, second ranked spore; γ, third ranked spore; δ, lowest ranked spore).  
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Deviation from either null hypothesis indicates non-2:2 segregation.  We used a single-
factor analysis of variance (ANOVA) (α=0.05) to test the 2:2 segregation null 
hypotheses. 
 We calculated the segregational variance ( 2s! ) as described elsewhere (LYNCH 
and WALSH 1998).  Broad sense heritability (H2) for each cross was calculated as 
described elsewhere (MOORE and MCCABE 2006), 
 2
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where 2e!  is the variance due to environment, which is equal to the pooled variance of 
the parents (LYNCH and WALSH 1998).  
 To test for epistasis, we used an adaptation, from (BREM and KRUGLYAK 2005), 
of the Δ–statistic of (LYNCH and WALSH 1998).     
Transcription profiling: Three clones each of JWY100, JWY101, and JWY102 were 
suspended in 3mL SC medium and incubated overnight at 30°C with shaking at 325rpm.  
On the next day, we diluted the 3mL overnight cultures in 125mL fresh SC medium.  We 
incubated these cultures at 30°C for six hours at 325rpm until all cultures were in 
exponential-phase growth.  The cell density of each culture was measured on an 
Eppendorf BioPhotometer (Westbury, NY).  We diluted each culture to 8x106 cells/mL in 
SC medium (50mL total volume) twice.  Either 7µL SC medium or 8.8M H2O2 (1.2mM 
H2O2 final) was added to each replicate.  Both treatments were incubated at 30°C for one 
hour at 325rpm. 
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RNA extractions, sample labeling, microarray hybridizations, and mixed-model 
ANOVA were performed as described by (GERKE et al. 2006) with the following 
changes. 
The first mixed ANOVA model removes the genomewide effects of strain and 
condition on transcript levels, 
mijkijijkjiijkm SCACSYLog )()(2 )( !µ +++++= , 
where ijkmY  is the median of ratios for each spot, µ  is the baseline expression at each spot 
independent of all other factors, iS  is the average strain main effect, jC  is the average 
condition main effect, )(ijkA  is the average array main effect, ijSC  is the average strain-
by-condition interaction effect, and mijk )(!  is the residual. 
 The second mixed ANOVA model, applied separately to each transcript using the 
residuals of the first model with outliers removed,  
 mgijkgijijgkgjgigmijkg SCACS )()()( !"""""# +++++= , 
where mijkg )(!  is the residual from the first mixed ANOVA model for each spot, g!  is the 
average gene expression for each gene g, giS!  is the expression due to strain i, gjC!  is the 
expression due to condition j, )(ijgkA!  is the expression due to array k, gijSC!  is the 
expression due to the strain-by-condition interaction effect, and mgijk )(!  is the residual.  
Genes with significant effects were determined using a false discovery rate (FDR) of 0.05 
as described in (GERKE et al. 2006).  For genes with significant strain main effects, 
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differences in expression between pairs of strains were identified by comparing the least-
square means of each strain using the t-test. 
 The unrooted tree and estimated branch lengths describing the relationships 
among transcription profiles were found using the CONTML from PHYLIP (Phylogeny 
Inference Package) version 3.6 (FELSENSTEIN 1985; FELSENSTEIN 1989; FELSENSTEIN 
2005).  Bootstrap support (FELSENSTEIN 1985) for this tree was determined using 1000 
pseudo-datasets by CONSENSE from PHYLIP version 3.6. 
RESULTS 
Oxidative stress resistance in ancestral and derived strains: In order to test whether 
the variation between rapidly selected strains might be useful in evolutionary studies, we 
isolated individual clones from two different populations of yeast that were selected for 
tolerance to multiple stresses (CAKAR et al. 2005) (Figure 1). JWY101 is an individual 
clone from the H1T2N3 population that was first selected for tolerance to the oxidizing 
agent hydrogen peroxide (H2O2) and then subjected to both a high temperature selection 
and a freeze/thaw selection. JWY102 is a clone from the H1H2 population, which was 
split from the H1T2N3 population after the initial selection in H2O2 and then subjected to 
additional selection in H2O2.  The ancestral strain for both populations is CEN.PK 113-
14A.   
We quantified the oxidative stress resistance phenotype of JWY100, an isogenic 
derivative of the ancestral strain, CEN.PK 113-14A, and of the two derived strains, 
JWY101 and JWY102. We measured the growth constants (Log2(A600)•s-1) of each of 
these strains in SC medium in either the presence or the absence of 1mM H2O2.  In 
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untreated SC medium, the growth curves for all three strains were similar (Figure 2A) 
and there was no statistical difference in growth constants in untreated media between the 
strains (P>0.044 for all comparisons, two-tailed student’s t-test, Figure 2B).  When 
challenged with H2O2, the two derived strains grew more rapidly than the ancestral strain 
(Figure 3A).  The growth constants of both JWY101 and JWY102 in oxidative stress are 
approximately two-fold greater than that of their ancestor, JWY100 (Figure 3B).  The 
differences between growth constants in oxidative stress for the two derived strains is not 
significant (P=0.087, two-tailed student’s t-test). 
Evidence that oxidative stress resistance segregates as a multigene trait: The 
derivation of JWY101 and JWY102 used a strong selection applied over a relatively 
small number of generations. We sought to determine if this scheme allowed time for 
multiple, adaptive, genetic changes to fix in these strains or if a single adaptive change 
could account for the phenotypic variation in the F2 generations of crosses between the 
ancestral strain, JWY100, and the derived strains, JWY101 and JWY102.    
The phenotypic distribution of the progeny of the JWY100 x JWY101 cross is not 
strictly bimodal, suggesting the phenotype is controlled by more than one locus (Figure 
4A).  The distribution of progeny phenotypes, however, is not significantly different from 
a composite of the two parental distributions (two-tailed P=0.1145, Mann-Whitney-
Wilcoxon test).  We, therefore, sought additional lines of evidence to determine whether 
oxidative stress resistance is a monogenic or a multigenic trait in JWY101. 
We took advantage of the fact that, in S. cerevisiae, the four meiotic products are 
encased in a structure called a tetrad and can be analyzed individually. In the case where 
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a single adaptive change is responsible for the oxidative stress resistance of a derived 
strain, the resistance phenotype should segregate 2:2 in tetrads. If more than one adaptive 
change is involved, the spores in tetrads will show a more complex pattern of 
segregation. 
We determined whether oxidative stress resistance segregates 2:2 in tetrads 
derived from the JWY100 x JWY101 cross. Among the progeny, the oxidative stress 
resistance phenotype does not segregate 2:2 in 44 of 54 tetrads (10/54 expected if all 
tetrads 2:2).  The phenotypes of the spores from a representative tetrad are shown in 
Figure 4B.  In this tetrad, there is significant variation in the mean oxidative stress 
resistance between JWY100 and the two lowest ranked spores (P=5.95x10-4, single-factor 
ANOVA) and between JWY101 and the two highest ranked spores (P=0.024, single-
factor ANOVA).  This segregation pattern is not consistent with oxidative stress 
resistance arising from a single genetic change in JWY101.  In addition, the progeny 
mean phenotypic value is located between the mean of JWY101 and the mid-parent 
value, suggesting epistasis between segregating loci.  In this cross, a t-test for epistasis 
was significant (P=0.024).  
Oxidative stress resistance is also a multigenic trait in JWY102. The progeny 
distribution from the JWY100 x JWY102 cross is not strictly bimodal suggesting the 
segregation of multiple involved genes (Figure 5A). This distribution of phenotypes in 
the progeny is significantly different from a composite of the JWY100 and JWY102 
phenotype distributions (two-tailed P=0.0007, Mann-Whitney-Wilcoxon test). Similarly, 
oxidative stress resistance does not segregate 2:2 in 38 of 48 tetrads (9/48 expected if all 
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tetrads 2:2) from the JWY100 x JWY102 cross.  The phenotypes of the spores from a 
representative tetrad are shown in Figure 5B.  In this tetrad, there is significant variation 
in the mean oxidative stress resistance between JWY100 and the two lowest ranked 
spores (P=2.16x10-8, single-factor ANOVA), but there is not significant variation 
between JWY102 and the two highest ranked spores (P=0.667, single-factor ANOVA).  
This segregation pattern strongly suggests that oxidative stress resistance is not a 
monogenic trait in JWY102.  In addition, the progeny mean phenotypic value is located 
between the mean of JWY102 and the mid-parent value, suggesting epistasis between 
segregating loci.  A t-test for epistasis was significant (P<0.0001).  
JWY101 and JWY102 have the same major effect adaptations: We sought to 
determine whether JWY101 and JWY102 contain the same or different genetic 
adaptations. We compared the segregational variance (the additional variation in the F2 
progeny due to the segregation of parental genes (LYNCH and WALSH 1998)) from a cross 
between JWY101 and JWY102 ( 102 1010.2 != xs" ) (Figure 6) to the variance observed in 
the crosses of these strains to the ancestral strain (JWY100 x JWY101: 102 1069.5 != xs"  
and JWY100 x JWY102: 102 1048.6 != xs" ) (Figures 4A & 5A).  There is a three-fold 
reduction in segregational variance in the cross between the derived lines, suggesting that 
fewer parental genes are segregating in the cross between the derived lines and that 
JWY101 and JWY102 have the same major effect adaptations for oxidative stress 
resistance.  
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 The broad sense heritability (H2) represents the portion of the variance in the 
progeny phenotypes that can be explained by variance in their genotypes.  The 
heritability in the progeny of the JWY101 x JWY102 cross (H2=0.490) indicates that 
additional loci of small effect, which differ between JWY101 and JWY102, are also 
segregating in this cross. Because a t-test for epistasis was highly significant (P<0.0001), 
these additional minor effect loci appear to have epistatic interactions with each other or 
with the major effect loci in this cross. 
Transcription profiling of derived strains: The oxidative stress response in yeast 
includes dramatic changes in transcriptional regulation (GASCH et al. 2000; JAMIESON 
1998).  Accordingly, the transcriptional response to H2O2 treatment can be used to assess 
the level of similarity in the oxidative stress response of JWY100, JWY101, and 
JWY102.  In order to assess the similarity of transcriptional regulatory responses, we 
extracted mRNA from three replicate cultures of JWY100, JWY101, and JWY102 grown 
in both the presence and the absence of H2O2. We used a mixed model ANOVA to 
identify transcripts with significant (FDR<0.05) strain main effects, condition main 
effects, and strain-by-condition main effects (Figure 7A). 
Down regulation of oxidative phosphorylation and increased proteolysis 
characterize the response to oxidative stress in yeast (GASCH et al. 2000; JAMIESON 
1998). Transcripts with significant strain-by-condition effects, that are expressed 
similarly in JWY101 and JWY102, but differently in JWY100, are enriched for Gene 
Ontology (GO) Function terms (BERRIZ et al. 2003) related to oxidative phosphorylation 
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and protein catabolism.  The derived strains appear to have an exaggerated version of the 
typical response to oxidative stress.  
We evaluated the relationship of the transcriptional response to oxidative stress 
among the three strains by constructing an unrooted tree from all eighteen samples, using 
transcripts with either a significant strain main effect or strain-by-condition interaction 
effect (Figure 7B).  We did not include transcripts with only a significant condition main 
effect, because these transcripts represent the response to oxidative stress that is common 
among the three strains.  Samples group by condition.  Within conditions, there is strong 
bootstrap support indicating that the transcription profiles of the two derived strains, 
JWY101 and JWY102, are closer to each other than to JWY100, in both conditions.  The 
transcription profiles of the derived strains have the greatest divergence from the 
ancestral strain in the presence of H2O2 (Figure 7B).   
Although the expression profiles of the derived strains are far more similar to 
each other then they are to the ancestral strain, there are at least some distinct differences. 
In particular, the transcriptional response of JWY102 appears to have diverged further 
from the ancestral response then JWY101. We therefore tested the hypothesis that 
JWY101 has significantly fewer mRNAs transcribed differently from the ancestral line 
than JWY102. The results of this test indicate that the transcriptional profile of JWY101 
has diverged less from the ancestral strain than that of JWY102 (P=6.36x10-40, χ2- test).   
DISCUSSION 
It has been previously shown that long term, weak selections in the laboratory can 
produce variation similar to that observed in natural isolates.  The traits generated are 
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generally genetic, quantitative, increase directionally throughout the period of selection, 
and involve both regulatory and structural adaptations (BUCKLING et al. 2003; CASTLE 
1951; COHAN and HOFFMANN 1986; COOPER et al. 2003; CROZAT et al. 2005; DE VISSER 
and LENSKI 2002; DE VISSER and ROZEN 2006; DUNHAM et al. 2002; ELENA and LENSKI 
2003; FEREA et al. 1999; GRIMBERG and ZEYL 2005; LAURIE et al. 2004; LENSKI and 
TRAVISANO 1994; PAQUIN and ADAMS 1983a; PAQUIN and ADAMS 1983b; PELOSI et al. 
2006; RIEHLE et al. 2003; RIFKIN et al. 2005; ZEYL et al. 2005; ZEYL et al. 2003).  These 
studies, however, can be intensive in both labor and resources.  As a result, these studies 
are limited in the number of replicate strains and conditions that can be explored.  If 
comparable variation can be generated from short selections in the laboratory, the 
reduction in labor and cost would allow key questions to be explored more 
systematically, such as the frequency of convergence relative to parallelism or the 
relationship of the strength of selection to the genetic complexity of adaptation. 
We examined the adaptation to oxidative stress in two strains derived in the 
laboratory to determine whether a short intense selection can generate variation 
comparable to long term, weak selections.  A key element of this selection was the use of 
ethyl methanesulfonate (EMS) mutagenesis to create genetic variation in the starting 
population, therefore reducing the time required for mutation accumulation.   
In natural populations, quantitative variation is the result of segregation of alleles 
at multiple loci.  A primary concern with short term selections in the laboratory is that 
they are likely to produce adaptive phenotypes arising from a single genetic change.  We 
sought to determine whether a short term selection for stress resistance produced 
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multigenic phenotypes in the derived lines.  The oxidative stress phenotype in JWY102 is 
clearly multigenic. Both biometric and tetrad analysis indicated the presence of multiple 
involved genes segregating among the progeny of a cross between JWY102 and the 
ancestral strain.  The results with JWY101 were less clear cut. Biometric analysis showed 
no significant deviation from the progeny distribution that would be expected if only one 
gene caused the oxidative stress phenotype, but tetrad analysis showed clear deviation 
from 2:2 segregation, suggesting more than one involved locus. The evidence for 
epistasis in the JWY100 x JWY101 cross and transgressive segregation in the JW101 x 
JWY102 cross also suggests the involvement of more than one gene in the oxidative 
stress resistance phenotype of JWY101. Our interpretation of these data is that oxidative 
stress resistance phenotype is a relatively simple complex trait, perhaps with as few as 
one major effect locus and a few additional minor effect loci.  Our results suggest that 
short term selection in the laboratory can generate traits with a complex genetic basis, but 
that sometimes these complex traits will have relatively simple architectures. 
 Given that the ancestral strain was selected for oxidative stress resistance before it 
was split into two strains (Figure 1), we asked whether JWY101 and JWY102 had the 
same adaptations to oxidative stress.  To answer this question, we crossed the two derived 
strains and examined the segregation of the phenotype in the F2 haploid progeny.  We 
observed a three-fold reduction in segregational variance in the progeny of this cross 
compared to the progeny of either strain backcrossed to the ancestral strain.  This result 
suggests that JWY101 and JWY102 have the same major effect adaptations to oxidative 
stress.  It also suggests that the major effect adaptations fixed in the population early, 
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before the strains were split at H1 (Figure 1).  The transcriptional profiles of JWY101 and 
JWY102 also show marked similarities in both treated and untreated cells that are distinct 
from the ancestral strain, JWY100.  These differences in expression may result, directly 
or indirectly, from the influence of shared major effect loci. 
The two derived strains also have distinct differences that likely accumulated after 
the culture was split. The heritability of stress resistance in the JWY101 x JWY102 cross 
(H2=0.490) and evidence for epistatic interactions between loci indicate that unique 
modifiers of the phenotype have arisen in each strain after they were split from their 
common ancestor. Likewise there are small, but significant, differences in the expression 
profiles between the two derived strains.  Overall, the transcription data are in agreement 
with the genetic data.  The transcriptional responses of JWY101 and JWY102 are very 
similar, with some differences (Figures 6 & 7B); but, both strains differ substantially 
from JWY100 (Figures 4A, 5A, & 7B).      
 Regulatory effects have been shown to be important for evolutionary changes in 
several different lineages (CARROLL 2005; WRAY 2007).  The set of transcripts with 
significant strain-by-condition effects were enriched for functions related to oxidative 
phosphorylation and protein degredation. These classes of genes are known to be 
regulated as part of the typical response to oxidative stress (GASCH et al. 2000; JAMIESON 
1998). The fact that the regulation of these classes of genes is altered in the derived 
strains suggests that they are likely part of the adaptation to oxidative stress.  
 Here we have shown that a short term selection on a mutagenized population can 
be used to develop genetically complex adapted strains. These strains may be suitable 
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substrates for testing theories of adaptive evolution. While long term selection in the 
laboratory will continue to play an important role in testing evolutionary theories, short 
term selections will be a useful complement to these studies, especially when the study 
design requires generating large numbers of parallel strains. 
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FIGURE LEGENDS 
Figure 1.—Derivation and phenotype of strains. (A) Schematic of selection used to derive 
JWY101 and JWY102 after (CAKAR et al. 2005).  JWY100 is an isogenic, clonal 
derivative of CEN.PK 113-14A.  (CAKAR et al. 2005) performed the selection for stress 
resistant populations as follows.  The ancestral population was EMS mutagenized and 
then treated with H2O2 for one hour.  The surviving population recovered overnight in 
minimal medium (YMM).  This population was EMS mutagenized and split into two 
lines.  One line was exposed to heat stress followed by overnight recovery in YMM and 
EMS mutagenesis and freeze/thaw stress (H1T2N3) from which a clonal derivative was 
isolated (JWY101).  The second line was exposed to H2O2 and allowed to recover 
overnight in YMM.  From this population (H1H2), a clonal derivative was isolated 
(JWY102).  
Figure 2.—Growth in untreated media. (A) Growth in untreated SC medium for 
JWY100, JWY101, and JWY102 over 20 hours.  (B) Growth constants in untreated SC 
medium of JWY100, JWY101, and JWY102.  Growth constants in untreated SC medium 
are approximately equal in the three strains.  
Figure 3.—Growth in oxidative stress conditions. (A) Growth in SC medium treated with 
1mM H2O2 for JWY100, JWY101, and JWY102.  JWY101 and JWY102 show greater 
growth in the presence of H2O2 than the ancestral strain, JWY100. (B) Growth constants 
in SC medium treated with 1mM H2O2 of JWY100, JWY101, and JWY102.  Growth 
constants for JWY101 and JWY102 are approximately equal, but are significantly greater 
than that of JWY100 (***: P<<0.001). 
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Figure 4.—Segregation of oxidative stress resistance in JWY100 x JWY101 cross. (A) 
Frequency distribution of growth constants in SC medium treated with 1mM H2O2 of 
JWY100, JWY101, and the F2 progeny of the JWY100 x JWY101 cross.  (B) Growth 
constants in SC medium treated with 1mM H2O2 for JWY100, JWY101, and the four 
spores (α, β, γ, and δ) of a representative tetrad from the JWY100 x JWY101 cross.  
Oxidative stress resistance does not segregate 2:2 in this tetrad.   
Figure 5.—Segregation of oxidative stress resistance in JWY100 x JWY102 cross. (A) 
Frequency distribution of growth constants in SC medium treated with 1mM H2O2 of 
JWY100, JWY102, and the F2 progeny of the JWY100 x JWY102 cross.  (B) Growth 
constants in SC medium treated with 1mM H2O2 for JWY100, JWY102, and the four 
spores (α, β, γ, and δ) of a representative tetrad from the JWY100 x JWY102 cross.  
Oxidative stress resistance does not segregate 2:2 in this tetrad.  
Figure 6.—Segregation of oxidative stress resistance in JWY100 x JWY102 cross. (A) 
Frequency distribution of growth constants in SC medium treated with 1mM H2O2 of 
JWY101, JWY102, and the F2 progeny of the JWY101 x JWY102 cross.   
Figure 7.—Transcription profiling. (A) Venn diagram showing the number of transcripts 
with significant effects from mixed model ANOVA.  (B) Heat map of relative transcript 
abundance of transcripts with a significant strain main effect or a strain-by-condition 
main effect (1635 transcripts).  Relationship between transcription profiles shown by an 
unrooted tree (empty circles are nodes).  Bootstrap support for each branch is indicated 
above branch and estimated branch lengths below.   
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CHAPTER THREE: USE OF LYMPHOBLASTOID CELL LINES IN THE 
STUDY OF HUMAN GENETIC VARIATION 
ABSTRACT 
 Understanding human genetic variation is one of the most important goals of 
biomedical research and one of the most constrained by ethical considerations and 
technical limitations. The study of lymphoblastoid cell lines derived from human blood 
samples has been suggested as a complementary approach that may avoid some of these 
complications. The reliability of these cell lines, not only as a representation of human 
biology, but also a consistent experimental resource has recently been called into 
question.  
To examine these issues, I quantified variation in the expression of cell surface 
proteins amongst a panel of 255 lymphoblastoid cell lines using flow cytometry. I found 
that lymphoblastoid cell lines are a reliable experimental platform that can be used for 
consistently repeatable phenotyping, providing that sensible approaches to cell culture, 
experiment design, and data processing are adopted. Almost all of the phenotypic 
variation can be explained by intrinsic differences between lines, a small, but significant, 
fraction of which can be explained by additive genetic variation, suggesting that it will be 
possible to identify the genomic location of some putatively, causal variants by linkage-
association mapping.  
While acknowledging concerns that lymphoblastoid cell lines only represent a 
fraction of the diversity of human cell types, I conclude that lymphoblastoid cell lines, as 
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well as other cell culture methods, are reliable experimental resources with distinct 
strengths and weaknesses. When used with careful consideration of those strengths and 
weaknesses, cell culture methods should be an integral part of a complementary program 
to study human genetic variation.   
INTRODUCTION 
Certain classes of experiments necessary to discover the genetic differences 
between humans, such as unpredictable variation in response to cytotoxic 
chemotherapeutics, critical for functional, personalized medicine cannot be ethically 
conducted in healthy humans. Technical successes in identifying genotype-phenotype 
association for both disease risk and general traits in humans contrast with the low 
predictive power conferred by these associations to highlight the issue of validation.  
Direct experimentation to confirm genotype-phenotype associations are rarely ethical or 
technically feasible in human subjects. In response to these considerations, 
lymphoblastoid cell lines (LCLs) - circulating B cells immortalized by Epstein-Barr virus 
(EBV) infection - have been suggested as a potential, ex vivo model system for the study 
of human genetic variation. 
LCLs have a number of characteristics that make them an attractive model for 
human genetic variation. Genetic variation in LCLs represents genetic variation that 
exists in human populations (BAUCHET et al. 2007; HE et al. 2009; LAO et al. 2008; 
MEUCCI et al. 2005; SMITH et al. 2006). As cell culture lines, LCLs are not subject to the 
same ethical restrictions as human subjects, allowing discovery based pharmacogenomic 
studies that would otherwise be unacceptable. There are also options for direct 
 82 
experimental confirmation of genetic hypotheses in LCLs that are not available in human 
subjects, such as siRNA (LI et al. 2009). These options are certain to expand for LCLs 
with technological advancements, while the options for human subjects may be 
fundamentally constrained by ethical considerations.       
In microorganisms, where it is possible to directly test genotype-phenotype 
associations, the nature of the genetic variation controlling phenotypic variation does not 
agree with the observations of genotype-phenotype association studies in humans, which 
indicate that human genetic variation is controlled by many loci with very small effect 
sizes. For example, variation sporulation efficiency between two isolates of the budding 
yeast Saccharomyces cerevisiae can be explained by only a few QTL resolved to the 
nucleotide level (quantitative trait nucleotides, QTN) of relatively large effect. The QTN 
effects are primarily additive, but there are significant epistatic interactions between QTN 
and with the genetic background. The effects of these QTN have been confirmed by 
direct experimentation (GERKE et al. 2009; GERKE et al. 2006). In contrast, height, a 
highly heritable human trait, has had 47 QTL associated with it by GWA studies, all of 
small effect. Although some of these QTL cover genes known to affect stature and the 
QTL can predict inclusion at the extremes of the height distribution, these QTL do not 
predict height for the vast majority of the population (LETTRE 2009).     
It is not known whether this discrepancy arises due to fundamental differences in 
the relationship of genotype and phenotype, such as different amounts of epistasis, 
between microorganisms and large, multicellular organisms, an artifact of technical 
challenges in human genetic studies, or a combination of both.    
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To date, quantitative genetic studies using LCLs have not provided a resolution to 
this question. The few QTL identified in LCLs in both pharmacogenomic and transcript 
abundance studies also explain only a fraction of the phenotypic variation, suggesting 
that phenotypic variation in humans at the level of transcription, cell survival, and 
organismal disease is controlled by many loci of small effect. Again, it is not clear 
whether the small effect sizes reflect the true biology of human genetic variation, a result 
of LCLs not being a representative human analog, or an artifact of measuring 
“phenotypes” with potentially small organismal phenotypic effects (i.e., transcript 
abundance).  
The reliability of LCLs as an experimental resource, however, has recently been 
called into question (CHOY et al. 2008). Estimating the heritability of phenotypes and the 
identification of genetic variation associated or linked to phenotypic variation is 
dependent on the reliability of phenotypic quantification. If phenotypic quantification is 
unreliable as suggested (CHOY et al. 2008), then not only must the use of LCLs as a 
resource for identifying genetic variation that controls phenotypic variation in humans be 
questioned, but so must the results of a number of studies using LCLs for this purpose 
(ATLAS et al. 1976; BERGEN et al. 2007; BLEIBEL et al. 2009; CHEUNG et al. 2003; 
CHEUNG and EWENS 2006; CHEUNG et al. 2005; CLOOS et al. 1999; CORREA and CHEUNG 
2004; DEUTSCH 2005; DOLAN et al. 2004; DUAN et al. 2007; DUAN et al. 2009; FORD et 
al. 2001; HARRIS et al. 2005; HARTFORD et al. 2009; HUANG et al. 2007a; HUANG et al. 
2008a; HUANG et al. 2008b; HUANG et al. 2007b; HUANG et al. 2007c; JEN and CHEUNG 
2003; KWAN et al. 2007; LI et al. 2008; LI et al. 2009; LOEUILLET et al. 2008; MONKS et 
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al. 2004; MORLEY et al. 2004; SCHORK et al. 2002; SHUKLA and DOLAN 2005; SHUKLA et 
al. 2008; SHUKLA et al. 2009; SMIRNOV et al. 2009; WANG et al. 2009a; WATTERS et al. 
2004; WEI et al. 1996; ZHANG et al. 2009). This experimental variation may not only 
reduce the ability to identify genetic variants controlling phenotypic variation (i.e., false 
negatives), but also may cause spurious genetic correlations (i.e., false positives), if the 
experimental variation is correlated to unmeasured, potentially heritable phenotypes like 
growth rate.  
While there are a number of steps during the establishment of LCLs that may 
contribute to non-genetic variation between lines, there are three general processes in 
LCL phenotyping that could contribute to experimental variation using established lines 
(e.g., the CEPH collection): variation in the freezing and thawing of individual sample 
aliquots (freeze/thaw variance), variation in cell culturing on technical replicates of the 
same sample preparation (culture variance), and variation in the phenotype assay (assay 
variance). The ability to make repeatable measurements of LCL phenotypes is critical to 
both the correlation of genetic variation with phenotypic variation and confidence in 
those correlations. Accordingly, I have examined both the repeatability of LCL 
phenotyping and the correlation of genetic variation with phenotypic variation using this 
cell culture based resource.   
In this study, I have used a panel of 255 LCLs in 19 three-generation pedigrees 
from a population representative of Northern and Western European decent (BAUCHET et 
al. 2007; HE et al. 2009; LAO et al. 2008; MEUCCI et al. 2005; SMITH et al. 2006) to 
identify the genetic underpinnings of phenotypic variation in humans. In doing so, I have 
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explicitly tested the reliability of LCLs as an experimental resource to study human 
genetic variation. I have also explored whether the use of alternative phenotyping 
strategies, namely quantifying cell surface expression of proteins instead of mRNA 
transcript abundance, enables larger proportions of phenotypic variation to be explained 
by genotype.  
RESULTS 
Description of sample pedigrees: In order to study the genetic variation in cell surface 
expression of proteins using LCLs, I established a panel of 255 LCLs (Supplemental 
Table 1) from 19 three-generation families from the Utah population in the Foundation 
Jean Dausset-Centre d’Etude du Polymorphisme Humain collection (CEPH-UT) 
(DAUSSET et al. 1990). Both parents (second generation) were present in all pedigrees 
(
! 
N = 2). All four grandparents (first generation) were present in most pedigrees 
(
! 
N = 3.5). Third generation sibships were large (
! 
N = 7.9). 
Description of phenotypes: Phenotypes were measured by flow cytometry following 
paraformaldehyde fixation (fixes cells without permeablizing the cell membrane) and 
labeling with phycoerythrin (PE) labeled monoclonal antibodies (mAb) to targeted 
proteins (Materials and Methods). Targeted proteins were CD4, CD19, CD23 (or 
FCER2), CD38, CD40, CD45RA (or Protein Tyrosine Phosphotase, Receptor Type C), 
CD86, Intercellular Adhesion Molecule 1 (ICAM-1), and Toll-like Receptor 9 (TLR-9).  
The CD4 and TLR-9 antibodies are used as controls for the other antibodies. CD4 
is a major histocompatibility complex class II co-receptor typically observed only on TH1 
and TH2 helper T cells, an expression pattern that is routinely used to identify T cells. 
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Therefore, it is not expected to observe CD4 on the B cell derived LCLs. Indeed, 
measured CD4 transcript abundance is extremely low in LCLs (MORLEY et al. 2004). 
Here, the CD4 mAb is used as an isotype control for level of background signal resulting 
from the combination of auto-fluorescence and non-specific binding. TLR-9 is expressed 
in B cells and recognizes CpG DNA, typically from bacteria, but is localized to an 
intracellular endosomal compartment. Therefore, the TLR-9 mAb is an isotype control 
for cell surface localization of labeling. Comparison to CD4 and TLR-9 staining allows 
for the detection of staining over background levels. 
CD38 and CD86 are expressed on mature activated B-cells. CD38 has a role in B 
cell proliferation and is expressed both in early and germinal center B cells. CD38 
expression has been implicated as both risk factor and prognostic marker for chronic 
lymphocytic leukemia (DEAGLIO et al. 2008; JAMROZIAK et al. 2009). CD86 is a ligand 
for CD28 and CTLA-4 and is expressed on activated B cells. CD86 has been suggested to 
be a factor in the development of asthma (CORYDON et al. 2007; ZHU et al. 2004).  While 
these proteins are generally expressed in activated B cells, it is mature, inactivated B cells 
that are immortalized to form LCLs. EBV immortalization, however, may confer an 
activated phenotype to the LCLs (POKROVSKAJA et al. 1996; SATOH et al. 2003), and 
inappropriate activation of B cells could contribute to autoimmune disorders. Assays with 
CD38 and CD86 will yield information on the genetic differences in unactivated B-cells, 
which could contribute to conditions where inappropriate activation of B-cells is part of 
the etiology.  
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The remaining targeted proteins are expressed on the surface of the mature, 
unactivated B cells from which LCLs are derived. CD19 is a component of the B cell co-
receptor with CD21 and CD81. CD19 overexpression has been associated with loss of 
tolerance, production of autoantibodies, and systematic sclerosis (TAYLOR et al. 2006). 
CD23 is a low-affinity receptor for IgE, regulates IgE synthesis, and is a ligand for the B 
cell co-receptor. CD23 expression has been connected with the development of B-chronic 
lymphocytic leukemia (CALAMINICI et al. 2004; JURISIC et al. 2008; SCHWARZMEIER et 
al. 2005). CD40 is the receptor for a co-stimulatory, activating signal from CD154 (CD40 
ligand) on helper T cells. Variation at the CD40 locus is a risk factor for rheumatoid 
arthritis (RAYCHAUDHURI et al. 2008). CD45RA is a B cell specific isoform of CD45, 
which enhances the signal from the antigen receptor. Variation at the CD45 locus had 
been associated with multiple sclerosis (BALLERINI et al. 2002), but this association has 
since been refuted by more comprehensive studies (GOMEZ-LIRA et al. 2003; SZVETKO et 
al. 2009). ICAM-1 helps create a tight junction between B cells and T cells following 
antigen specific binding of the cells. Variation at the ICAM-1 locus has been associated 
with differentiation of colorectal cancer (WANG et al. 2009b). 
To obtain linear and informative measurements of this diverse set of cell surface 
expression phenotypes by flow cytometry, both “low” and “high” values were used for 
the photomultiplier tube (PMT) settings (Materials and Methods). CD4, CD38, CD40, 
CD45RA, and ICAM-1 were assayed using the “low” settings. CD4, CD19, CD23, 
CD86, and TLR-9 were assayed using the “high” settings. All flow cytometry 
measurements are reported below in arbitrary fluorescence units (AFU). 
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 Mean CD4 cell surface expression was not significantly different from auto-
fluorescence in the 1 PBS/0.2% BSA control (
! 
µPBS = 22.28; 
! 
µCD4 = 21.01; 
! 
P = 0.39 , 
two-tailed student’s t-test) suggesting that the effects of non-specific binding are low in 
this assay. Mean TLR-9 cell surface expression was significantly greater than CD4 
(
! 
P = 6.25 "10#73 , one-tailed, paired student’s t-test; Figure 1A) indicating that there are 
either low levels of cell surface expression of TLR-9 or that the fixed cell membrane is 
somewhat permeable to the PE-mAbs.  
Mean CD19 cell surface expression was significantly greater than CD4high 
(
! 
µCD4 high = 59.30; 
! 
µCD19 = 63.67; 
! 
P =1.19 "10#20 , one-tailed, paired student’s t-test), but 
was not greater than TLR-9 (
! 
µTLR "9 = 81.06 ; 
! 
µCD19 = 63.67; 
! 
P = 5.93 "10#66, one-tailed, 
paired student’s t-test). A bimodal distribution of CD19 cell surface expression levels 
would suggest that CD19 expression is not a binary character where some lines are 
actively expressing (i.e., equal to or greater than TLR-9) and others are not (i.e., equal to 
CD4high. The distribution of CD19 cell surface expression levels is unimodal (Figure 1B), 
indicating that significant CD19 cell surface expression cannot be detected in this assay 
using standardized settings and protocols.  
The mean cell surface expression of all other phenotypes measured was 
significantly greater than the relevant controls (
! 
P " 5.00 #10$30, one-tailed, paired 
student’s t-test; Figure 1C-H). For the majority of phenotypes, the flow cytometry assay 
was able to quantify cell surface expression levels above the noise of auto-fluorescence 
and non-specific binding.    
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Experimental components of phenotypic variance: Previous work did not separate 
freeze/thaw variance and cell culture/assay variance (CHOY et al. 2008), making it 
difficult to identify factors contributing to poor replication. I separated freeze/thaw 
variance from cell culture/assay variance, by measuring cell surface expression of all 
targeted proteins and a no antibody control (1X phosphate buffered saline/0.2% bovine 
serum albumin [1X PBS/0.2% BSA]) for three independent cultures that were grown 
from a single frozen aliquot of each LCL in the panel. A subset (
! 
n Ab = 20.6 , 
! 
18 " nAb " 22 ) of the LCL panel was measured for each phenotype. Poorly growing 
samples were removed from analysis (Materials and Methods). Cell surface expression 
was repeatable between cell culture/assay replicates for control phenotypes (
! 
r = 0.76 ; 
! 
0.35 " r " 0.92) and experimental phenotypes (
! 
r = 0.86 ; 
! 
0.73 " r " 0.95).   
Due to the number of culture replicates measured (n=3), these data were highly 
sensitive to outlier data points. This supposition was supported by the fact that the lowest 
correlation (
! 
r = 0.35) was an isolate event that was an extreme deviation from all other 
observations (
! 
0.73 " r " 0.95) and appeared to be due to a single set of replicates (data 
not shown).  I removed outlier data points (Materials and Methods) and repeated the 
analysis.    
I found that cell surface expression was repeatable between cell culture/assay 
replicates for both control phenotypes (
! 
r = 0.93; 
! 
0.88 " r " 0.96) and experimental 
phenotypes (
! 
r = 0.94 ; 
! 
0.91" r " 0.97). Despite the potential increase in variance due to 
the culturing process, this result compares favorably with the assay repeatability reported 
previously for both drug response (Spearman’s rank correlation: 
! 
0.86 " # " 0.99) (CHOY 
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et al. 2008) and transcript abundance (
! 
r = 0.98 ; 
! 
0.94 " r " 0.99) (MORLEY et al. 2004). 
These results suggest that cell culture/assay variance only makes a minor contribution to 
total phenotypic variation (Figure 2). 
In order to determine the total experimental variation, the cell surface expression 
levels of the full panel were quantified for all phenotypes using four independent 
freeze/thaw replicates of each line. The number of freeze/thaw replicates assayed for each 
phenotype (
! 
n = 4) and experience from the cell culture/assay variance discovery 
indicated that the phenotypic mean would be highly sensitive to individual outlier data 
points.  
To test the impact of outlier data points, I quantified the repeatability before and 
after the removal of outlier data points (as above). Before the removal of outlier data 
points, freeze/thaw replicates had substantially lower repeatability for control (
! 
r = 0.48 ; 
! 
0.32 " r " 0.64) and experimental phenotypes (
! 
r = 0.65 ; 
! 
0.57 " r " 0.71) relative to the 
cell culture/assay replicates. These repeatablities for the experimental phenotypes were 
still at the upper limit of the range reported previously (CHOY et al. 2008). This result 
would suggest that experimental variance makes up a large portion of the total 
phenotypic variance.   
After the removal of outlier data points, however, freeze/thaw repeatability 
improved dramatically for both control (
! 
r = 0.84 ; 
! 
0.77 " r " 0.89; Table 1) and 
experimental phenotypes (
! 
r = 0.90 ; 
! 
0.87 " r " 0.92; Table 1). These results suggest that 
experimental variance is not a major component of the total phenotypic variance and that 
freeze/thaw variance does add substantially to cell culture/assay variance (Figure 2).  
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Because the median is robust to outliers, the median phenotype for each line was 
used in all subsequent analyses, instead of the mean following outlier removal with which 
the median is highly correlated (
! 
r = 0.98 ).    
Covariate components of phenotypic variance: The CEPH-UT LCLs are associated 
with limited information on the individuals from which they were derived (pedigree 
position, sex, and age at sampling). Females and males had approximately equal 
representation in the full panel (
! 
female = 47.8% ; 
! 
male = 52.1%). Due to the structure of 
the pedigrees, ages (years) were not evenly distributed, but cluster into three groups 
corresponding to generation within the pedigree (
! 
˜ g1 = 70.5; 
! 
˜ g2 = 45; 
! 
˜ g3 =16; Figure 3A). 
In addition, the LCLs in the panel were randomly distributed into three 96-well sampling 
plates (Materials and Methods). Pedigree position, sex, and age are all potential 
covariates that may have non-genetic effects on phenotype.   
I used mixed model analysis of variance (ANOVA) to assess the significance or 
the effects of the potential covariates of generation in the pedigree, sex, age at sampling, 
and plate:   
! 
"ij = µi + a i gen j( ) +bi sex j( ) + c i age j( ) +di plate j( ) +# ij , 
where 
! 
"ij  is the median value for the 
! 
ith  phenotype of the 
! 
j th  line, 
! 
µi  is the population 
mean value for the 
! 
ith  phenotype, 
! 
gen j  is the generation in the pedigree of the 
! 
j th  line, 
! 
sex j  is the sex of the 
! 
j th  line, 
! 
age j is the age at sampling of the 
! 
j th  line, 
! 
plate j  is the 
plate of the 
! 
j th  line, and 
! 
" ij  is the residual for the 
! 
ith  phenotype of the 
! 
j th  line. 
Generation in the pedigree, sex, and plate were treated as class variables. Age was treated 
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as a continuous variable. As noted above, generation in the pedigree and age are not 
independent variables.  
Generation, sex, and age had a significant effect (
! 
" = 0.05) on a minority of 
phenotypes. Generation (Figure 3B; Table 2) had a significant effect on TLR-9 
(
! 
P = 8.38 "10#3; Figure 3C) and CD38 (
! 
P =1.83 "10#2 ; Figure 3D). Sex (Figure 4A; 
Table 2) had a significant effect on ICAM-1 (
! 
P =1.02 "10#2; Figure 4B). Age (Figure 5; 
Table 2) had a significant effect on TLR-9 (
! 
P = 4.43 "10#2; Figure 5B). Only the effect 
of generation on TLR-9 cell surface expression remained significant after Bonferroni 
correction for multiple hypothesis testing (
! 
" = 5 #10$3 ).           
 Plate assignment had a significant effect (Bonferroni correction) on half of the 
phenotypes measured (
! 
P < 5 "10#3; Table 2). Lines were randomized to sampling plates 
prior to any other steps (Materials and Methods). A given line had the same plate 
assignment in all replicates and all phenotype assays. Therefore, the significant plate 
effect could be due to experimental error or to differences in the phenotype value 
distributions between plates, as a result of the random assortment of a finite number of 
samples. If experimental error caused the plate effect, statistical correction of the plate 
effect would be necessary. If differences in phenotype distributions caused the plate 
effect, statistical correction would be undesirable, as it would alter accurate phenotype 
measurements unnecessarily. Therefore, determining the cause of the plate effect is 
important for all further data analyses.  
Comparing of replicate variation between plates could suggest the cause of the 
plate effect. Because all three sampling plates were handled at the same time for each 
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independent freeze/thaw replicate, the experimental error between replicates of a 
sampling plate is expected to be the same as the set of all plates assayed. If experimental 
error caused the plate effect, variation between sampling plate replicates would be 
expected to be the same as the variation between plates. If differences in phenotype 
distributions caused the plate effect, variation between sampling plate replicates would be 
expected to be less than the variation between plates. 
Because the scale phenotypic measurements vary by more than an order of 
magnitude, I used the coefficient of variation (CV) for this comparison. For phenotypes 
with a significant plate effect, the mean sampling plate CV (
! 
c v = 0.05) was the same as 
phenotypes without a significant plate effect (
! 
c v = 0.05), with one exception. The mean 
CV of CD4high (
! 
c v = 0.18) was inflated by an easily identified outlier replicate (Figure 6), 
the removal of which reduces the mean CV to the same level as other phenotypes 
(
! 
cv = 0.05). In contrast, the sampling plate CV (
! 
c v = 0.07) was greater than the replicate 
CV (
! 
c v = 0.05) for phenotypes with a significant plate effect, but not for phenotypes 
without a significant plate effect (
! 
c v = 0.02). The difference between sampling plate CV 
and replicate CV increases with the significance of the plate effect (e.g., CD40: 
! 
Pplate = 6.33 "10#12; 
! 
cvplate = 0.19 ; 
! 
cvthaw = 0.05 ; Figure 6B). These results suggest that the 
plate effect is most likely the result of uneven distribution of certain phenotypes across 
the sampling plates during randomization and should not be statistically corrected as it 
primarily represents actual phenotypic variation between lines, not the effect of a 
covariate and experimental error.   
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Differences in cell surface expression between lines: The demonstration of consistency 
in phenotypic measurements between replicates is not sufficient for identifying the 
genetic basis of phenotypic variation. There must also be variation between lines that is 
intrinsic to the lines themselves, which is distinct from the background variation due to 
experimental noise. The proportion of the total phenotypic variation that can be explained 
by differences between lines was estimated:  
! 
L =1" # E
2
#P
2 , 
where 
! 
L  is the proportion of phenotypic variance explained by , 
! 
"P
2  is the total 
phenotypic variance, and 
! 
" E
2  is the mean environmental variance. Intrinsic differences 
between lines explain the vast majority of variation in all phenotypes assayed 
(
! 
0.75 " L " 0.91; 
! 
˜ L = 0.89; Table 1).   
 Because there are known, plausible non-genetic components to variation between 
lines that are undefined, the proportion of the phenotypic variance explained by 
differences between lines does not necessarily represent the proportion of the phenotypic 
variance explained by differences in genotypes, but does represent the upper bound on 
the variation that might be explained by genetic variation. Almost all of the phenotypic 
variation is due to intrinsic difference between lines both for every phenotype assayed 
(Figure 2). 
Narrow-sense heritability of cell surface protein expression: The observation that 
differences between lines explain most variation for all phenotypes suggests that a 
portion of the total phenotypic variation may be under the control of additive genetic 
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variation. The proportion of the total phenotypic variation controlled by additive genetic 
variation can be estimated as the narrow-sense heritability (FALCONER 1989).    
 The narrow-sense heritabilities of all phenotypes assayed were estimated (Table 
1) with collaboration of Aldi Kraja and Michael Province from the Washington 
University School of Medicine Division of Statistical Genomics (Materials and 
Methods). The narrow-sense heritabilities ranged from 
! 
h2 = 0.03 ± 0.07 for CD23 to 
! 
h2 = 0.30 ± 0.11 (
! 
P = 3.54 "10#5) for CD38. These heritabilities were significant for 
seven of ten phenotypes (Table 1), but are on the low end of the range observed for 
common phenotypes in human subjects (e.g., 
! 
0.06 " h2 " 0.52 for lung function) (OBER 
et al. 2001). Although most of the phenotypic variation is due to difference between 
lines, only a fraction of that variation is controlled by additive genetic variation (Figure 
2).  
Comparison to pilot study: I compared the results of the full panel to those of a pilot 
study that had been restricted to measuring auto-flourescence (1X PBS), CD40 cell 
surface expression, and CD86 cell surface expression. The pilot’s sample set 
(Supplemental Table 2) partially overlapped (
! 
Npilot =108 ; 
! 
N" = 79 ) with the full panel 
(Supplemental Table 1). CD40 cell surface expression was more heritable in the pilot 
(
! 
hCD402 = 0.42) than in the full panel (
! 
hCD402 = 0.19). CD86 cell surface expression was less 
heritable in the pilot (
! 
hCD862 = 0.12) than in the full panel (
! 
hCD862 = 0.24 ).   
 In order to understand the causes of the divergence in narrow-sense heritability 
estimates, I compared measurements of cell surface expression of CD40 and CD86 in the 
samples shared samples by both the full panel and the pilot. Although cell surface 
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expression is highly repeatable within both the full panel (e.g., 
! 
rCD40 = 0.89 ; Figure 7A) 
and the pilot (e.g., 
! 
rCD40 = 0.81; Figure 7B), cell surface expression of CD40 
(
! 
rCD40 = 0.59 ) and CD86 (
! 
rCD86 = 0.69 ) in the pilot was not highly correlated with the full 
panel. These incomplete correlations may reflect methodological differences between the 
full panel and the pilot.   
 Because methodological differences, especially when phenotyping by flow 
cytometry, may cause nonlinear changes in the phenotypic measurement of a line, but 
should not change the phenotypic rank order of the line, I confirmed the divergence 
between the two sets by calculating Spearman’s rank correlation between the pilot and 
full panel for CD40 (
! 
"CD40 = 0.61; Figure 7C) and CD86 (
! 
"CD86 = 0.72; Figure 7D). The 
slight improvement in the rank correlation suggests that there may be a slight 
contribution of nonlinear effects. In light of the precision of these assays, as demonstrated 
above, these results likely represent real differences between the pilot and the full panel. 
Due to the methodological differences, it may be most accurate to consider the 
phenotypes, which are nominally the same, as being measured under different conditions 
and, therefore, not equivalent phenotypes.   
DISCUSSION 
Due to the challenges inherent in the study of genetic variation in humans, 
complementary approaches that do not require repeated recruitment or consent of large 
numbers of human subjects may have great utility. LCLs are non-adherent cell lines that 
are grown with simple culturing procedures allowing many, repeated samples to be taken 
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under conditions that are either technically or ethically impossible in human subjects. 
Most importantly LCLs are cell lines derived from human subjects. The genetic variation 
in LCLs is the genetic variation that is in the human population (BAUCHET et al. 2007; HE 
et al. 2009; LAO et al. 2008; MEUCCI et al. 2005; SMITH et al. 2006). These 
characteristics make LCLs an attractive model system for the study of human genetic 
variation.  
Yet, these characteristics alone are not sufficient to make LCLs a productive 
model system for the study of human genetic variation. The identification of genetic 
variants that control phenotypic variation is dependent on the ability to accurately 
phenotype individuals and to identify variation between individuals in those phenotypes.  
 There have been previous efforts to describe some components of phenotypic 
variance in LCLs. Assay variance has been a focus in transcript abundance phenotypes, 
in order to define a significant change relative to background noise (MORLEY et al. 2004). 
While quantification of assay variance is of technical import, it is not relevant to the 
suitability of LCLs individually as a model system – assuming that the utility of the 
model system is not strictly limited by the reliability of the assays available for that 
system. Understanding the relative contributions of both experimental and genetic 
components to the total phenotypic variance is relevant to the evaluation of LCLs as a 
model system for human genetic variation. This work represents the first reported effort 
that separates the components of the phenotypic variance in a way that allows intrinsic 
differences between LCLs to be explicitly separated from experimental sources of 
variation (i.e., freeze/thaw and cell culture/assay variance). 
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 A prior report by Choy et al. raised the concern that LCLs are unreliable due to 
excessive amounts of variation between freeze/thaw aliquots, but in their study 
freeze/thaw variance was confounded with cell culture/assay variance. They reported that 
phenotypic differences between aliquots within lines were larger than the differences 
between lines (CHOY et al. 2008).  In contrast, having experimentally separated cell 
culture/assay variance and freeze/thaw variance, I found that both culture/assay replicates 
and freeze/thaw replicates were highly repeatable. The discrepancy between these 
conclusions has several possible explanations based on cell culture methods, phenotypes 
assayed, and data processing.  
The cell culture methods used by Choy et al. may have contributed to increased 
experimental error relative to this work. The marginal decrease in repeatability from cell 
culture/assay replicates (
! 
r = 0.94 ) to freeze/thaw replicates (
! 
r = 0.90 ) in this work is 
consistent with the expectation that experimental error will increase with the number of 
manipulations. The cell culture methods used here involve no manipulations of the 
samples between thawing of a frozen aliquot and fixation of the culture (Materials and 
Methods). Choy et al., however, counted cell densities daily and adjusted cell densities to 
a target population size over a seven-day cell culture period. If each manipulations 
represents an independent opportunity to introduce additional experimental error, then the 
decrease in experimental error here would be expected based on the cell culture methods 
used.  
Data processing made a large, definable contribution to the improvement in 
repeatability relative to Choy et al. Any collection of large numbers of data points will 
 99 
likely experience both technical failures and outliers, which are categorically distinct 
from the effects of covariates. Outliers may be due to statistical chance or experimental 
error. Repeatability of all phenotypes (
! 
r = 0.65 ) was substantially improved by the 
identification of outliers in the data (
! 
r = 0.90 ). 
There are several strategies for dealing with outiers. Large replicate sample size 
can minimize the influence of outliers on the data without explicit identification of the 
outlying data points (WATTERS et al. 2004). Such sample sizes are not always possible, 
due to factors like cost or availability of samples. In these cases, outliers may be 
identified and removed, or the median, which is robust to outliers, may be used 
preferentially to the mean. Choy et al. only had two replicate samples per measurement, 
at which sample size outliers cannot be identified and the robust median becomes 
equivalent to the sensitive mean. Furthermore, the impact of outliers increases as the 
sample size decreases. The ability, due to experimental design, to identify outliers (for the 
calculation of experimental repeatability) and to use the median may explain, in part, the 
substantial improvement here relative to previous work with LCLs (CHOY et al. 2008). 
The high repeatability of cells surface expression levels indicates that the majority 
of phenotypic variance was due to intrinsic, but not necessarily genetic, differences, 
between lines (Figure 2). This variance due to differences between lines may be divided 
into a genetic and non-genetic component. One potential source of non-genetic variation 
is potential covariates associated with lines in the panel, such as generation in the 
pedigree, sex, age, and plate assignment of the sample. The mixed model ANOVA 
demonstrated that, overall, the few known, potential covariates did not have significant 
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effects on phenotype. The significant plate effect is more likely due to differences in 
phenotype distributions (i.e., differences between plate median values are true 
differences) than due to bias or experimental error. Known, potential covariates were not 
significant contributors of non-genetic variation to the differences between lines.     
While, all components of the genetic differences between lines, like epistatic and 
dominance variance, cannot be estimated, the additive component may be estimated due 
to the pedigree structure of the full panel. The narrow-sense heritability estimates for 
most phenotypes were significant, but fell on the low end of the range of heritability 
estimates for common human phenotypes (OBER et al. 2001). Only a fraction of the 
differences between lines is composed of additive genetic variance. The remainder is 
composed of undefined contributions from epistasis, dominance, and non-genetic 
components.    
The pilot identified substantially greater narrow-sense heritability of CD40 cell 
surface expression compared to the full panel, which could indicate that the methods used 
in the pilot increase the additive genetic component of the differences between lines. 
Although, the narrow-sense heritability of CD86 cell surface expression was substantially 
greater in the full panel. Some of the methodological differences between the full panel 
and the pilot – the use of fluorescein (FITC) conjugated monoclonal antibodies, instead 
of phycoerithrin (PE) were used, requiring the use of different flow cytometer settings, 
antibody dilutions, and antibody incubation times - could cause non-linear scaling 
differences between the full panel and the pilot, resulting in imperfect correlation 
between the full panel and pilot. The rank correlation between the full panel and pilot, 
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however, is not substantially larger than the standard correlation, suggesting that the 
imperfect correlation is the result of real differences in the phenotypes measured in the 
full panel and pilot, not non-linear scaling effects. Because samples in the pilot were 
cultured in flasks, not plates, as in the full panel, it is possible that the phenotypes 
measured in the full panel and the pilot are not precisely equivalent, with a larger additive 
genetic component to CD40 cell surface expression and a smaller additive genetic 
component to CD86 cell surface expression when grown in flasks.  
Unfortunately, the samples necessary to assess the other components of the non-
genetic differences between lines, such as sampling and immortalization variation, do not 
exist for either the CEPH-UT or the International HapMap Project (2003; FRAZER et al. 
2007; THE INTERNATIONAL HAPMAP 2005) LCL collections. Because the non-genetic 
components are undefined, it is not possible to estimate the non-additive genetic 
components. Contributions to the non-genetic variation from sampling and 
immortalization variation could be defined by analyzing multiple LCLs derived from a 
single sample and LCLs derived from multiple samples from a single individual. These 
samples are absent from current collections because these collections were designed for 
genotype mapping, not studying phenotypic effect of genetic variation. They would, 
however, be an important addition to future collections.    
The ability to identify genotype-phenotype associations is dependent on the 
proportion of phenotypic variance that is controlled by additive genetic variance. While 
the non-additive component of the genetic variation is a product of the genetics of the 
system, the non-genetic variation can be minimized through the use of highly repeatable 
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experimental methods, such as those described here. Variation in the cell surface 
expression of the proteins measured was due to differences between lines. Because high 
experimental repeatability of cell surface expression is due to consistency between 
freeze/thaw replicates, I expect that this high repeatability will also be observed in other 
phenotypes, provided that similar cell culture methods, sample sizes, and data processing 
steps are used.   
With appropriate handling and experimental design to control for experimental 
sources of variation, LCLs can be used as a reliable resource for the study of genetic 
variation. This effort would benefit from quantification of the effects of sampling and 
immortalization, as well as increased sample sizes, requiring extensive additional 
sampling within the pedigree structures that made it possible to accurately estimate 
components contributing to variation between LCLs. These studies may also benefit from 
expanding genetic variation studies in cell culture to other cell types, perhaps through the 
use of induced pluripotent stem cell methods.  
It is not clear that there are any advantages to using localized protein expression 
as a phenotype when compared with transcript abundance in terms of the degree that 
phenotypic variation is controlled by additive genetic variance and the identification of 
QTL. The QTL identified for localized protein expression may still be more likely to be 
associated with traits in human subjects, like disease risk. Direct experimental 
confirmation of the causal hypotheses Establishing this relationship is an important goal 
for future research. 
 103 
The measurement of phenotypes in LCLs is both highly repeatable within 
individual lines and variable between lines, important characteristics for any model 
system of genetic variation. The high repeatability of phenotypes measured here (cell 
surface expression of protein) is expected to extend to other phenotypes, including those 
that cannot ethically or technically be studied in human subjects. Provided that rigorous 
methods, reasonable data processing, and sensible experimental design are used, these 
conclusions may extend to other cell lines, like induced pluripotent stem cells, which 
would allow human genetic variation to be investigated in the cell type most relevant to 
the particular question. These characteristics, in combination with the developing 
capacity to test genotype-phenotype associations (SHUKLA et al. 2009) and the 
accessibility to independent research groups, strongly recommend cell culture as a 
complementary approach to the study of human genetic variation.   
MATERIALS AND METHODS 
Cell lines and culture conditions in the full panel: A panel of 255 lymphoblastoid cell 
lines (LCLs) was established from the CEPH-UT collection (Supplemental Table 1). 
Prior to any assays, a single, 1mL, frozen (-140°C) aliquot of each cell line was thawed in 
a 37°C water bath for five minutes.  The thawed aliquot was diluted in 10mL 37°C 1X 
phosphate buffered saline (PBS) and centrifuged (290xg for five minutes at room 
temperature [RT]) to pellet the cells.  The supernatant was aspirated and the cells were 
suspended in 1mL 37°C standard LCL media (media): RPMI-1640 media (Gibco), 15% 
fetal bovine serum (FBS) (Gibco), 2mM L-glutamine, 50µg/mL gentamycin (Gibco).  
The 1mL samples were diluted in 10mL 37°C media in 25cm2 flasks (Corning) and 
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incubated at 37°C with 5% CO2 and 95% humidity.  At five days post-thaw, 10mL 37°C 
media was added to each sample.  At nine days post-thaw, samples were transferred into 
larger 75cm2 flasks (Corning) and an additional 10mL 37°C media was added.  At twelve 
days post-thaw, 20mL 37°C was added for a total volume of 50mL. 
On day 15 post-thaw, cell line samples were frozen as follows.  50mL samples 
were transferred to conical vials and pelleted by centrifugation (290xg for five minutes at 
RT).  The supernatant was aspirated and the cells were suspended in 10mL freezing 
media (RPMI-1640 media, 20% FBS, and 10% DMSO).  1mL aliquots were distributed 
into 96-well deep well plates.  Plates were incubated for 48 hours at -80°C and then at -
140°C afterwards.    
To prepare samples for phenotyping, frozen (-140°C) plates were thawed by 
incubation in a 37°C water bath for 30 minutes.  20µL samples were diluted in 180µL 
37°C media in tissue culture treated 96-well flat bottom plates with low evaporation lids.  
Samples were incubated at 37°C with 5% CO2 and 95% humidity prior to antibody 
labeling. 
Quantification of cell surface expression in the full panel: On Day 5 after aliquot 
thawing, samples were fixed by adding a 150µL sample to 50µL 4% paraformaldehyde 
(PFA) in 96-well 2µM filter plates (Corning) and incubated for 10 minutes at RT.  Media 
was removed using a vacuum manifold (Millipore) with a pressure between -5 mmHg 
and -10 mmHg.  Cells were washed once with 100µL 1X PBS and then suspended in 100 
µL of R-phycoerythrin (PE) conjugated monoclonal antibody (mAb) diluted 1:500 in 
1XPBS/0.2% bovine serum albumin (BSA). All antibodies were from US Biological, 
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raised in mouse, and were IgG1 isotype.  An αCD4-PE (IgG1) mAb was used as an 
isotype control.  Samples were incubated for two hours at 4°C in the dark.  Following 
antibody labeling, media was removed with a vacuum manifold.  Cells were washed once 
in 100µL 1X PBS, suspended in 180µL 1X PBS, and transferred to 96-well round bottom 
assay plates.  Samples were stored at 4°C in the dark until assayed by flow cytometry. 
 Quantification of cell surface fluorescence was performed using a Cytomics 
FC500MPL flow cytometer and data was processed using FlowJo 8.8 software.  
Individual samples were measured for 30 seconds using the low flow setting.  PE 
fluorescence was measured in a channel defined by a 565±10nm band pass filter using 
one of two settings (low: PMT=750, gain=1.0; high: PMT=900, gain=1.0. Cell surface 
expression was defined as the median fluorescence magnitude for a sample.  
 Data were initially screened for samples that failed to grow. Any sample with 
fewer than a threshold number of cell counts during flow cytometry (n=75) was removed 
from analysis.  
 Outlier data points were identified as follows. For any phenotype (i) measurement 
for a line (j) combinations with three or more replicate samples after cell count filtering, a 
scaled deviation score (
! 
" ijk ) was calculated for each sample based on the line median for 
each phenotype: 
! 
" ijk =
xijk # ˜ xij
˜ xij
, 
where 
! 
" ijk  is the scaled deviation for the phenotype of the k
th replicate of the jth line for 
the ith phenotype, 
! 
xijk  is the phenotypic measurement for the kth replicate of the jth line for 
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the ith phenotype, and 
! 
˜ xij  is the median phenotypic measurement for the jth line for the ith 
phenotype. This metric was compared to a scaled deviation threshold (
! 
" = 0.13). For any 
set of line measurements for a phenotype where at least one replicate’s scaled deviation 
exceeded the scaled deviation threshold (
! 
" ijk > # ), the replicate with the greatest scaled 
deviation was identified as the outlier and eliminated from further analysis. 
Cell lines, culture conditions, and quantification of cell surface expression in the 
pilot: A panel of 108 lymphoblastoid cell lines (LCLs) was established from the CEPH-
UT collection (Table 4). On Day 0, a single, 1mL, frozen aliquot was thawed for five 
minutes at 37°C in a water bath. The sample was diluted in 10mL 1X PBS, centrifuged at 
290xg for five minutes at room temperature and the supernatant was removed. The pellet 
was resuspended in 1mL media. The sample was diluted in 10mL media in a 25cm2 flask 
and incubated at 37°C with 5% CO2 and 95% humidity for four days.   
 On Day 4, samples were fixed by aliquoting 75µL samples into 96-well 2µM 
filter plates and adding 25µL 4% PFA. Plates were incubated at room temperature for 
five minutes and then spun at 1000xg for ten minutes at 4°C. Samples were washed once 
in 100µL 1X PBS, resuspended in 90µL 1X PBS, and stored at 4°C until assayed. 
 Prior to the phenotype assay, 10µL of either 1X PBS or a 1:10 dilution of a 
flouroscein (FITC) conjugated mAb. Antibodies were specific to CD40 and CD86. 
Samples were incubated with mAb for ten minutes at room temperature in the dark and 
then spun at 1000xg for ten minutes at 4°C. Samples were washed once in 100µL 1X 
PBS, resuspended in 170µL 1X PBS, and 150µL was transferred to 96-well round bottom 
assay plates. 
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 Quantification of cell surface fluorescence was performed as above with the 
following exceptions. FITC fluorescence was measured in a channel defined by a 
565±10nm band pass filter using the following settings: PMT=1000, gain=1.0.  
Estimation of narrow sense heritability: Narrow-sense heritability estimates used the 
multivariate and multilocus, variance components method in SEGPATH (PROVINCE et al. 
2003) as described previously (WATTERS et al. 2004). Due to high kurtosis in the CD19 
cell surface expression, median CD19 cell surface expression levels were log10 
transformed prior to analysis.   
SUPPLEMENTAL FILES 
Complete data for all replicates of all lines for all phenotypes is available upon request. 
Supplemental Table 1: Details of the full 255 LCL panel with phenotypic values. 
Supplemental Table 2: Details of 79 LCLs from pilot that are shared with the full 255 
LCL panel. 
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TABLES 
Table 1: Phenotype distributions and variance components 
Phenotype N 
! 
x (AFU) 
! 
"P
2  
! 
"E
2  L 
! 
h2 
! 
SE h2( ) 
! 
P h2( )  
CD4low 249 17.57 13.93 1.67 0.88 0.20 0.09 1.78E-03 
CD4high 248 59.41 180.40 29.04 0.84 0.20 0.10 3.49E-03 
CD19 251 64.37 178.61 15.62 0.91 0.20 0.11 5.50E-03 
CD23 247 115.20 512.04 67.89 0.87 0.03 0.07 3.04E-01 
CD38 249 23.83 27.62 2.57 0.91 0.30 0.11 3.54E-05 
CD40 250 171.95 2585.54 277.39 0.89 0.19 0.09 1.55E-03 
CD45RA 250 40.73 93.69 9.53 0.90 0.22 0.09 6.91E-04 
CD86 249 93.07 351.28 38.43 0.89 0.24 0.12 2.76E-03 
ICAM-1 250 46.66 160.24 24.40 0.85 0.09 0.09 1.21E-01 
TLR-9 254 81.22 205.54 52.38 0.75 0.07 0.07 1.42E-01 
 
Table 2: P-values for covariate effects from mixed model ANOVA 
Phenotype Generation Sex Age Plate Assignment 
CD4low 0.316 0.473 0.467 1.51E-02 
CD4high 0.343 0.603 0.593 5.19E-13 
CD19 8.38E-03 0.693 4.43E-02 2.81E-03 
CD23 0.367 0.139 0.969 9.11E-05 
CD38 1.83E-02 0.337 0.528 0.435 
CD40 0.549 0.306 0.306 6.33E-12 
CD45RA 0.676 0.951 7.89E-02 8.42E-03 
CD86 0.159 0.522 0.361 2.95E-03 
ICAM-1 7.20E-02 1.02E-02 0.641 5.32E-02 
TLR-9 0.228 0.104 0.339 0.683 
*Italicized text indicates nominal significance (
! 
" = 0.05).  
**Bold and italicized text indicates significance after Bonferroni correction (
! 
" = 0.005).  
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FIGURE LEGENDS 
Figure 1: Distribution of cell surface expression of proteins compared to background. 
Histograms of the distribution of cell surface expression levels in arbitrary fluorescence 
units (AFU) across the entire panel relative to background controls. (A) TLR-9 (brown) 
control for cell surface localization versus CD4high (green). (B) CD19 (pink) versus 
CD4high (green) and TLR-9 (brown). (C) CD23 (pink) versus CD4high (green) and TLR-9 
(brown). (D) CD86 (pink) versus CD4high (green) and TLR-9 (brown). (E) CD38 (pink) 
versus CD4low (green). (F) CD40 (pink) versus CD4low (green). (G) CD45RA (pink) 
versus CD4low (green). (H) ICAM-1 (pink) versus CD4low (green). 
Figure 2: Components of phenotypic variance. Bars represent the cumulative 
contributions of different variance components (y-axis) to the total variance for each 
phenotype assayed (x-axis). The summed contributions of all variance components must 
equal the total phenotypic variance (i.e., 100% phenotypic variance explained) for each 
phenotype assayed. Therefore, the bars do not indicate the relative amounts of total 
variance of phenotypes in comparison to each other. Line variance (pink) indicates the 
amount of phenotypic variance that is due to differences between lines. Variance between 
cell culture/assay replicates is indicated by the cell culture/assay variance (teal). (B) Line 
variance (pink) indicates the amount of phenotypic variance that is due to differences 
between lines, including additive genetic variance (green). Error bars indicate standard 
error of narrow-sense heritability estimates. Statistically significant narrow-sense 
heritability estimates are indicated (*). Variation between freeze/thaw replicates is 
indicated by the freeze/thaw variance (teal), which includes cell culture/assay variance. 
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Differences between lines explain the majority of variation for all phenotypes assayed, 
but additive genetic variance does not explain a majority of the line variance for these 
phenotypes. 
Figure 3: Effect of generation on phenotype. (A) Histogram of distribution of ages in the 
panel. Due to generation structure within the pedigrees in the panel, the distribution of 
ages is not uniform. (B) Scatter plot comparing median cell surface expression (AFU) of 
indicated proteins of the first generation (grandparents; x-axis) with the median cell 
surface expression of the second (parents; green) and third (progeny; pink) generations 
(y-axis). Error bars indicate the 25th and 75th percentile values for the respective 
generation. Phenotypes with a significant generation effect from the mixed model 
ANOVA are indicated (*: 
! 
P < 0.05). (C) Histograms of TLR-9 cell surface expression 
(AFU), which had a significant generation effect (
! 
P = 8.38 "10#3), in the full panel for 
the first (grandparents; blue), second (parents; green) and third (progeny; pink) 
generations. (D) Histograms of CD38 cell surface expression (AFU), which had a 
significant generation effect (
! 
P =1.83 "10#2 ), in the full panel for the first (grandparents; 
blue), second (parents; green), and third (progeny; pink) generations.   
Figure 4: Effect of sex on phenotype. (A) Scatter plot compares the median cell surface 
expression level of proteins (as indicated) in arbitrary fluorescence units (AFU) in the 
panel for females (x-axis) and males (y-axis). Error bars indicate the 25th and 75th 
percentile values of their respective sex. Phenotypes with a significant generation effect 
from the mixed model ANOVA are indicated (*: 
! 
P < 0.05). (B) Histograms of ICAM-1 
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cell surface expression (AFU), which had a significant sex effect (
! 
P =1.02 "10#2), in the 
full panel for females (green) and males (green) generations. 
Figure 5: Effect of age on phenotype. (A) Relationship between age (years) and cell 
surface expression (AFU) shown as the best-fit linear regression of cell surface 
expression on age. (B) Scatter plot comparison of age (years; x-axis) with TLR-9 cell 
surface expression (brown; y-axis). TLR-9 cell surface expression had a significant age 
effect (
! 
P = 4.43 "10#2) in the mixed model ANOVA. Best-fit linear regression of TLR-9 
cell surface expression on age (blue) represents general trend of gradual increase in 
expression with age (
! 
m = 0.052  AFU/yr). 
Figure 6: Effect of plate assignment on phenotype. Median cell surface expression values 
(AFU; y-axis) for both sampling plates (large, empty circles) and freeze/thaw replicates 
of sampling plates (small, filled circles) are shown. Sampling plates are distinguished by 
color (plate A: pink, plate B: green, and plate C: blue; see Supplemental Table 1 for plate 
assignments). Each phenotype is in a separate column (x-axis). Phenotypes with a 
significant plate assignment effect from the mixed model ANOVA are indicated by the 
phenotype label (*:
! 
P < 0.05; and after Bonferroni correction **:
! 
P < 0.005).  
Figure 7: Comparison of the full panel and pilot. (A) Scatter plot of CD40 cell surface 
expression level (AFU) for two, representative replicates in the full panel. (B) Scatter plot 
of CD40 cell surface expression level (AFU) for two, representative replicates in the 
pilot. (C) Scatter plot of CD40 cell surface expression rank in the respective sample set 
for LCLs shared by the pilot (x-axis) and the full panel (y-axis). (D) Scatter plot of CD86 
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cell surface expression rank in the respective sample set for LCLs shared by the pilot (x-
axis) and the full panel (y-axis).           
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CHAPTER FOUR: CONCLUSION AND DISCUSSION 
INTRODUCTION 
 The primary utility of cell culture model systems for the study of genetic variation 
lies in the control over experimental conditions and the experimental tractability. Their 
primary weakness lies in the fact that cell culture model systems are somewhat artificial 
and divorced from natural conditions; even in those using mircoorganims or those in 
which the genetic variation is the same as variation observed in natural populations. 
While the phenotypes measured for cell culture model systems in the lab may be 
analogous or similar to those with fitness effects outside the lab, one cannot argue that 
they are the same. Therefore, cell culture model systems are only a useful resource for 
research when the question and application allow the utility of the system to overcome 
the weakness. Unfortunately, many applications of cell culture model systems do not 
maximize their utility. I have examined the use of two cell culture model systems, 
laboratory selection on yeast and human-derived LCL pedigrees, for the study of natural 
genetic variation.   
LABORATORY SELECTION ON YEAST AS A MODEL SYSTEM  
In this work, I have assessed the use of laboratory selection on S. cerevisiae as a 
model system for natural genetic variation. Although laboratory selections have been 
used experimentally to test aspects of evolutionary theory, their use as a resource to 
overcome the limitations of natural isolates in the study of natural genetic variation has 
not been explored. The selected lines described in Chapter Two had adaptive phenotypes 
with a complex genetic basis similar to that observed in natural isolates of S. cerevisiae, 
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confirming that laboratory selection could be used to generate genetic variation with the 
characteristics of natural variation. This alone, however, does not demonstrate that 
laboratory selection on yeast is a useful model system for natural genetic variation. 
Evaluating laboratory selection on yeast as a model system is dependent on both the 
genetic variation in the derived lines and the particular advantages of yeast as an 
experimental organism.  
 There are many advantages to the use of microorganisms and yeast, in particular, 
for the study of genetic variation; but there are a few advantages specific to yeast strains 
developed in the laboratory that make them particularly attractive complements to the use 
of natural isolates to study natural genetic variation. The specific advantages of 
laboratory selection on yeast focus around two points: the ability to observe the entire 
evolutionary history of the derived lines and to study many replicates simultaneously. 
 The ability to observe the entire evolutionary history of a line is based on two 
factors. First, samples can be taken and stored throughout the process. These samples can 
be revived later to allow direct comparison between different time points in the 
evolutionary history. Second, the ancestral population can be defined, allowing both the 
response to selection to be quantified and the genetic underpinnings of that response to be 
investigated. Although the lines studied in this work represent only the ancestral sample 
and the derived lines without any intermediate samples, simple knowledge of the 
selection procedure permitted additional conclusions (i.e., that major effect mutations 
fixed in the population during the initial selection) to be drawn with confidence that 
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would not have been possible had the evolutionary history been unknown, as in the case 
of natural isolates. 
 The ability to define the ancestral population and to control the cell culture 
environment is critical for the use of multiple replicates and conditions in laboratory 
selections. Defining the ancestral population ensures that the initial genotype for all 
replicates is the same. Not only does this control an important variable during selection, 
but it may also simplify the identification of adaptive polymorphisms due to the reduced 
background noise of neutral polymorphisms (GRESHAM et al. 2008; GRESHAM et al. 
2006). Similarly, the ability to control the cell culture environment during selection 
allows the variable of interest to be manipulated while keeping all other environmental 
variables either constant or documented between lines. Genotype and environmental 
control are important advantages for laboratory selections that allow both rigorous 
experimentation and the use of many replications.       
 The ability to usefully exploit multiple replicates is also dependent on the 
development of methods to efficiently and accurately phenotype samples. I developed a 
high-throughput, quantitative method for phenotyping yeast to identify the response to 
selection. The ability to compare phenotypes by accurately and efficiently quantify the 
response to selection alone, however, is not sufficient for genetic analysis of replicates. 
The ability to efficiently compare the replicate genotypes is also needed. 
 Next-generation sequencing and microarray technology make it possible to 
identify polymorphisms throughout the entire genome in yeast. The associated costs of 
this approach, however, become impractical, as the number of replicate samples gets 
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larger. Because the high-throughput, quantitative growth assay described in this work 
could easily be used for multiple growth conditions in liquid media (e.g., carbon source, 
amino acid depletion, toxic challenge, etc.), the distribution of phenotypic value for 
characters that were not under selection can be used to obtain information on genotypic 
similarities between lines. Differences in these characters between lines may result from 
genetic variants that were selectively neutral, but affect the character in question. The 
characters may also be correlated characters – traits that are not directly under selection, 
but change due to pleiotropic effects from adaptive variants under selection. Phenotypic 
similarity for these characters would suggest genotypic similarity. The distance between 
the phenotypic values of lines for these characters (plotted in n-dimensional space, where 
n is the number of characters assayed) is expected to be proportional to the genotypic 
distance between lines. Two lines possessing the same adaptive, genetic variants (i.e., the 
same genotype) would not only have identical phenotypic values for the character under 
selection, but would have identical phenotypic values for all correlated characters 
measured. The high-throughput, quantitative growth assay provides the opportunity to 
estimate genotypic similarities between lines in order to prioritize comparisons for more 
labor intensive and costly analyses, such as crosses and genotyping. 
 Replicate samples would also be particularly useful for questions of frequency 
and probability in adaptive evolution. For example, two independent studies examining 
sporulation efficiency in two different sets of S. cerevisiae strains both identified causal 
polymorphisms at the RME1 locus, but not at any of the other four, combined loci that 
were identified (DEUTSCHBAUER and DAVIS 2005; GERKE et al. 2009; GERKE et al. 
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2006). That they did not identify the same polymorphism (DEUTSCHBAUER and DAVIS 
2005; GERKE et al. 2009; GERKE et al. 2006) suggests that the genetic variants arose, 
were selected for, and fixed independently in the strains, instead of sharing a common 
ancestor with the polymorphisms. This, in turn, suggests that the RME1 locus is the most 
likely site of large effect, beneficial mutations affecting sporulation efficiency.  
The hypothesis that RME1 is the most likely site of large effect, beneficial 
mutations affecting sporulation efficiency could be tested by placing a large number of 
replicate samples under selection for sporulation (e.g., by flow assisted cell sorting or 
ether treatment). Sporulation efficiency in the derived lines can be readily quantified by 
flow cytometry (GERKE et al. 2009; GERKE et al. 2006). Because the experiment is 
directed at a specific locus, genetic variation at the RME1 locus can be determined by 
direct sequencing. Stored samples during the selection process could be used to identify 
when variants arose. If the hypothesis that the RME1 locus is the most likely site of large 
effect, beneficial mutations affecting sporulation efficiency is correct, variants at the 
RME1 locus would be expected, on average, to fix early in the selection process. The 
effect of variants on phenotype can be established by allelic replacement via homologous 
recombination. The same samples could be used to apply similar analyses to the other 
sporulation efficiency QTL that have been identified (DEUTSCHBAUER and DAVIS 2005; 
GERKE et al. 2009; GERKE et al. 2006). They could also be used to study the possible 
distribution of variants with effects on sporulation efficiency or the influence of the 
genetics of sporulation efficiency on correlated characters. Laboratory selections on yeast 
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have the capacity to be applied to specific hypotheses in evolutionary biology and general 
discovery.  
These questions require the ability to generate both many replicate samples and 
genetic variation like that observed in nature. The first is a well-known advantage of 
microorganisms as a model system. The latter is demonstrated in this thesis work. Yet, 
the capacity to generate many sample lines in a yeast laboratory selection experiment has 
been underexploited due, perhaps, to a new focus on obtaining genome-wide sequence 
data, as opposed to other methods for genotypic comparison. The constraints imposed by 
genome-wide sequencing may also be alleviated by building on the knowledge gained in 
prior studies of both laboratory and natural isolates, as described above.           
LYMPHOBLASTOID CELL LINES AS A MODEL SYSTEM  
In this work, I have assessed the components of phenotypic variation in LCLs, in 
order to evaluate their use as a model system for human genetic variation. In addition, I 
examined the use of localized protein expression level as quantifiable alternative to 
transcript abundance studies that might better represent functional variation underlying 
phenotypes on the scale of human subjects.  
 Contrary to other work suggesting that LCLs are unreliable (CHOY et al. 2008), I 
found that the majority of phenotypic variation between LCLs is due to intrinsic 
difference between lines. The proportion of this variation that can be explained by 
additive genetic variation is not large (
! 
0.03 " h2 " 0.30).  
 There are two general explanations for the observation that additive genetic 
variance does not explain a majority of the differences between lines, which explains 
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most of the phenotypic variance in the LCLs for the phenotypes assayed. The remaining 
line variance is composed of non-additive genetic variance (e.g., dominance and 
epistasis) and non-genetic variance (e.g., sampling and immortalization). While it is 
generally believed that additive genetic variance dominates the genetic contribution to 
variance, even in human traits (HILL et al. 2008), this observation may indicate that the 
genetic component of phenotypic variation between the lines may be dominated by non-
additive genetic effects. Because it is not possible to define the non-genetic component of 
the variation between lines, the non-additive genetic hypothesis cannot be considered as 
anything more than a possibility. Indeed, parsimony favors the hypothesis that non-
genetic effects dominate the remaining line variance.   
 The large, publicly available LCL collections (CEPH and the International 
HapMap Project) completely lack the types of samples necessary to estimate the non-
genetic components of the line variance. The collections themselves can hardly be faulted 
for this oversight. These collections were established to investigate the distribution of 
DNA polymorphisms in human genomes in extant populations. The DNA sequence at a 
given base pair is not a continuous variable making the estimation of variance 
components, such as those with which I have been concerned, irrelevant. Therefore, these 
collections could not be expected to prioritize samples to address these issues. 
 As large LCL collections continue to be collected, now with an interest in using 
the LCLs for both phenotyping and genotyping, it would useful to comment on the types 
of samples that should be included in such collections in order to allow all the 
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components of phenotypic variance to be understood, in order to identify useful 
phenotypes and inform experimental design. 
 First, there may be variation in the immortalization process that causes LCLs to 
vary from each other by chance. With current collections, this variation is a component of 
variation between LCLs. The effect of variation in immortalization process could be 
defined by generating multiple LCLs by independent immortalization of aliquots from a 
single B cell sample from a single individual. The ability to generate these samples would 
be dependent on the efficiency of the immortalization process. These samples could 
easily be added to any new LCL collection, allowing the contribution of immortalization 
variation to the differences between LCLs to be defined for each phenotype of interest.   
Second, there may be variation in the sampling process from subjects that causes 
LCLs to vary from each other by chance. Some variation between independent samples is 
expected by chance. With current collections, this variation is a component of variation 
between LCLs. Although variation between independent samples from the same 
individual is expected to be small, it is not defined. Quantification of variation between 
independent samples from a single individual would require the development of LCLs 
from multiple, independent B cell samples from a single individual. Including this class 
of sample in new LCL collections in combination with replicate immortalization samples 
would allow key, non-genetic components of line variance to be defined. 
 Third, the age of the subject at the time of the sampling may affect phenotypes 
measured in LCLs. The analysis in Chapter 3 shows that the distribution of phenotypic 
values does not change with age. Although this suggests that the LCL phenotypes of an 
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individual remain constant as they age, it does not rigorously confirm that conclusion. 
Longitudinal collection of LCLs from the same subject over time, especially across the 
developmental stages represented in existing collections (e.g., esterus, puberty, 
menopause), would make it possible to explicitly define age dependent variability in 
phenotypic values. Because the relationship of age to phenotype may be different, this 
class of samples should be included in new LCL collections in order that this relationship 
can be defined for the phenotypes of interest for a particular research question. While it 
may difficult to identify subjects who are willing to be sampled multiple times over a 
period of years, only a small number of individuals, representing a tiny fraction of total 
individuals in a collection, would be needed to describe the relationship between age and 
phenotype. 
 Finally, immortalization converts B cells with normal physiology into 
continuously growing LCLs . This process changes the growth phenotype. It is 
reasonable to assume that this process causes changes in other phenotypes. The effect of 
these changes could be estimated by measuring the same phenotypes in isolated B cells 
before immortalization and the resulting LCLs after immortalization. This knowledge 
would help us understand how to connect the cell culture results in LCLs to the actual 
physiology of B cells in the human body. Because the B cells described would be primary 
cell culture, not immortalized cell culture, it would not be possible to add these cells to a 
publicly accessible cell repository. Furthermore, the phenotypes of interest would have to 
be identified before collection. Interest in new phenotypes would require the collection of 
new samples, negating a major advantage of cell culture relative to human subjects (i.e., 
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eliminating the need for new sampling for each new research question). This class of 
sample is both the least practical of the four listed and does not directly define 
components of variation between LCLs. It could reasonably be omitted from any future 
LCL collections. 
 How well LCLs represent normal B cell physiology could be addressed by 
comparing transcriptional profiles between LCLs and B cells across multiple samples 
from one individual and multiple individuals. There is evidence that transcript abundance 
QTL identified in LCLs replicate in primary tissue samples (BULLAUGHEY et al. 2009). 
Assaying transcript abundances using next generation sequencing (RNAseq) would allow 
these comparisons to be made efficiently. Efficient comparisons might be used in the 
construction of new collections to screen for the most representative lines amongst the 
sampling/immortalization replicates described above.     
 As LCLs have transitioned from being a renewable nucleic acid source to being a 
genetic model system, variables in the collection of LCLs that were not important before 
have become relevant as they may affect phenotypes measured in LCLs. Because current 
collections do not contain the samples necessary to evaluate these effects, new LCL 
collections would be needed to add the necessary samples.     
 If the goal of genetic research with LCLs is simply to identify genotype-
phenotype associations, then current collections may be sufficient. If, however, the goal 
is to understand the genetic underpinnings of complex traits, the samples described above 
needed to define the non-genetic sources of variation are necessary to understand the 
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genetics of complex traits - the relative contributions of additive, dominance, and 
epistatic genetic effects to overall genetic control of phenotype.     
The conclusion that existing new LCL collections are needed if LCLs are to be 
used a genetic model system for the basic study of complex traits in humans, highlights a 
more general issue regarding the utility of LCLs as a model system for human genetic 
variation, including practical genotype-phenotype association discovery, such as in 
pharmacogenomics.  
It was hoped that the ability to control the cell culture environment would, by 
reducing the non-genetic components of phenotypic variation, make it easier to identify 
the genetic variants controlling the phenotypes of interest more completely. Genotype-
phenotpe association studies using LCLs, however, have shown similar results, including 
small additive genetic effect sizes for identified QTL and low predictive power to those 
using human subjects. Because phenotypes measured in human subjects have the distinct 
advantage of being the biomedically relevant phenotypes of interest - LCL phenotypes 
are, at best, a proxy for these phenotypes, can situations in which LCLs are preferable to 
human subjects be identified, even without an improvement in genotype-phenotype 
association performance?  
Pharmacogenomics is an obvious area of research for which cell culture is 
preferable, because many of the experiments, such as evaluating genetic factors that 
determine the response to chemotherapeutics, cannot be ethically conducted with human 
subjects. LCLs, however, are derived from a single cell type (B cells), which may not 
represent the appropriate cell type for the chemical in question. Induced pluripotent stem 
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(iPS) cells may be a better resource for pharmacogenomics, as they can be differentiated 
into the appropriate cell type for the chemical in question.  
 Gene expression, primarily transcript abundance (BERGEN et al. 2007; CHEUNG et 
al. 2003; CHEUNG and EWENS 2006; CHEUNG et al. 2005; CHOY et al. 2008; CORREA and 
CHEUNG 2004; DEUTSCH 2005; DUAN et al. 2007; DUAN et al. 2009; FORD et al. 2001; 
HUANG et al. 2007; HUANG et al. 2008; JEN and CHEUNG 2003; LI et al. 2008; LI et al. 
2009; MONKS et al. 2004; MORLEY et al. 2004; PRICE et al. 2008; SMIRNOV et al. 2009; 
SPIELMAN et al. 2007; STRANGER et al. 2007; WANG et al. 2009; ZHANG et al. 2009), is 
also commonly studied in LCLs. Unlike pharmacogenomic studies, the fact that LCLs 
represent a single cell type is not necessarily a weakness. The reliability of expression 
levels are not influenced by the possible inclusion of multiple cell types, such as in 
primary tissue samples. Still, iPS cell lines may be preferable, as they would permit the 
study of expression differences between cell types and individuals.     
Transcript abundance studies measure thousands of phenotypes. The small effect 
sizes and multiple hypothesis penalties are accommodated with a low false discovery rate 
because the number of phenotypes assayed would allow an expected, high false negative 
rate to be tolerated. Protein expression cannot be quantified in such a high-throughput 
manner. As effect sizes do not appear to be significantly increased over transcript 
abundance phenotypes, it is not clear that protein expression enjoys a significantly lower 
false negative rate than transcript abundance. Similarly, the smaller number of 
phenotypes assayed does not allow protein expression studies to have the same flexibility 
with the false discovery rate that is enjoyed by transcript abundance studies. At this time, 
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localized protein expression levels do not appear to be inherently superior phenotypes for 
developing an understanding of complex human genetic variation. The use of both 
transcript abundance and protein expression to study the genetic basis of phenotypic 
variation in humans would benefit from the addition of samples to define the non-genetic 
components of phenotypic variation in LCLs. 
LCLs may be preferable to human subjects due to cost and labor. Genotype-
phenotype association studies using human subjects require sample sizes of thousands of 
individuals. These samples are not reusable. The phenotypes that can be studied are 
limited by the study design. Addressing phenotypes outside those included in the original 
sample collection requires recruiting new subjects. These factors have made genotype-
phenotype association studies the exclusive domain of large, collaborative research 
groups.  
LCL collections, however, are an accessible resource for individual research 
groups. Although obtaining LCLs from repositories are not without cost, the expense and 
administrative issues are substantially less daunting than obtaining comparable numbers 
of human subjects. While weaknesses in current collections have been discussed 
previously and may require new collections to be developed, these collections will allow 
independent research groups to participate in the study of human genetic variation while 
building a community knowledge base from research on a shared set of samples. 
Finally, LCLs carry some hope of testing genotype-phenotype association 
hypotheses by direct experimentation. These types of experiments are, in general, 
technically or ethically impossible, especially at the small effect sizes being discovered, 
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in human subjects. Already, siRNA technology has been used to confirm a genotype-
phenotype association in LCLs (SHUKLA et al. 2009). These experiments may further 
benefit from future, technological developments. The use of cell culture to test genotype-
phenotype associations discovered in human subjects may, again, benefit from the use of 
iPS cell lines, which would allow disease-relevant cell types to be tested, instead of using 
B cell derived LCLs as a proxy.   
CONCLUSION 
 Laboratory selection on yeast can be used to produce genetic variation with the 
same characteristics as natural genetic variation: quantitative phenotypic variation 
controlled by a small number of loci of large effect. Many question of interest in 
evolutionary biology and quantitative genetics involve rare events, small differences in 
variables, or the interaction of multiple variables. These questions would benefit from the 
ability to systematically generate and phenotype samples. The demonstration that 
laboratory selection on yeast is relevant to natural genetic variation and the high-
throughput, quantitative growth curve method developed here make this systematic 
approach possible.  
The measurement of phenotypes in LCLs is both highly repeatable within 
individual lines and variable between lines, important characteristics for any model 
system of genetic variation. The high repeatability of phenotypes measured here (cell 
surface expression of protein) is expected to extend to other phenotypes and other cell 
types. If the advantages of cell culture for the study of human genetic variation are to be 
fully exploited, the non-genetic components of phenotypic variation must be well 
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defined. This will require new collection of cell lines, which provides the opportunity to 
consider other cell types, like iPS cells, as a resource.    
The costs of large genotype-phenotype studies with human subjects have 
increasingly excluded the independent laboratory from the leading edge of human genetic 
variation. Cell culture methods, as a complement to human subject studies, are accessible 
to individual researchers and may, once again, allow the creativity and flexibility of the 
independent laboratory to impact the direction of human genetic variation research. 
Cell culture, in both microorganisms and humans, provides an important 
complementary approach to the study of natural genetic variation that addresses many of 
the challenges inherent to this field of research. 
 140 
LITERATURE CITED 
BERGEN, A. W., A. BACCARELLI, T. K. MCDANIEL, K. KUHN, R. PFEIFFER et al., 2007 
Cis sequence effects on gene expression. BMC Genomics 8: 296. 
BULLAUGHEY, K., C. I. CHAVARRIA, G. COOP and Y. GILAD, 2009 Expression 
quantitative trait loci detected in cell-lines are often present in primary tissues. 
Hum Mol Genet. 
CHEUNG, V., L. CONLIN, T. WEBER, M. ARCARO, K. JEN et al., 2003 Natural variation in 
human gene expression assessed in lymphoblastoid cells. Nat Genet 33: 422-425. 
CHEUNG, V. G., and W. J. EWENS, 2006 Heterozygous carriers of Nijmegen Breakage 
Syndrome have a distinct gene expression phenotype. Genome Res 16: 973-979. 
CHEUNG, V. G., R. S. SPIELMAN, K. G. EWENS, T. M. WEBER, M. MORLEY et al., 2005 
Mapping determinants of human gene expression by regional and genome-wide 
association. Nature 437: 1365-1369. 
CHOY, E., R. YELENSKY, S. BONAKDAR, R. PLENGE, R. SAXENA et al., 2008 Genetic 
Analysis of Human Traits In Vitro: Drug Response and Gene Expression in 
Lymphoblastoid Cell Lines. PLoS Genet 4: e1000287. 
CORREA, C. R., and V. G. CHEUNG, 2004 Genetic variation in radiation-induced 
expression phenotypes. Am J Hum Genet 75: 885-890. 
DEUTSCH, S., 2005 Gene expression variation and expression quantitative trait mapping 
of human chromosome 21 genes. Human Molecular Genetics 14: 3741-3749. 
DEUTSCHBAUER, A. M., and R. W. DAVIS, 2005 Quantitative trait loci mapped to single-
nucleotide resolution in yeast. Nat Genet 37: 1333-1340. 
DUAN, S., W. BLEIBEL, R. HUANG, S. SHUKLA, X. WU et al., 2007 Mapping Genes that 
Contribute to Daunorubicin-Induced Cytotoxicity. Cancer Research 67: 5425-
5433. 
DUAN, S., R. S. HUANG, W. ZHANG, S. MI, W. K. BLEIBEL et al., 2009 Expression and 
alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines. 
Pharmacogenomics 10: 549-563. 
FORD, B. N., D. WILKINSON, E. M. THORLEIFSON and B. L. TRACY, 2001 Gene 
expression responses in lymphoblastoid cells after radiation exposure. Radiat Res 
156: 668-671. 
GERKE, J., K. LORENZ and B. COHEN, 2009 Genetic interactions between transcription 
factors cause natural variation in yeast. Science 323: 498-501. 
GERKE, J. P., C. T. CHEN and B. A. COHEN, 2006 Natural isolates of Saccharomyces 
cerevisiae display complex genetic variation in sporulation efficiency. Genetics 
174: 985-997. 
GRESHAM, D., M. M. DESAI, C. M. TUCKER, H. T. JENQ, D. A. PAI et al., 2008 The 
repertoire and dynamics of evolutionary adaptations to controlled nutrient-limited 
environments in yeast. PLoS Genet 4: e1000303. 
GRESHAM, D., D. M. RUDERFER, S. C. PRATT, J. SCHACHERER, M. J. DUNHAM et al., 
2006 Genome-wide detection of polymorphisms at nucleotide resolution with a 
single DNA microarray. Science 311: 1932-1936. 
 141 
HILL, W., M. GODDARD, P. VISSCHER and T. MACKAY, 2008 Data and Theory Point to 
Mainly Additive Genetic Variance for Complex Traits. PLoS Genetics 4: 
e1000008. 
HUANG, R. S., S. DUAN, W. K. BLEIBEL, E. O. KISTNER, W. ZHANG et al., 2007 A 
genome-wide approach to identify genetic variants that contribute to etoposide-
induced cytotoxicity. Proc Natl Acad Sci U S A 104: 9758-9763. 
HUANG, R. S., S. DUAN, E. O. KISTNER, W. ZHANG, W. K. BLEIBEL et al., 2008 
Identification of genetic variants and gene expression relationships associated 
with pharmacogenes in humans. Pharmacogenet Genomics 18: 545-549. 
JEN, K. Y., and V. G. CHEUNG, 2003 Transcriptional response of lymphoblastoid cells to 
ionizing radiation. Genome Res 13: 2092-2100. 
LI, L., B. FRIDLEY, K. KALARI, G. JENKINS, A. BATZLER et al., 2008 Gemcitabine and 
cytosine arabinoside cytotoxicity: association with lymphoblastoid cell 
expression. Cancer Res 68: 7050-7058. 
LI, L., B. L. FRIDLEY, K. KALARI, G. JENKINS, A. BATZLER et al., 2009 Gemcitabine and 
Arabinosylcytosin Pharmacogenomics: Genome-Wide Association and Drug 
Response Biomarkers. PLoS One 4: e7765. 
MONKS, S. A., A. LEONARDSON, H. ZHU, P. CUNDIFF, P. PIETRUSIAK et al., 2004 Genetic 
inheritance of gene expression in human cell lines. Am J Hum Genet 75: 1094-
1105. 
MORLEY, M., C. MOLONY, T. WEBER, J. DEVLIN, K. EWENS et al., 2004 Genetic analysis 
of genome-wide variation in human gene expression. Nature 430: 743-747. 
PRICE, A. L., N. PATTERSON, D. C. HANCKS, S. MYERS, D. REICH et al., 2008 Effects of 
cis and trans genetic ancestry on gene expression in African Americans. PLoS 
Genet 4: e1000294. 
SHUKLA, S. J., S. DUAN, X. WU, J. A. BADNER, K. KASZA et al., 2009 Whole-genome 
approach implicates CD44 in cellular resistance to carboplatin. Hum Genomics 3: 
128-142. 
SMIRNOV, D. A., M. MORLEY, E. SHIN, R. S. SPIELMAN and V. G. CHEUNG, 2009 Genetic 
analysis of radiation-induced changes in human gene expression. Nature 459: 
587-591. 
SPIELMAN, R. S., L. A. BASTONE, J. T. BURDICK, M. MORLEY, W. J. EWENS et al., 2007 
Common genetic variants account for differences in gene expression among 
ethnic groups. Nat Genet 39: 226-231. 
STRANGER, B. E., A. C. NICA, M. S. FORREST, A. DIMAS, C. P. BIRD et al., 2007 
Population genomics of human gene expression. Nat Genet 39: 1217-1224. 
WANG, L., A. L. OBERG, Y. W. ASMANN, H. SICOTTE, S. K. MCDONNELL et al., 2009 
Genome-wide transcriptional profiling reveals microRNA-correlated genes and 
biological processes in human lymphoblastoid cell lines. PLoS One 4: e5878. 
ZHANG, W., S. DUAN, W. K. BLEIBEL, S. A. WISEL, R. S. HUANG et al., 2009 
Identification of common genetic variants that account for transcript isoform 
variation between human populations. Hum Genet 125: 81-93. 
 
 
L
in
e
F
a
m
il
y
G
e
n
e
ra
ti
o
n
S
e
x
A
g
e
 (
Y
e
a
rs
)
P
la
te
M
e
d
ia
n
 C
D
4
 (
H
ig
h
)
M
e
d
ia
n
 C
D
4
 (
L
o
w
)
M
e
d
ia
n
 C
D
1
9
M
e
d
ia
n
 C
D
2
3
M
e
d
ia
n
 C
D
3
8
M
e
d
ia
n
 C
D
4
0
M
e
d
ia
n
 C
D
4
5
R
A
M
e
d
ia
n
 C
D
8
6
M
e
d
ia
n
 I
C
A
M
-1
M
e
d
ia
n
 T
L
R
-9
6
9
8
0
1
3
2
9
1
3
F
1
3
C
5
1
.4
5
1
4
.5
0
5
2
.1
5
9
3
.6
0
1
9
.9
5
1
5
4
.5
0
3
0
.2
0
8
0
.0
0
3
8
.7
0
6
7
.3
0
6
9
8
1
1
3
2
9
1
3
F
1
5
C
5
4
.9
5
1
5
.9
5
5
7
.2
5
1
1
0
.5
0
1
9
.3
0
1
7
9
.5
0
2
4
.5
0
7
4
.4
5
3
6
.6
0
6
9
.3
0
6
9
8
2
1
3
3
3
3
M
1
6
B
5
3
.7
5
1
4
.7
0
5
5
.2
5
1
1
3
.5
0
2
1
.8
5
1
4
2
.0
0
4
4
.4
0
9
7
.0
5
6
9
.5
0
8
3
.3
0
6
9
8
3
1
3
3
1
3
M
1
1
C
8
1
.3
0
2
1
.8
0
8
0
.8
0
1
6
0
.0
0
2
7
.5
0
2
5
9
.5
0
3
3
.3
0
1
0
9
.0
0
5
7
.3
5
9
3
.3
5
6
9
8
4
1
3
2
9
3
1
M
6
3
A
4
9
.1
0
1
4
.9
5
5
7
.7
5
1
5
2
.5
0
2
0
.4
0
1
4
0
.5
0
2
3
.9
0
8
3
.5
0
5
2
.5
5
9
3
.0
5
6
9
8
5
1
3
4
1
1
F
6
9
A
4
3
.8
0
1
3
.3
0
4
7
.6
0
9
9
.2
0
1
8
.0
5
8
3
.5
5
2
4
.5
0
9
6
.2
0
4
0
.1
5
9
1
.0
0
6
9
8
6
1
3
2
9
1
1
M
7
4
A
3
4
.8
0
1
0
.4
1
4
6
.1
5
1
4
7
.0
0
1
5
.4
0
1
1
7
.0
0
3
9
.0
5
6
5
.6
5
4
3
.9
5
1
1
4
.0
0
6
9
8
7
1
3
3
3
2
F
3
9
A
5
7
.6
0
1
8
.2
0
6
4
.2
0
1
2
6
.0
0
3
0
.9
0
1
9
1
.5
0
4
3
.3
0
9
4
.2
0
5
8
.1
5
8
4
.4
5
6
9
8
8
1
3
3
1
3
F
1
3
A
3
3
.3
0
1
2
.3
5
4
5
.8
0
1
1
0
.0
0
1
6
.1
0
8
5
.7
0
2
3
.4
0
8
6
.2
0
4
3
.0
0
6
5
.1
0
6
9
8
9
1
3
2
9
3
1
F
6
2
B
1
0
1
.1
0
2
5
.6
0
1
0
0
.1
0
1
3
5
.5
0
3
5
.7
5
2
6
2
.5
0
6
0
.8
0
1
3
7
.0
0
6
7
.2
5
1
1
3
.0
0
6
9
9
0
1
3
3
1
2
F
4
1
A
5
9
.8
5
1
7
.4
5
5
9
.6
0
1
3
1
.0
0
2
2
.2
5
1
6
0
.0
0
3
6
.4
5
9
2
.7
0
4
0
.3
0
8
4
.0
0
6
9
9
1
1
3
4
1
2
F
4
2
C
6
3
.4
0
1
6
.4
0
5
9
.2
0
9
7
.4
0
2
0
.9
0
1
6
8
.0
0
4
6
.6
5
7
9
.1
0
3
9
.3
0
7
4
.7
5
6
9
9
2
1
3
3
1
3
M
8
C
5
2
.9
5
1
2
.0
6
5
5
.1
0
8
7
.8
0
1
7
.5
0
1
7
6
.0
0
3
8
.4
0
7
4
.7
0
3
0
.7
0
6
7
.1
0
6
9
9
3
1
3
4
1
1
M
7
4
C
7
0
.3
0
1
8
.7
0
6
8
.7
0
9
4
.4
0
2
3
.6
0
2
6
2
.5
0
4
5
.8
5
1
3
3
.0
0
3
7
.3
0
8
7
.2
5
6
9
9
4
1
3
4
0
1
M
6
8
A
7
3
.6
5
2
5
.9
0
9
0
.3
5
1
4
5
.0
0
2
9
.4
0
2
2
1
.0
0
4
7
.8
5
1
2
6
.0
0
6
5
.8
5
1
0
0
.9
0
6
9
9
5
1
3
2
9
1
2
M
4
5
C
5
3
.5
5
1
5
.4
0
5
4
.8
0
9
5
.8
0
1
8
.6
5
1
9
8
.0
0
3
4
.5
0
7
0
.9
0
4
4
.0
5
6
7
.7
5
6
9
9
7
1
3
2
9
1
2
F
4
0
C
8
9
.1
0
2
5
.2
0
8
1
.0
0
1
3
7
.0
0
2
8
.8
0
2
0
6
.0
0
3
7
.8
5
9
3
.2
0
6
8
.9
0
1
3
8
.5
0
6
9
9
8
1
3
2
9
2
3
M
1
3
C
6
3
.5
5
1
7
.6
0
6
0
.4
0
8
5
.9
5
2
1
.4
5
2
0
5
.0
0
3
5
.8
5
8
2
.9
0
3
5
.0
5
8
3
.1
5
6
9
9
9
1
3
3
1
3
F
1
5
B
5
4
.2
0
1
4
.6
5
5
6
.2
0
9
9
.1
0
1
6
.9
0
1
7
9
.5
0
3
6
.5
0
8
2
.7
0
3
5
.1
0
6
7
.0
5
7
0
0
0
1
3
4
0
1
F
6
6
B
7
2
.9
5
2
0
.2
0
7
2
.3
5
1
3
7
.5
0
2
4
.6
0
1
8
4
.5
0
4
1
.1
0
9
8
.6
0
4
3
.0
0
9
3
.6
0
7
0
0
1
1
3
2
9
2
3
M
1
0
B
5
1
.8
0
1
3
.7
0
5
7
.1
5
1
2
7
.0
0
2
1
.0
0
1
4
8
.0
0
3
7
.5
0
8
6
.5
0
4
1
.7
5
7
7
.8
0
7
0
0
2
1
3
3
3
1
F
6
3
A
5
4
.9
0
1
8
.3
0
6
7
.0
5
9
1
.4
5
2
8
.2
0
1
8
2
.5
0
4
3
.8
5
1
2
9
.0
0
4
2
.0
0
7
5
.9
5
7
0
0
3
1
3
2
9
2
3
F
1
9
B
6
6
.1
5
2
0
.0
5
7
4
.8
5
1
2
1
.0
0
2
5
.4
0
2
0
5
.5
0
4
0
.8
5
1
0
4
.0
0
7
3
.3
0
9
0
.6
0
7
0
0
4
1
3
3
3
3
M
1
9
C
6
9
.7
0
1
7
.9
5
6
7
.4
0
1
0
5
.5
0
2
3
.9
5
2
0
5
.5
0
4
6
.8
0
9
9
.8
0
5
3
.2
5
8
1
.8
5
7
0
0
5
1
3
3
1
3
F
1
6
B
7
7
.9
0
1
9
.3
0
8
5
.3
0
1
3
0
.5
0
2
4
.5
5
2
2
8
.5
0
2
9
.3
0
1
2
3
.0
0
4
9
.4
0
9
4
.7
0
7
0
0
6
1
3
4
1
3
F
1
0
C
5
7
.4
0
1
6
.6
5
5
9
.6
5
8
6
.5
0
1
9
.4
5
1
6
7
.5
0
5
7
.7
5
1
0
9
.5
0
3
0
.6
5
7
4
.5
0
7
0
0
7
1
3
3
1
1
M
9
5
B
5
5
.1
0
1
4
.6
0
5
5
.5
0
9
5
.7
5
1
9
.3
5
1
7
3
.0
0
3
0
.4
0
9
6
.3
5
5
3
.8
5
7
2
.1
0
7
0
0
8
1
3
4
0
3
M
2
3
B
6
8
.8
0
2
0
.2
5
7
2
.3
5
1
1
9
.5
0
2
4
.6
0
1
6
7
.5
0
4
7
.2
0
1
1
6
.0
0
4
2
.3
0
8
5
.1
5
7
0
0
9
1
3
3
3
3
M
1
2
A
5
8
.5
0
1
8
.3
0
6
9
.1
0
1
1
5
.0
0
2
5
.7
5
1
9
4
.5
0
3
5
.2
0
1
0
7
.0
0
5
2
.8
0
7
8
.2
5
7
0
1
0
1
3
4
1
3
F
8
A
4
6
.0
5
1
4
.3
0
5
6
.2
0
1
1
3
.0
0
2
0
.4
5
1
1
5
.0
0
4
9
.2
0
7
8
.6
5
4
4
.2
5
9
7
.4
5
7
0
1
1
1
3
3
3
3
F
1
4
B
7
9
.2
0
2
3
.7
0
8
6
.2
0
1
5
1
.0
0
3
8
.4
5
2
4
5
.0
0
5
2
.8
0
1
2
0
.5
0
7
8
.5
5
9
8
.1
0
7
0
1
2
1
3
4
1
3
F
1
8
C
6
4
.8
5
1
8
.9
5
6
5
.6
5
1
1
5
.5
0
2
0
.6
0
2
0
8
.0
0
6
7
.8
0
1
0
6
.5
0
4
5
.2
0
7
8
.4
5
7
0
1
4
1
3
2
9
2
2
F
3
9
B
5
5
.7
5
1
5
.7
0
5
8
.3
5
1
0
4
.5
0
1
7
.8
5
1
1
6
.5
0
5
2
.6
0
7
9
.5
5
3
3
.3
5
7
1
.8
5
7
0
1
6
1
3
3
1
1
M
7
1
C
6
8
.4
5
1
7
.8
5
6
8
.7
5
1
4
8
.5
0
2
2
.8
5
2
3
8
.5
0
5
3
.1
5
8
7
.5
5
5
1
.0
5
8
1
.4
5
7
0
1
7
1
3
3
3
1
M
6
1
A
4
9
.4
0
1
4
.7
5
5
4
.8
5
9
9
.9
5
1
8
.7
5
1
4
3
.5
0
3
5
.8
5
8
7
.6
0
3
3
.5
0
6
8
.8
0
7
0
1
8
1
3
2
9
1
3
M
1
8
C
4
9
.0
5
1
4
.4
0
5
1
.1
0
1
1
4
.0
0
1
9
.1
0
1
7
6
.0
0
1
8
.8
0
7
3
.9
0
4
8
.4
0
6
2
.9
0
7
0
1
9
1
3
4
0
2
F
4
5
C
5
9
.0
5
1
6
.9
5
6
3
.1
5
1
0
8
.0
0
2
0
.6
5
1
8
5
.5
0
4
2
.9
0
8
4
.0
0
3
6
.4
5
7
2
.6
0
7
0
2
0
1
3
4
1
3
M
7
B
7
3
.1
0
2
1
.5
0
7
6
.7
5
1
2
3
.0
0
2
6
.6
5
2
4
0
.0
0
3
4
.5
0
1
3
0
.5
0
4
8
.3
5
9
7
.1
5
7
0
2
1
1
3
4
1
3
M
1
4
A
4
5
.9
0
1
3
.9
0
5
3
.3
5
1
2
2
.0
0
2
0
.6
5
1
3
7
.0
0
4
0
.5
0
6
5
.4
0
4
6
.4
5
5
6
.9
0
7
0
2
2
1
3
4
0
1
M
6
3
B
7
9
.4
5
2
4
.9
0
7
9
.1
5
1
4
7
.5
0
2
7
.1
0
2
2
7
.0
0
4
3
.7
5
1
2
4
.0
0
5
5
.5
5
1
0
4
.0
0
7
0
2
3
1
3
3
1
3
F
2
1
B
6
7
.1
5
1
8
.7
0
6
8
.3
0
1
1
3
.5
0
2
1
.7
0
2
3
2
.0
0
4
8
.3
0
9
7
.3
0
4
3
.4
0
8
1
.3
5
7
0
2
5
1
3
2
9
3
3
F
1
3
C
6
1
.1
0
1
6
.5
5
6
1
.4
0
1
3
1
.0
0
2
2
.2
0
2
0
1
.0
0
2
8
.1
0
8
1
.7
0
4
6
.9
5
7
3
.7
0
7
0
2
6
1
3
3
3
3
M
6
B
6
3
.7
0
1
6
.4
0
6
3
.2
0
1
2
4
.0
0
2
1
.0
5
2
0
7
.0
0
5
7
.1
0
7
7
.9
0
5
5
.1
5
7
9
.1
0
7
0
2
7
1
3
4
0
3
M
1
1
B
6
8
.0
0
1
9
.5
5
6
8
.6
0
1
1
0
.0
0
2
2
.3
5
1
2
6
.0
0
3
7
.9
0
1
0
7
.0
0
4
5
.6
5
8
9
.8
5
7
0
2
8
1
3
2
9
3
3
M
1
6
B
7
7
.6
5
2
3
.4
0
7
8
.3
0
1
4
6
.0
0
2
7
.2
0
1
9
9
.0
0
3
6
.4
0
1
2
0
.5
0
5
1
.2
0
8
5
.3
5
7
0
2
9
1
3
4
0
2
M
4
7
C
6
7
.1
5
1
9
.2
0
7
1
.3
5
1
1
5
.0
0
2
7
.5
0
2
1
4
.5
0
4
5
.7
5
9
7
.3
5
5
4
.2
0
8
4
.0
0
7
0
3
0
1
3
3
1
3
M
9
C
6
7
.4
0
1
7
.8
0
6
5
.5
0
1
3
5
.0
0
2
3
.0
5
2
0
3
.5
0
2
9
.1
0
9
9
.5
5
4
2
.1
0
8
1
.4
0
7
0
3
1
1
3
2
9
4
1
F
6
3
C
5
5
.5
5
1
4
.7
0
5
4
.8
5
7
3
.2
5
2
1
.4
0
1
8
6
.0
0
4
1
.4
5
7
4
.8
0
3
1
.8
0
6
6
.7
0
7
0
3
2
1
3
2
9
2
3
M
1
1
A
4
3
.2
5
1
5
.1
5
5
5
.5
0
9
6
.9
5
2
2
.5
0
1
2
6
.5
0
4
4
.6
0
9
4
.7
0
3
7
.0
0
6
9
.1
0
7
0
3
3
1
3
3
1
3
M
2
0
C
6
5
.0
0
1
8
.8
5
6
4
.5
0
1
1
3
.0
0
2
3
.4
0
1
9
1
.5
0
4
3
.3
0
1
0
5
.0
0
5
2
.3
5
8
2
.2
0
7
0
3
4
1
3
4
1
1
M
7
1
C
8
2
.3
0
2
3
.2
0
8
2
.4
0
1
6
5
.5
0
2
7
.4
0
2
6
1
.0
0
4
0
.4
0
1
2
8
.0
0
8
8
.3
5
9
9
.9
5
7
0
3
6
1
3
2
9
1
3
M
1
7
C
5
6
.7
5
1
5
.3
0
5
7
.1
0
1
0
5
.0
0
2
2
.5
5
1
7
3
.5
0
2
7
.2
0
7
4
.4
5
4
9
.3
0
7
1
.6
5
7
0
3
7
1
3
2
9
4
1
F
6
5
A
5
7
.4
0
1
7
.4
0
6
0
.7
0
1
1
5
.0
0
2
8
.4
0
1
7
0
.5
0
4
1
.7
5
7
4
.2
5
4
8
.0
5
7
4
.0
5
7
0
3
8
1
3
3
3
2
M
4
1
C
8
2
.1
0
2
1
.4
0
7
1
.6
5
1
2
9
.5
0
3
2
.4
5
1
9
6
.0
0
4
9
.9
0
1
0
1
.6
0
5
1
.2
0
9
4
.2
0
7
0
3
9
1
3
2
9
3
3
M
1
5
A
6
0
.3
0
1
8
.4
0
6
8
.6
0
1
2
7
.0
0
2
8
.6
0
1
9
8
.0
0
3
7
.5
5
1
1
4
.5
0
7
2
.6
0
7
6
.4
5
7
0
4
0
1
3
4
0
3
M
1
9
A
6
8
.9
0
2
2
.4
0
7
7
.9
0
1
0
4
.0
0
2
1
.9
0
1
9
1
.5
0
3
8
.6
5
1
2
1
.0
0
4
4
.1
5
8
2
.6
5
7
0
4
1
1
3
2
9
3
2
F
3
8
B
4
1
.7
5
1
4
.8
0
5
2
.8
5
1
1
8
.5
0
1
9
.5
0
1
5
4
.5
0
4
4
.3
0
7
4
.2
5
4
1
.6
0
7
1
.8
5
7
0
4
2
1
3
2
9
2
2
M
4
4
B
9
1
.0
5
3
1
.8
0
1
0
4
.0
0
1
2
0
.0
0
2
8
.1
5
2
8
5
.0
0
4
6
.4
5
1
3
7
.0
0
6
9
.5
0
1
0
7
.0
0
7
0
4
4
1
3
4
1
3
F
2
0
B
6
6
.6
0
1
6
.9
0
6
4
.9
0
7
9
.0
0
1
9
.1
5
2
0
2
.5
0
3
7
.6
0
1
1
6
.0
0
4
6
.8
5
8
2
.3
5
7
0
4
5
1
3
2
9
1
1
F
6
7
C
5
3
.8
5
1
3
.0
0
4
9
.7
5
1
2
6
.0
0
2
3
.0
0
1
4
7
.0
0
2
9
.6
0
7
5
.5
0
3
9
.5
0
7
0
.2
5
7
0
4
6
1
3
2
9
3
2
M
3
9
B
7
7
.6
0
2
2
.0
5
8
6
.5
0
1
2
7
.0
0
2
3
.0
0
2
6
7
.0
0
4
0
.0
0
1
0
3
.6
0
5
1
.8
0
8
5
.2
0
7
0
4
7
1
3
2
9
1
3
M
1
1
C
6
2
.7
5
1
8
.3
0
6
1
.3
5
1
0
3
.5
0
2
1
.1
0
1
7
6
.0
0
3
4
.9
0
8
2
.7
0
3
3
.9
0
7
5
.5
0
7
0
4
8
1
3
4
1
2
M
4
3
C
5
8
.3
5
1
6
.8
0
5
9
.4
0
1
2
5
.0
0
2
1
.5
0
1
7
0
.0
0
3
7
.0
5
8
1
.9
5
4
8
.7
5
7
2
.0
5
7
0
4
9
1
3
3
3
1
M
6
8
A
6
5
.1
0
2
2
.4
0
7
8
.2
0
1
2
2
.0
0
3
3
.3
0
2
3
6
.5
0
5
0
.9
5
1
0
6
.0
0
7
5
.8
5
7
4
.0
5
7
0
5
0
1
3
3
1
1
F
6
2
B
6
9
.9
0
1
8
.2
0
7
2
.2
0
1
2
7
.0
0
2
5
.5
0
2
0
6
.0
0
2
8
.5
0
1
0
0
.2
5
5
1
.1
0
8
7
.9
5
7
0
5
1
1
3
2
9
4
1
M
6
7
B
7
9
.0
5
2
3
.9
5
8
3
.2
0
1
0
9
.0
0
2
5
.2
5
2
0
3
.0
0
3
7
.5
0
1
1
6
.0
0
4
7
.2
0
9
2
.1
5
7
0
5
2
1
3
3
3
3
M
1
7
A
4
5
.5
0
1
5
.4
0
5
5
.9
0
1
0
5
.0
0
2
0
.9
0
1
4
2
.5
0
2
9
.6
0
9
7
.6
0
6
4
.3
5
6
9
.6
0
7
0
5
3
1
3
4
0
3
F
2
4
C
8
3
.6
0
2
4
.6
0
8
4
.2
0
1
3
1
.5
0
2
8
.0
0
2
3
5
.0
0
4
4
.1
0
1
0
5
.0
0
5
3
.1
5
1
0
8
.5
0
7
0
5
5
1
3
4
1
1
F
7
0
B
5
9
.8
0
1
5
.0
0
5
7
.6
0
9
0
.6
5
2
1
.6
5
1
7
4
.0
0
4
9
.2
0
9
1
.1
0
3
7
.8
5
7
1
.7
0
7
0
5
6
1
3
4
0
1
F
6
5
C
6
1
.3
0
1
6
.5
5
5
9
.4
0
1
0
3
.0
0
2
0
.9
0
1
7
6
.5
0
5
5
.4
0
7
8
.9
5
3
4
.5
0
7
2
.5
0
7
0
5
7
1
3
3
1
2
M
4
8
A
3
5
.0
0
1
0
.1
8
4
0
.8
5
1
3
7
.0
0
2
2
.2
5
1
1
5
.0
0
2
6
.7
0
1
2
1
.0
0
8
3
.0
0
1
0
9
.0
0
7
0
5
8
1
3
2
9
1
3
F
7
C
5
7
.3
0
1
6
.0
5
5
7
.0
5
9
3
.9
0
2
0
.4
0
1
8
8
.0
0
2
2
.8
0
8
5
.7
0
3
7
.5
0
7
2
.4
5
S
u
p
p
le
m
e
n
ta
l 
T
a
b
le
 1
: 
L
y
m
p
h
o
b
la
to
id
 C
e
ll
 L
in
e
 P
a
n
e
l 
(1
 o
f 
4
)
142
L
in
e
F
a
m
il
y
G
e
n
e
ra
ti
o
n
S
e
x
A
g
e
 (
Y
e
a
rs
)
P
la
te
M
e
d
ia
n
 C
D
4
 (
H
ig
h
)
M
e
d
ia
n
 C
D
4
 (
L
o
w
)
M
e
d
ia
n
 C
D
1
9
M
e
d
ia
n
 C
D
2
3
M
e
d
ia
n
 C
D
3
8
M
e
d
ia
n
 C
D
4
0
M
e
d
ia
n
 C
D
4
5
R
A
M
e
d
ia
n
 C
D
8
6
M
e
d
ia
n
 I
C
A
M
-1
M
e
d
ia
n
 T
L
R
-9
7
0
5
9
1
3
3
1
3
F
1
8
C
4
7
.7
5
1
4
.1
0
5
1
.2
0
7
9
.7
5
1
7
.3
5
1
6
4
.5
0
4
1
.8
5
6
6
.5
5
3
0
.5
0
6
2
.0
5
7
0
6
0
1
3
2
9
3
3
M
1
1
B
6
7
.5
0
1
9
.8
5
7
3
.1
0
1
2
3
.0
0
2
8
.7
0
2
0
4
.0
0
3
4
.7
0
1
2
2
.5
0
3
9
.7
5
8
5
.9
5
7
0
6
1
1
3
2
9
3
3
M
8
A
5
1
.0
0
1
5
.9
5
5
5
.3
5
1
1
7
.0
0
2
5
.5
0
1
2
5
.5
0
3
4
.3
5
9
1
.5
5
3
9
.7
5
1
0
0
.8
5
7
0
6
2
1
3
4
0
3
F
2
7
C
7
1
.0
0
1
9
.6
0
6
7
.7
0
1
0
7
.5
0
2
3
.4
0
1
8
9
.0
0
4
4
.5
5
9
5
.1
5
3
4
.1
0
8
5
.7
0
7
3
4
0
1
3
3
1
1
F
8
3
A
2
8
.3
0
1
1
.6
5
3
3
.2
0
1
2
9
.0
0
1
4
.5
5
1
3
4
.0
0
2
7
.1
0
7
9
.5
5
5
0
.1
0
7
8
.8
0
7
3
4
1
1
3
3
3
1
F
6
1
C
5
0
.2
5
1
4
.1
0
5
0
.1
0
1
3
6
.5
0
2
3
.0
0
1
8
0
.5
0
4
4
.5
5
8
5
.3
0
5
5
.5
5
6
4
.2
5
7
3
4
2
1
3
4
0
3
M
1
6
B
7
0
.2
0
2
3
.0
0
8
4
.6
5
1
3
0
.0
0
2
6
.2
5
2
0
5
.5
0
6
6
.3
5
1
0
5
.0
0
5
1
.0
0
1
1
1
.5
0
7
3
4
3
1
3
4
1
3
F
2
2
A
4
2
.4
5
1
4
.2
0
5
2
.6
0
9
5
.9
0
1
9
.2
0
9
4
.8
5
5
4
.8
5
7
8
.5
0
3
1
.5
0
7
1
.6
0
7
3
4
4
1
3
4
1
3
F
1
7
A
4
2
.6
5
1
3
.4
0
4
7
.6
0
1
1
2
.5
0
1
6
.7
5
1
1
2
.5
0
2
5
.5
5
7
4
.4
0
3
8
.0
0
7
6
.8
0
7
3
4
5
1
3
4
5
1
F
6
9
C
5
7
.1
0
1
6
.5
5
5
7
.4
5
9
8
.3
5
2
1
.3
5
2
0
5
.0
0
4
8
.7
0
7
5
.9
0
4
1
.8
5
6
8
.2
5
7
3
4
6
1
3
4
5
1
F
8
5
B
6
5
.5
0
1
8
.0
0
6
2
.1
0
1
2
4
.0
0
2
1
.9
5
1
5
7
.0
0
4
0
.2
5
9
5
.6
5
5
1
.5
0
8
0
.2
5
7
3
4
7
1
3
4
5
1
M
8
6
A
2
9
.3
0
2
8
.9
5
9
4
.4
0
1
3
1
.0
0
3
7
.1
5
2
6
1
.0
0
4
9
.9
0
1
4
0
.0
0
9
8
.4
5
9
3
.6
0
7
3
4
8
1
3
4
5
2
F
4
5
C
7
8
.7
5
2
1
.8
5
8
4
.0
0
1
5
0
.5
0
2
6
.7
5
2
2
1
.0
0
4
6
.2
0
1
0
9
.0
0
4
8
.7
5
9
2
.8
0
7
3
4
9
1
3
4
5
2
M
4
9
C
5
9
.1
0
1
6
.0
5
5
5
.8
0
1
1
5
.0
0
1
8
.7
0
1
3
9
.5
0
2
8
.8
5
7
7
.4
0
4
0
.2
5
6
9
.2
5
7
3
5
0
1
3
4
5
3
F
2
5
B
5
5
.3
5
1
5
.2
0
5
9
.3
0
1
0
1
.7
5
1
6
.1
0
1
0
4
.9
0
3
8
.9
5
7
8
.3
5
3
1
.5
0
6
9
.2
0
7
3
5
1
1
3
4
5
3
M
2
3
B
6
2
.7
5
1
6
.8
0
6
3
.3
0
1
1
2
.5
0
2
0
.5
0
1
5
9
.5
0
4
1
.1
5
8
8
.0
5
3
4
.3
0
7
5
.8
5
7
3
5
2
1
3
4
5
3
M
2
2
C
6
4
.5
0
1
8
.5
0
6
5
.4
0
1
1
8
.0
0
2
3
.5
0
1
8
5
.5
0
3
9
.7
5
9
0
.7
5
5
5
.7
5
7
6
.0
5
7
3
5
3
1
3
4
5
3
M
2
0
B
5
7
.1
0
1
5
.8
0
5
7
.1
0
8
1
.0
5
1
8
.9
5
1
5
2
.5
0
3
5
.4
0
7
3
.6
5
3
0
.9
0
6
9
.7
0
7
3
5
4
1
3
4
5
3
F
1
9
A
5
0
.9
0
1
6
.0
0
5
4
.5
5
1
0
2
.0
0
1
9
.0
5
1
2
1
.0
0
2
6
.4
5
8
2
.2
5
3
4
.5
0
6
9
.2
5
7
3
5
5
1
3
4
5
3
M
1
6
B
7
9
.4
0
2
5
.2
0
9
1
.3
0
1
7
2
.0
0
2
9
.6
5
2
2
8
.5
0
4
7
.1
5
1
2
6
.0
0
6
2
.8
5
1
0
2
.3
5
7
3
5
6
1
3
4
5
3
M
1
3
C
N
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
7
9
.1
0
7
3
5
7
1
3
4
5
1
M
6
9
B
7
1
.4
0
2
0
.8
5
7
9
.0
0
1
1
7
.5
0
2
4
.5
0
1
5
9
.5
0
3
4
.5
0
1
2
8
.5
0
4
0
.8
5
8
6
.3
5
7
4
3
1
1
3
2
9
2
3
M
9
C
6
4
.1
0
1
7
.3
5
6
2
.6
5
1
2
4
.5
0
2
5
.2
0
1
9
0
.5
0
4
0
.0
0
8
3
.7
5
4
4
.1
0
8
1
.1
5
7
4
3
2
1
3
2
9
3
3
M
6
A
4
6
.3
0
1
4
.5
5
5
5
.4
0
9
4
.2
0
2
1
.6
5
9
1
.2
5
4
2
.6
5
8
6
.9
5
4
7
.5
5
8
7
.1
5
7
4
3
3
1
3
2
9
1
3
M
N
A
C
5
8
.8
0
1
6
.9
5
6
0
.9
5
1
2
1
.0
0
1
9
.6
0
2
1
5
.0
0
2
3
.9
0
8
2
.8
5
4
6
.6
5
7
2
.5
5
7
4
3
5
1
3
2
9
4
1
M
7
7
A
4
7
.7
0
1
3
.4
0
5
1
.0
0
1
0
0
.4
0
2
9
.7
0
1
0
6
.5
0
4
1
.4
5
9
9
.2
5
5
1
.3
5
8
9
.4
5
7
4
3
6
1
3
2
9
2
3
F
1
8
A
6
7
.4
0
2
2
.1
5
7
4
.7
0
1
1
5
.0
0
2
8
.3
5
1
5
5
.5
0
3
1
.6
0
1
2
9
.0
0
5
4
.5
5
9
0
.8
0
7
4
3
7
1
3
2
9
3
3
F
1
2
A
5
6
.0
5
1
6
.2
0
5
7
.2
5
8
0
.9
0
3
3
.5
0
9
5
.2
0
4
2
.8
0
9
4
.6
0
3
5
.2
0
7
4
.1
0
7
6
7
8
1
3
3
3
3
M
1
2
B
5
3
.9
5
1
4
.7
0
5
6
.8
5
9
5
.5
5
1
8
.8
0
1
6
1
.0
0
4
0
.2
5
7
1
.9
5
4
0
.3
0
6
9
.1
5
7
6
7
9
1
3
3
3
3
M
6
C
6
1
.9
0
1
5
.9
0
6
1
.5
5
1
0
6
.0
0
1
9
.6
0
2
2
2
.5
0
4
3
.5
0
8
7
.6
0
4
8
.1
5
7
8
.0
5
7
6
9
4
1
3
2
9
2
3
F
1
7
B
4
6
.7
5
1
4
.6
0
5
3
.4
5
1
0
5
.5
0
1
9
.0
0
1
2
0
.0
0
3
3
.0
5
7
7
.4
0
3
7
.6
5
7
5
.1
5
1
0
8
3
2
1
4
1
3
2
M
4
9
B
9
9
.0
0
2
9
.9
0
1
0
7
.0
0
1
6
1
.0
0
3
6
.2
0
2
9
3
.0
0
7
9
.2
0
1
3
0
.0
0
7
0
.5
0
1
2
5
.0
0
1
0
8
3
3
1
4
1
3
2
F
4
8
A
7
1
.1
0
2
4
.8
5
8
0
.8
0
1
1
6
.0
0
3
6
.1
0
2
7
2
.0
0
4
6
.6
0
9
9
.1
0
6
3
.2
0
1
0
9
.6
5
1
0
8
3
4
1
4
1
6
2
F
4
0
C
5
2
.5
0
1
4
.6
0
5
4
.4
5
1
0
6
.5
0
1
8
.9
0
1
8
1
.5
0
3
4
.5
0
7
0
.2
0
3
7
.8
5
6
5
.5
5
1
0
8
3
5
1
4
1
6
2
M
3
9
B
5
6
.3
0
1
4
.2
0
5
8
.3
5
8
5
.3
5
2
9
.2
0
1
4
3
.5
0
3
0
.9
0
7
4
.7
0
3
8
.2
0
6
7
.2
0
1
0
8
3
8
1
4
2
0
2
M
6
0
C
6
9
.7
5
1
9
.1
0
7
2
.0
5
1
1
1
.5
0
2
9
.6
5
2
1
4
.5
0
5
1
.7
5
9
6
.8
0
5
2
.3
0
8
6
.9
0
1
0
8
3
9
1
4
2
0
2
F
5
5
A
6
5
.2
0
1
9
.0
5
6
8
.6
0
1
0
1
.2
5
3
0
.9
5
1
6
3
.0
0
5
6
.3
0
9
1
.0
0
4
6
.0
0
8
3
.2
0
1
0
8
4
2
1
4
2
3
2
M
4
3
C
5
0
.7
5
1
4
.2
0
5
2
.6
5
1
3
1
.0
0
1
6
.8
5
1
2
0
.5
0
3
4
.6
5
6
6
.3
0
3
5
.2
5
6
4
.7
5
1
0
8
4
3
1
4
2
3
2
F
4
9
A
5
4
.6
5
1
9
.2
5
6
7
.7
0
1
1
2
.0
0
2
5
.9
0
1
2
5
.0
0
3
7
.1
5
1
2
6
.0
0
5
1
.0
5
1
0
3
.6
0
1
0
8
4
4
1
4
2
4
2
F
5
0
B
6
5
.6
0
1
7
.5
5
6
8
.2
5
1
1
3
.0
0
2
4
.9
5
1
5
7
.5
0
3
5
.5
0
9
5
.2
0
4
3
.3
5
9
0
.5
5
1
0
8
4
5
1
4
2
4
2
M
4
9
B
6
0
.2
5
1
6
.1
0
6
2
.7
5
9
7
.5
0
2
3
.4
0
1
5
8
.5
0
3
4
.8
0
9
2
.2
0
3
9
.0
0
7
4
.1
0
1
0
8
4
8
1
3
3
2
2
M
4
8
B
5
7
.1
0
1
5
.3
0
5
8
.4
5
8
9
.1
5
3
0
.1
5
1
5
0
.5
0
2
5
.9
5
9
4
.8
0
4
5
.4
0
7
1
.1
5
1
0
8
4
9
1
3
3
2
2
F
4
8
B
5
8
.6
5
1
6
.3
5
6
3
.7
0
8
3
.8
0
3
0
.4
0
2
1
1
.0
0
4
0
.7
0
1
0
1
.2
5
5
3
.3
0
8
2
.3
0
1
0
8
5
0
1
3
4
4
2
F
4
8
C
5
4
.3
0
1
4
.6
0
5
5
.6
0
1
1
4
.0
0
1
9
.6
5
1
6
3
.5
0
3
2
.8
0
7
7
.4
0
4
0
.0
5
7
0
.4
5
1
0
8
5
1
1
3
4
4
2
M
5
2
A
5
6
.2
0
1
6
.9
0
5
9
.9
0
1
1
9
.0
0
2
5
.0
5
1
3
3
.0
0
4
7
.4
0
8
9
.2
0
4
4
.6
5
8
2
.6
0
1
0
8
5
2
1
3
4
6
2
F
4
8
A
4
9
.2
5
1
4
.2
5
5
2
.9
0
9
0
.7
0
1
8
.2
0
1
3
7
.5
0
3
7
.2
5
8
5
.6
0
4
2
.0
5
6
5
.6
5
1
0
8
5
3
1
3
4
9
2
M
4
5
C
6
0
.0
5
1
6
.6
5
6
1
.4
0
1
1
6
.0
0
2
8
.0
0
2
0
5
.0
0
3
4
.0
0
9
3
.8
0
4
5
.1
0
7
7
.7
0
1
0
8
5
4
1
3
4
9
2
F
4
2
A
6
0
.1
0
1
9
.0
0
6
2
.6
5
9
3
.4
0
2
1
.8
5
1
6
2
.5
0
4
2
.0
0
9
4
.6
5
3
3
.8
0
7
8
.0
0
1
0
8
5
7
1
3
4
6
2
M
4
7
A
5
1
.7
0
1
8
.7
0
6
6
.5
5
1
2
7
.5
0
2
5
.0
5
1
6
5
.5
0
4
5
.3
5
8
8
.5
5
4
8
.1
5
7
7
.7
5
1
0
8
5
8
1
3
4
7
2
M
4
2
A
3
9
.4
5
1
4
.2
5
5
1
.5
5
1
1
3
.5
0
2
8
.4
5
1
0
7
.5
0
4
1
.9
0
9
7
.5
5
4
1
.7
0
1
0
2
.0
5
1
0
8
5
9
1
3
4
7
2
F
4
1
A
4
2
.7
5
1
4
.0
5
5
4
.1
5
9
7
.0
0
3
0
.0
5
7
9
.4
5
3
9
.5
0
8
4
.2
0
4
4
.3
5
8
6
.1
0
1
0
8
6
0
1
3
6
2
2
M
5
0
B
6
8
.0
0
1
9
.3
0
7
6
.2
5
1
3
7
.0
0
2
3
.8
5
1
9
7
.5
0
4
9
.3
5
9
4
.4
5
5
0
.7
0
8
6
.2
5
1
0
8
6
1
1
3
6
2
2
F
4
9
A
8
8
.3
0
3
2
.1
0
1
0
7
.0
0
1
9
7
.0
0
3
6
.1
0
2
7
7
.5
0
4
2
.4
0
1
5
3
.0
0
8
0
.0
0
1
1
2
.0
0
1
1
8
3
3
1
3
4
9
3
F
2
4
B
5
4
.5
0
1
4
.5
0
5
4
.5
5
9
8
.5
5
1
7
.9
0
1
7
7
.0
0
5
3
.4
5
7
4
.3
5
3
1
.2
0
6
7
.0
5
1
1
8
3
5
1
3
4
9
3
F
1
8
A
4
1
.8
0
1
2
.3
0
4
7
.2
0
1
0
7
.5
0
2
1
.1
5
9
2
.5
0
3
3
.7
0
7
8
.2
0
5
4
.4
0
7
8
.1
5
1
1
8
3
6
1
3
4
9
3
F
1
7
C
6
3
.0
5
1
6
.9
5
7
2
.6
5
1
2
5
.0
0
2
9
.1
5
2
1
1
.5
0
3
8
.4
5
9
5
.1
0
4
6
.3
0
8
3
.3
0
1
1
8
3
7
1
3
4
9
3
F
9
A
4
2
.6
0
1
3
.5
0
4
6
.5
0
8
6
.7
5
2
2
.7
0
1
1
6
.5
0
3
0
.5
0
7
0
.8
5
3
5
.6
0
7
1
.9
5
1
1
8
3
8
1
3
4
9
3
M
5
A
6
0
.6
0
2
1
.0
0
7
7
.7
0
1
2
0
.5
0
N
A
1
5
2
.5
0
4
5
.4
5
9
3
.4
0
4
1
.8
5
8
5
.3
5
1
1
8
3
9
1
3
4
9
1
M
6
7
B
N
A
N
A
1
5
1
.0
0
N
A
N
A
N
A
N
A
N
A
6
1
.9
0
1
1
1
.0
0
1
1
8
4
0
1
3
4
9
1
F
6
7
C
5
6
.1
5
1
5
.6
0
5
8
.5
0
1
3
2
.0
0
3
3
.2
5
1
5
1
.5
0
3
6
.8
0
9
4
.7
0
3
4
.9
0
7
2
.8
5
1
1
8
4
1
1
3
4
9
3
M
2
3
C
5
8
.2
5
1
6
.1
5
5
8
.3
0
1
0
2
.5
0
2
0
.4
0
1
7
4
.0
0
2
9
.7
5
7
6
.4
0
3
0
.6
0
7
2
.3
0
1
1
8
4
2
1
3
4
9
3
F
2
1
A
3
1
.7
0
1
0
.8
5
4
0
.5
5
9
0
.3
5
2
0
.2
0
7
1
.8
0
2
9
.5
5
1
0
0
.5
0
3
6
.7
5
7
0
.7
5
1
1
8
4
3
1
3
4
9
1
M
7
7
C
6
1
.5
5
1
7
.3
0
6
0
.9
0
1
1
6
.5
0
2
1
.1
0
1
5
2
.0
0
3
9
.8
0
7
9
.9
5
3
8
.0
5
7
7
.0
0
1
1
8
7
0
1
3
4
7
3
F
2
1
C
7
3
.7
0
2
3
.0
0
8
5
.9
0
1
3
9
.0
0
3
0
.6
0
2
4
5
.5
0
4
5
.1
0
1
0
0
.0
0
5
3
.6
0
9
1
.5
0
1
1
8
7
1
1
3
4
7
3
M
1
9
B
4
7
.8
5
1
3
.2
0
4
7
.7
0
8
7
.2
5
2
0
.1
5
1
3
8
.0
0
4
8
.8
5
8
3
.9
5
3
4
.8
0
7
4
.4
0
1
1
8
7
2
1
3
4
7
3
M
1
8
B
4
9
.0
5
1
3
.6
5
5
0
.2
5
9
1
.2
0
1
8
.1
5
1
2
3
.5
0
4
2
.0
0
7
3
.6
0
4
1
.2
5
6
8
.9
5
1
1
8
7
3
1
3
4
7
3
M
1
6
C
5
1
.9
5
1
4
.8
0
5
5
.5
0
1
0
2
.5
0
2
8
.0
0
1
6
6
.0
0
3
6
.7
0
7
7
.5
0
4
3
.7
5
6
7
.3
0
1
1
8
7
4
1
3
4
7
3
F
1
6
B
5
5
.5
5
1
6
.8
0
6
0
.0
0
1
1
7
.0
0
2
2
.0
5
1
5
3
.0
0
3
6
.6
5
7
9
.4
0
5
4
.6
0
8
2
.9
5
1
1
8
7
5
1
3
4
7
3
F
1
3
B
4
9
.3
0
1
3
.7
0
5
0
.7
5
8
2
.7
5
2
2
.6
5
1
0
7
.0
0
3
8
.1
5
7
4
.8
0
3
9
.5
0
6
6
.9
5
1
1
8
7
6
1
3
4
7
3
M
1
1
A
8
1
.6
0
2
3
.2
0
9
6
.7
5
1
7
3
.0
0
3
9
.4
0
2
4
7
.0
0
4
7
.5
5
1
1
2
.0
0
8
1
.0
0
9
8
.0
0
1
1
8
7
7
1
3
4
7
3
M
8
B
7
4
.2
0
2
0
.3
0
7
7
.0
0
1
1
5
.0
0
2
6
.0
0
2
4
9
.0
0
4
3
.8
5
9
6
.2
0
6
7
.9
0
8
9
.3
5
1
1
8
7
8
1
3
4
7
3
M
6
C
4
8
.3
5
1
3
.5
5
4
8
.5
5
7
6
.1
0
2
1
.4
0
1
4
1
.0
0
3
7
.5
5
6
3
.5
0
3
8
.0
0
5
6
.5
0
S
u
p
p
le
m
e
n
ta
l 
T
a
b
le
 1
: 
L
y
m
p
h
o
b
la
to
id
 C
e
ll
 L
in
e
 P
a
n
e
l 
(2
 o
f 
4
)
143
L
in
e
F
a
m
il
y
G
e
n
e
ra
ti
o
n
S
e
x
A
g
e
 (
Y
e
a
rs
)
P
la
te
M
e
d
ia
n
 C
D
4
 (
H
ig
h
)
M
e
d
ia
n
 C
D
4
 (
L
o
w
)
M
e
d
ia
n
 C
D
1
9
M
e
d
ia
n
 C
D
2
3
M
e
d
ia
n
 C
D
3
8
M
e
d
ia
n
 C
D
4
0
M
e
d
ia
n
 C
D
4
5
R
A
M
e
d
ia
n
 C
D
8
6
M
e
d
ia
n
 I
C
A
M
-1
M
e
d
ia
n
 T
L
R
-9
1
1
8
7
9
1
3
4
7
1
M
6
6
A
3
0
.8
0
1
0
.2
0
4
2
.6
5
8
0
.1
0
2
1
.0
0
5
6
.1
0
4
1
.5
5
8
1
.5
5
3
4
.6
0
8
7
.2
5
1
1
8
8
1
1
3
4
7
1
M
6
2
C
4
8
.5
0
1
3
.5
5
5
0
.5
0
7
8
.9
0
2
1
.3
0
1
4
9
.5
0
3
5
.7
5
6
5
.6
0
4
2
.0
5
6
1
.2
0
1
1
8
8
2
1
3
4
7
1
F
6
1
B
7
7
.7
5
2
1
.0
0
7
9
.0
0
1
2
8
.0
0
2
6
.7
0
1
5
5
.5
0
4
9
.5
0
1
0
5
.0
0
4
9
.3
5
9
2
.0
0
1
1
9
0
9
1
4
2
3
3
M
1
9
B
5
7
.8
0
1
5
.7
0
6
0
.6
5
9
2
.4
5
1
8
.4
5
1
6
4
.0
0
3
9
.4
5
8
5
.9
0
3
1
.8
5
7
1
.0
5
1
1
9
1
0
1
4
2
3
3
F
1
7
B
5
4
.3
0
1
4
.8
0
5
9
.7
5
9
9
.1
0
2
0
.4
5
9
9
.4
5
5
6
.8
0
9
6
.3
0
3
9
.1
0
9
9
.1
5
1
1
9
1
1
1
4
2
3
3
F
1
5
B
6
1
.6
5
1
8
.1
0
6
1
.9
0
9
3
.5
0
1
9
.9
0
1
7
4
.5
0
5
4
.4
0
9
3
.2
5
3
2
.6
0
7
6
.8
0
1
1
9
1
2
1
4
2
3
3
M
1
2
C
7
0
.6
5
1
9
.0
5
7
0
.9
5
9
7
.8
5
2
3
.6
5
2
2
0
.5
0
3
7
.1
0
1
0
2
.0
0
5
2
.5
5
8
0
.9
0
1
1
9
1
3
1
4
2
3
3
M
1
1
C
6
2
.3
0
1
6
.9
0
6
3
.3
5
1
1
8
.5
0
2
2
.9
5
2
0
0
.5
0
5
0
.6
0
8
8
.0
5
4
5
.9
5
7
9
.5
0
1
1
9
1
4
1
4
2
3
3
F
9
C
5
1
.5
5
1
4
.5
0
5
0
.6
5
9
4
.7
0
1
7
.7
0
1
5
4
.5
0
3
9
.9
0
6
7
.2
5
3
6
.7
0
6
1
.8
5
1
1
9
1
5
1
4
2
3
3
F
8
A
4
2
.4
0
1
3
.7
0
5
1
.2
0
1
5
0
.0
0
1
7
.8
5
9
6
.5
5
2
5
.8
5
1
1
4
.0
0
6
0
.2
0
8
4
.1
5
1
1
9
1
6
1
4
2
3
3
M
5
C
5
7
.7
5
1
6
.8
0
5
8
.8
5
1
0
2
.5
0
1
9
.4
0
1
8
9
.5
0
4
7
.8
5
8
8
.8
5
3
4
.6
0
7
5
.0
0
1
1
9
1
7
1
4
2
3
1
M
6
6
A
2
9
.3
5
8
.2
5
3
5
.7
0
1
6
7
.5
0
1
3
.1
5
5
3
.1
5
3
7
.5
0
7
3
.4
0
5
4
.0
0
9
2
.3
0
1
1
9
1
8
1
4
2
3
1
F
6
4
A
3
5
.9
0
1
3
.2
0
4
9
.2
0
1
3
7
.0
0
2
1
.8
0
1
1
6
.0
0
4
0
.8
5
1
1
3
.5
0
4
0
.4
0
6
8
.0
0
1
1
9
1
9
1
4
2
3
1
M
6
7
B
5
1
.3
5
1
5
.3
0
5
5
.5
5
1
2
7
.0
0
2
0
.9
0
1
3
1
.0
0
3
6
.3
0
9
1
.2
5
5
5
.5
0
7
8
.1
5
1
1
9
2
0
1
4
2
3
1
F
6
6
A
4
2
.2
5
1
2
.7
5
4
9
.3
5
1
2
8
.0
0
2
2
.4
0
7
7
.6
5
3
1
.1
0
9
4
.0
5
6
5
.7
0
7
5
.8
0
1
1
9
2
1
1
4
2
3
3
F
7
B
2
9
.3
0
8
.5
2
3
7
.3
0
1
1
2
.0
0
1
1
.5
0
7
7
.1
5
3
0
.0
0
7
6
.7
5
4
4
.8
0
8
5
.2
5
1
1
9
2
2
1
4
2
4
3
M
3
0
C
5
0
.8
0
1
3
.7
0
5
0
.1
0
7
7
.5
0
1
9
.6
0
1
3
5
.5
0
2
6
.3
0
7
6
.9
0
2
6
.8
0
6
0
.6
0
1
1
9
2
3
1
4
2
4
3
M
2
9
A
4
2
.4
0
1
2
.7
5
4
8
.9
0
1
1
8
.5
0
2
5
.0
5
9
8
.3
5
3
1
.2
5
9
2
.5
0
4
3
.6
0
6
7
.9
5
1
1
9
2
4
1
4
2
4
3
F
2
7
A
4
6
.4
5
1
3
.2
5
4
5
.3
5
1
7
6
.0
0
2
3
.2
0
8
2
.3
5
3
5
.7
5
7
6
.5
5
5
1
.0
0
1
0
3
.0
0
1
1
9
2
5
1
4
2
4
3
M
2
5
B
6
5
.1
5
1
8
.5
0
6
5
.9
5
8
9
.8
0
2
1
.4
0
1
7
7
.0
0
4
6
.7
0
9
5
.9
5
3
0
.7
0
8
2
.7
5
1
1
9
2
6
1
4
2
4
3
F
2
1
B
6
3
.1
0
1
8
.3
0
6
1
.8
0
1
1
2
.0
0
2
0
.8
0
2
0
8
.0
0
5
3
.8
0
8
9
.3
5
3
5
.5
0
7
6
.7
5
1
1
9
2
7
1
4
2
4
3
M
1
9
A
4
4
.7
0
1
3
.0
0
4
8
.8
5
8
3
.8
0
2
0
.6
5
1
4
6
.5
0
3
0
.8
0
7
0
.1
5
3
9
.8
5
6
5
.1
5
1
1
9
2
8
1
4
2
4
3
M
1
5
A
5
2
.3
5
1
6
.7
0
6
0
.0
5
1
2
4
.0
0
2
2
.4
0
1
4
4
.0
0
3
4
.9
0
8
5
.6
5
3
0
.3
0
8
5
.5
5
1
1
9
2
9
1
4
2
4
3
M
1
3
B
5
6
.7
5
1
6
.3
0
5
8
.6
0
1
2
0
.5
0
1
7
.5
5
1
9
2
.0
0
3
3
.5
0
7
4
.9
5
4
1
.7
0
7
0
.9
0
1
1
9
3
0
1
4
2
4
1
M
N
A
B
5
7
.7
0
1
6
.9
0
6
2
.6
0
1
3
4
.5
0
2
3
.2
5
1
6
1
.5
0
3
2
.7
5
8
5
.2
5
5
6
.7
0
7
7
.3
0
1
1
9
3
1
1
4
2
4
1
F
7
8
C
6
0
.4
5
1
7
.1
0
6
3
.8
0
1
1
5
.5
0
2
3
.5
5
2
1
7
.0
0
2
5
.7
0
9
0
.4
0
3
9
.6
5
7
3
.9
0
1
1
9
3
2
1
4
2
4
1
M
7
6
A
5
2
.3
0
1
4
.5
0
5
9
.7
0
1
2
6
.5
0
2
0
.9
5
1
2
0
.5
0
2
9
.4
5
7
4
.5
5
5
0
.3
0
9
8
.7
5
1
1
9
3
3
1
4
2
4
1
F
7
4
C
6
9
.9
0
2
0
.0
0
7
5
.2
5
1
1
1
.0
0
2
6
.4
5
2
1
4
.0
0
3
7
.0
5
1
2
6
.0
0
4
5
.5
5
8
8
.8
5
1
1
9
8
2
1
3
6
2
3
F
2
8
B
6
8
.2
0
1
8
.0
5
7
0
.5
0
1
1
3
.5
0
2
3
.1
0
1
9
6
.5
0
4
5
.4
0
8
7
.6
0
3
6
.5
0
7
7
.3
5
1
1
9
8
4
1
3
6
2
3
M
2
6
A
4
6
.8
5
1
5
.3
0
5
4
.8
0
9
2
.2
0
1
8
.8
0
1
2
9
.0
0
5
9
.7
0
8
5
.9
0
3
0
.1
0
6
6
.0
0
1
1
9
8
5
1
3
6
2
3
F
2
4
B
5
8
.5
0
1
6
.7
0
6
4
.9
0
1
1
4
.5
0
1
9
.5
0
1
9
0
.0
0
2
9
.6
5
1
0
5
.5
0
2
7
.3
5
8
1
.0
5
1
1
9
8
6
1
3
6
2
3
F
2
2
B
7
8
.8
0
2
2
.8
0
8
1
.0
0
1
2
8
.5
0
2
7
.6
5
2
1
1
.5
0
3
6
.9
5
1
1
5
.5
0
3
7
.9
5
1
0
3
.0
0
1
1
9
8
7
1
3
6
2
3
M
1
9
B
6
7
.3
5
2
0
.0
5
7
2
.9
0
1
6
7
.0
0
2
6
.4
0
1
8
5
.0
0
4
8
.6
0
9
3
.4
5
6
4
.0
5
8
3
.2
5
1
1
9
8
8
1
3
6
2
3
F
1
7
B
6
4
.1
5
1
7
.4
0
6
9
.1
5
1
2
0
.0
0
2
2
.8
5
1
4
9
.5
0
7
8
.2
0
9
0
.1
5
4
1
.1
0
8
1
.4
5
1
1
9
8
9
1
3
6
2
3
F
1
4
C
6
4
.7
0
1
8
.1
5
6
0
.5
0
1
1
1
.0
0
2
1
.5
0
1
9
7
.5
0
4
5
.4
5
7
8
.2
5
2
8
.3
5
7
8
.2
0
1
1
9
9
0
1
3
6
2
3
M
9
B
8
6
.4
5
2
7
.6
0
1
0
4
.0
0
1
8
6
.0
0
3
4
.2
0
3
1
7
.5
0
4
9
.9
0
1
4
1
.5
0
8
6
.7
0
1
1
6
.5
0
1
1
9
9
1
1
3
6
2
3
F
7
A
4
2
.0
5
1
3
.7
5
5
5
.1
0
1
6
7
.5
0
1
8
.8
0
8
2
.3
0
4
4
.3
5
7
4
.2
0
7
2
.8
5
8
1
.0
0
1
1
9
9
2
1
3
6
2
1
M
8
6
C
5
3
.1
5
1
5
.0
5
5
5
.5
0
8
8
.7
0
1
8
.6
0
1
5
5
.5
0
5
1
.6
0
7
3
.3
0
2
8
.9
0
6
9
.4
5
1
1
9
9
3
1
3
6
2
1
F
8
0
B
6
2
.7
5
1
7
.1
5
6
4
.3
0
9
9
.5
0
2
0
.9
0
1
4
3
.0
0
3
4
.8
0
1
0
1
.3
5
3
6
.2
0
7
8
.5
0
1
1
9
9
4
1
3
6
2
1
M
8
0
A
4
8
.6
0
1
6
.2
0
5
3
.3
0
1
0
4
.1
5
2
2
.4
0
1
1
1
.0
0
4
9
.3
5
7
2
.0
5
4
5
.5
5
7
3
.8
0
1
1
9
9
5
1
3
6
2
1
F
8
4
A
4
2
.3
5
1
5
.3
5
5
4
.3
5
7
8
.0
0
1
9
.3
0
1
2
8
.0
0
5
6
.3
5
8
0
.6
0
3
5
.0
0
6
8
.7
0
1
1
9
9
6
1
3
6
2
3
M
2
1
B
7
0
.1
5
1
9
.4
0
7
2
.4
5
1
1
6
.0
0
2
4
.5
0
2
0
5
.0
0
5
2
.8
5
1
1
5
.5
0
4
1
.4
0
8
7
.3
5
1
1
9
9
7
1
4
2
0
3
F
3
1
A
5
2
.4
0
2
0
.2
0
7
0
.5
0
1
2
3
.0
0
2
5
.3
5
1
2
7
.5
0
4
7
.5
0
9
7
.5
0
4
0
.0
5
7
6
.8
0
1
1
9
9
8
1
4
2
0
3
F
2
7
B
1
1
0
.0
0
2
7
.2
5
8
9
.5
0
1
2
7
.0
0
3
2
.1
0
1
9
4
.0
0
4
9
.4
5
1
1
4
.0
0
4
7
.7
5
1
0
1
.7
0
1
1
9
9
9
1
4
2
0
3
F
2
8
C
9
8
.8
0
2
8
.6
0
9
6
.4
0
1
3
8
.5
0
4
2
.5
0
2
6
1
.0
0
6
4
.1
0
1
4
8
.0
0
7
8
.0
0
1
0
3
.9
5
1
2
0
0
0
1
4
2
0
3
F
2
2
A
5
4
.7
0
1
9
.5
0
6
8
.3
0
1
1
3
.0
0
2
2
.5
0
1
8
6
.0
0
3
1
.1
0
9
6
.6
5
3
9
.7
0
8
4
.4
0
1
2
0
0
1
1
4
2
0
3
F
2
0
C
5
4
.1
0
1
5
.0
5
5
4
.5
5
1
0
0
.5
0
1
7
.2
5
1
6
4
.0
0
3
7
.3
0
7
1
.0
5
2
9
.1
0
6
6
.6
0
1
2
0
0
2
1
4
2
0
3
F
2
0
B
5
5
.1
0
1
5
.5
0
5
4
.1
5
9
7
.1
0
2
2
.0
0
1
3
3
.0
0
5
3
.7
0
7
6
.1
5
3
4
.6
5
6
7
.3
0
1
2
0
0
3
1
4
2
0
1
M
9
7
A
6
8
.0
5
1
9
.9
0
7
4
.3
0
1
2
2
.0
0
2
9
.3
0
1
9
0
.0
0
4
8
.2
0
1
1
0
.5
0
5
2
.4
0
8
4
.2
5
1
2
0
0
4
1
4
2
0
1
F
9
2
C
7
0
.3
5
2
1
.5
0
6
9
.5
0
1
4
9
.5
0
2
8
.5
5
2
0
6
.0
0
5
7
.5
5
9
6
.9
5
4
9
.8
5
8
5
.9
5
1
2
0
0
5
1
4
2
0
1
M
7
7
C
5
1
.0
5
1
4
.3
0
5
1
.4
5
8
8
.1
0
1
6
.9
5
1
3
7
.5
0
3
0
.3
5
6
5
.1
0
3
0
.6
0
6
0
.8
0
1
2
0
0
6
1
4
2
0
1
F
7
5
B
7
5
.7
5
2
2
.5
0
8
1
.9
0
1
3
5
.0
0
3
3
.2
5
2
1
3
.0
0
3
9
.9
0
1
0
8
.5
0
4
8
.0
0
8
9
.9
0
1
2
0
0
7
1
4
2
0
3
M
2
8
A
4
8
.5
0
1
5
.0
0
5
6
.2
5
1
0
9
.0
0
2
9
.9
5
1
4
8
.0
0
4
2
.1
5
7
4
.3
0
3
9
.4
0
7
3
.2
0
1
2
0
3
5
1
3
4
6
3
M
2
7
A
4
5
.3
0
1
4
.1
0
5
0
.6
0
1
0
9
.5
0
1
6
.4
5
1
2
4
.5
0
2
8
.2
5
6
2
.6
5
3
4
.2
5
6
3
.9
0
1
2
0
3
6
1
3
4
6
3
M
2
5
A
6
0
.9
0
1
8
.4
0
6
6
.9
0
1
1
7
.0
0
2
3
.0
5
1
5
6
.5
0
3
6
.4
0
9
9
.5
0
3
8
.3
5
8
1
.3
0
1
2
0
3
7
1
3
4
6
3
M
2
4
B
5
3
.6
5
1
4
.9
0
5
5
.3
0
1
2
7
.5
0
1
9
.4
5
1
1
1
.3
0
3
7
.7
0
7
3
.1
0
6
4
.7
0
7
0
.6
5
1
2
0
3
8
1
3
4
6
3
M
2
1
A
4
6
.8
0
1
5
.1
5
5
3
.5
5
1
2
9
.5
0
1
9
.4
5
8
8
.1
5
3
8
.3
0
7
3
.1
0
4
8
.8
0
8
2
.3
0
1
2
0
3
9
1
3
4
6
3
M
2
1
C
5
2
.7
5
1
4
.5
0
5
2
.1
0
8
5
.9
0
2
1
.6
5
1
5
6
.0
0
3
9
.3
0
7
2
.4
0
3
5
.8
5
6
5
.6
0
1
2
0
4
0
1
3
4
6
3
F
1
6
C
5
9
.5
0
1
6
.5
5
5
8
.7
5
1
1
5
.5
0
1
9
.5
5
1
6
6
.0
0
3
6
.2
0
7
1
.6
5
2
9
.0
5
7
3
.9
5
1
2
0
4
1
1
3
4
6
3
F
1
3
A
7
6
.8
0
N
A
8
1
.6
0
1
2
3
.0
0
3
0
.0
0
1
4
5
.5
0
5
1
.3
5
1
0
6
.0
0
3
6
.4
0
9
1
.7
5
1
2
0
4
3
1
3
4
6
1
M
7
4
A
3
4
.1
5
1
3
.5
0
4
9
.9
5
1
5
0
.0
0
3
1
.0
0
8
3
.9
5
3
7
.6
5
8
3
.6
5
5
1
.4
5
7
8
.2
0
1
2
0
4
4
1
3
4
6
1
F
7
0
C
6
4
.6
0
2
0
.8
0
6
4
.9
0
1
1
5
.0
0
2
4
.8
5
2
1
1
.0
0
3
8
.9
0
9
6
.5
0
4
5
.6
0
8
7
.0
0
1
2
0
4
5
1
3
4
6
1
M
7
4
A
5
1
.8
0
1
7
.9
0
6
9
.8
5
8
2
.9
0
2
7
.7
0
1
3
1
.0
0
3
8
.2
0
9
6
.2
0
4
8
.1
0
8
4
.9
0
1
2
0
4
6
1
3
4
6
1
F
7
2
B
9
1
.9
5
2
6
.5
0
1
0
4
.0
0
1
2
7
.5
0
3
1
.2
0
2
6
8
.0
0
3
8
.9
0
1
3
0
.0
0
5
9
.4
0
1
1
3
.0
0
1
2
0
4
7
1
3
4
4
3
F
2
7
A
3
2
.7
0
1
8
.4
0
6
2
.5
0
1
2
5
.5
0
2
1
.9
0
2
0
5
.5
0
3
4
.3
0
8
7
.1
0
5
5
.9
0
6
8
.6
0
1
2
0
4
8
1
3
4
4
3
F
2
5
A
5
6
.6
5
1
5
.9
0
6
1
.0
0
1
2
6
.0
0
2
6
.5
5
1
0
5
.6
0
4
1
.8
5
7
8
.1
5
4
5
.4
5
7
7
.9
0
1
2
0
4
9
1
3
4
4
3
F
2
2
B
5
8
.6
5
1
6
.2
0
5
9
.7
5
9
4
.6
0
2
1
.2
5
1
7
2
.5
0
4
1
.0
5
7
9
.8
5
4
3
.1
0
7
5
.1
5
1
2
0
5
1
1
3
4
4
3
M
1
7
C
5
8
.7
0
1
6
.6
0
6
0
.2
0
1
5
4
.0
0
2
2
.6
0
1
4
5
.0
0
4
2
.8
5
7
2
.7
0
6
0
.8
0
7
6
.7
0
1
2
0
5
2
1
3
4
4
3
M
1
6
B
6
2
.3
5
1
9
.3
0
6
6
.7
0
1
2
8
.0
0
2
4
.7
0
1
7
0
.0
0
4
8
.1
0
9
3
.0
0
5
1
.5
5
7
9
.3
5
1
2
0
5
3
1
3
4
4
3
F
1
4
C
6
5
.6
5
1
9
.4
5
6
8
.7
5
1
1
0
.0
0
2
2
.3
0
2
1
6
.0
0
2
8
.4
5
9
4
.3
5
5
0
.3
5
8
1
.3
5
1
2
0
5
4
1
3
4
4
3
F
1
1
B
5
2
.2
0
1
4
.6
0
5
1
.6
0
1
2
4
.0
0
2
2
.4
0
1
5
2
.0
0
3
3
.4
0
6
9
.4
0
3
6
.6
5
6
5
.9
5
1
2
0
5
5
1
3
4
4
3
M
8
B
5
7
.3
0
1
5
.0
0
5
6
.9
0
1
0
0
.4
0
2
0
.3
5
1
8
1
.0
0
4
1
.1
0
7
5
.3
0
4
1
.9
5
7
0
.2
5
S
u
p
p
le
m
e
n
ta
l 
T
a
b
le
 1
: 
L
y
m
p
h
o
b
la
to
id
 C
e
ll
 L
in
e
 P
a
n
e
l 
(3
 o
f 
4
)
144
L
in
e
F
a
m
il
y
G
e
n
e
ra
ti
o
n
S
e
x
A
g
e
 (
Y
e
a
rs
)
P
la
te
M
e
d
ia
n
 C
D
4
 (
H
ig
h
)
M
e
d
ia
n
 C
D
4
 (
L
o
w
)
M
e
d
ia
n
 C
D
1
9
M
e
d
ia
n
 C
D
2
3
M
e
d
ia
n
 C
D
3
8
M
e
d
ia
n
 C
D
4
0
M
e
d
ia
n
 C
D
4
5
R
A
M
e
d
ia
n
 C
D
8
6
M
e
d
ia
n
 I
C
A
M
-1
M
e
d
ia
n
 T
L
R
-9
1
2
0
5
6
1
3
4
4
1
M
7
9
C
6
7
.8
0
1
9
.6
0
7
0
.7
0
1
5
0
.0
0
2
4
.6
0
2
2
3
.5
0
5
0
.6
5
8
7
.5
0
4
1
.7
0
8
5
.7
5
1
2
0
5
7
1
3
4
4
1
F
7
5
B
5
6
.1
5
1
6
.2
5
5
6
.8
5
1
0
1
.5
0
1
9
.3
5
1
3
5
.0
0
4
0
.4
0
7
7
.3
0
3
7
.3
0
7
7
.4
5
1
2
0
5
8
1
3
4
4
1
F
8
1
B
N
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
1
2
0
8
9
1
3
3
2
3
F
2
5
B
6
2
.8
0
1
8
.1
5
6
6
.8
5
9
7
.2
0
2
8
.5
0
2
0
3
.0
0
3
2
.7
5
1
3
4
.0
0
6
2
.3
5
7
7
.5
0
1
2
0
9
1
1
3
3
2
3
M
1
5
A
6
9
.7
5
2
7
.5
0
8
8
.7
0
N
A
4
1
.6
5
1
2
2
.0
0
4
2
.0
0
1
1
5
.0
0
4
5
.1
0
7
6
.8
0
1
2
0
9
2
1
3
3
2
3
F
1
4
C
6
6
.9
0
2
0
.0
5
6
9
.8
0
1
0
7
.0
0
2
5
.9
5
2
5
6
.5
0
3
6
.2
0
9
6
.0
0
5
1
.5
0
8
5
.7
0
1
2
0
9
3
1
3
3
2
3
F
1
3
B
6
4
.1
5
1
6
.1
5
6
3
.4
0
9
7
.1
5
2
4
.5
0
1
5
6
.0
0
6
7
.5
0
8
7
.5
0
4
6
.1
0
7
5
.0
0
1
2
0
9
5
1
3
3
2
3
M
8
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
6
1
.0
0
1
2
0
9
6
1
3
3
2
1
M
9
4
A
5
1
.0
5
1
4
.8
0
5
4
.9
0
1
2
3
.5
0
2
4
.6
0
1
1
3
.5
0
5
8
.0
5
8
0
.4
0
5
9
.7
0
8
5
.6
5
1
2
0
9
7
1
3
3
2
1
F
8
5
C
5
2
.9
5
2
1
.5
0
7
2
.1
0
1
0
5
.0
0
2
7
.6
0
3
1
0
.5
0
3
5
.7
0
9
8
.9
5
4
4
.6
0
6
1
.9
0
1
2
0
9
9
1
3
3
2
1
M
7
3
B
7
6
.3
0
2
0
.0
0
7
8
.2
0
1
3
8
.5
0
3
3
.0
5
2
0
6
.0
0
4
1
.4
0
1
2
2
.5
0
7
5
.3
0
8
9
.3
5
1
2
1
0
1
1
4
1
3
3
M
2
8
A
5
1
.2
0
1
8
.0
0
6
3
.3
0
9
0
.3
0
2
7
.3
0
2
3
8
.0
0
4
2
.8
0
1
1
2
.0
0
4
5
.0
5
7
9
.1
5
1
2
1
0
4
1
4
1
3
3
F
2
3
C
N
A
3
0
.1
0
6
4
.1
0
N
A
2
6
.6
0
2
5
4
.0
0
4
2
.9
5
N
A
N
A
8
9
.1
0
1
2
1
0
6
1
4
1
3
3
M
2
1
A
7
5
.0
0
2
0
.9
0
8
6
.3
0
1
3
9
.0
0
3
1
.4
5
2
6
5
.5
0
4
5
.9
0
1
1
7
.5
0
7
6
.4
5
1
0
0
.4
0
1
2
1
0
7
1
4
1
3
3
M
1
9
C
7
1
.8
5
1
9
.4
0
7
3
.3
0
1
1
6
.5
0
2
8
.9
0
2
2
0
.5
0
3
9
.6
0
9
1
.5
0
5
2
.7
0
9
2
.3
0
1
2
1
0
8
1
4
1
3
3
M
1
8
C
8
6
.3
0
2
3
.4
5
8
3
.9
5
1
7
6
.5
0
3
3
.7
0
1
9
9
.5
0
4
6
.6
0
1
2
8
.0
0
5
2
.7
0
9
9
.7
0
1
2
1
0
9
1
4
1
3
3
M
1
7
C
6
0
.4
0
1
6
.5
5
6
2
.3
0
1
1
8
.5
0
2
1
.8
5
2
0
5
.5
0
3
0
.1
5
8
6
.5
5
4
3
.4
0
7
3
.8
0
1
2
1
1
0
1
4
1
3
3
F
1
5
A
4
9
.2
5
1
4
.9
5
5
2
.4
0
8
9
.9
0
1
7
.9
0
1
3
7
.5
0
3
1
.9
0
8
5
.1
0
3
5
.2
5
6
8
.1
5
1
2
1
1
1
1
4
1
3
3
M
1
3
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
N
A
8
3
.4
0
1
2
1
1
2
1
4
1
3
3
M
1
2
C
6
4
.4
0
2
0
.5
5
6
6
.8
5
1
3
2
.5
0
2
4
.6
5
2
2
5
.0
0
3
5
.9
0
9
7
.1
5
4
3
.6
0
8
5
.4
0
1
2
1
1
3
1
4
1
3
3
M
1
1
A
5
3
.5
5
1
9
.1
0
7
2
.0
0
1
2
7
.0
0
2
4
.9
0
2
2
1
.0
0
4
2
.4
0
9
2
.9
0
4
7
.1
5
8
2
.4
0
1
2
1
1
4
1
4
1
3
3
F
1
0
A
5
0
.1
5
1
5
.8
0
5
7
.5
0
9
3
.6
0
2
7
.1
5
1
6
4
.0
0
4
2
.9
5
9
1
.2
0
4
3
.0
5
9
6
.5
5
1
2
1
1
5
1
4
1
3
3
M
6
A
5
3
.4
0
1
5
.1
0
5
6
.7
5
9
5
.6
5
2
0
.4
5
1
1
1
.0
0
3
0
.5
0
8
1
.6
0
4
3
.2
0
8
5
.1
0
1
2
1
1
6
1
4
1
3
1
F
6
8
C
6
1
.0
0
1
5
.6
0
6
6
.0
5
1
0
3
.7
5
1
8
.5
0
1
5
0
.0
0
3
5
.7
0
9
4
.2
5
4
8
.0
5
7
1
.8
0
1
2
1
1
7
1
4
1
3
1
F
7
2
B
6
1
.3
0
1
7
.7
0
6
3
.5
0
1
0
2
.0
0
2
8
.4
0
1
9
4
.5
0
4
9
.5
0
9
6
.0
5
4
9
.2
0
8
6
.2
0
1
2
2
3
7
1
3
3
2
3
F
9
B
7
9
.9
5
2
2
.7
0
8
5
.0
0
1
1
0
.5
0
3
0
.1
0
2
2
1
.0
0
4
7
.0
5
1
1
0
.5
0
5
7
.2
0
9
6
.8
0
1
2
2
4
0
1
4
1
6
3
M
1
9
B
5
2
.9
0
1
4
.9
5
5
5
.5
5
1
0
7
.0
0
1
8
.4
0
1
4
3
.5
0
5
3
.2
5
7
8
.4
5
4
4
.9
5
7
0
.0
0
1
2
2
4
1
1
4
1
6
1
M
1
6
A
N
A
2
6
.2
0
9
2
.7
5
N
A
3
0
.0
0
2
0
5
.0
0
5
0
.7
5
9
1
.9
0
3
6
.4
0
9
1
.9
0
1
2
2
4
3
1
4
1
6
3
M
1
3
A
4
7
.5
0
1
6
.1
0
5
3
.5
5
7
8
.0
5
2
2
.4
0
1
5
5
.5
0
3
8
.9
0
8
8
.4
0
3
7
.3
0
6
5
.6
0
1
2
2
4
4
1
4
1
6
3
F
1
2
C
5
1
.4
0
1
4
.4
0
5
3
.0
0
1
1
9
.0
0
1
8
.3
0
1
6
4
.0
0
3
1
.9
5
7
1
.5
0
4
9
.0
0
6
2
.6
5
1
2
2
4
5
1
4
1
6
3
M
1
0
B
5
4
.5
5
1
4
.6
5
5
7
.6
5
1
2
5
.0
0
1
8
.3
5
1
5
3
.5
0
3
6
.7
5
8
7
.7
5
5
0
.5
5
6
9
.9
5
1
2
2
4
6
1
4
1
6
3
F
8
B
5
3
.3
0
1
4
.5
5
5
5
.1
5
1
1
6
.0
0
2
0
.3
0
1
5
9
.5
0
4
3
.2
5
7
1
.8
5
3
3
.1
5
6
7
.3
5
1
2
2
4
7
1
4
1
6
3
F
5
A
4
9
.5
0
1
5
.1
5
5
6
.6
5
1
0
1
.5
0
1
8
.7
5
1
4
4
.0
0
2
6
.2
5
6
8
.9
5
3
7
.6
0
7
0
.9
0
1
2
2
4
9
1
4
1
6
1
M
7
7
C
5
3
.2
0
1
4
.3
5
5
5
.5
5
1
0
4
.0
0
2
0
.4
5
1
7
7
.0
0
4
5
.3
5
8
8
.2
0
4
4
.9
5
6
9
.0
5
1
2
2
5
0
1
4
1
6
1
M
6
6
C
1
0
3
.0
0
2
7
.7
5
1
0
4
.5
0
1
4
7
.0
0
3
5
.4
0
2
1
4
.0
0
5
5
.9
0
1
2
8
.0
0
5
5
.1
0
9
4
.1
0
1
2
2
5
1
1
4
1
6
3
F
6
3
C
5
4
.2
0
1
4
.7
5
5
4
.9
5
8
1
.6
0
2
3
.2
5
1
7
6
.5
0
4
7
.3
0
8
3
.6
5
4
1
.1
5
6
6
.9
0
1
2
2
5
2
1
4
1
6
1
F
5
A
4
1
.1
0
1
1
.9
0
5
0
.6
5
1
2
1
.0
0
2
2
.9
0
8
1
.0
5
3
2
.0
0
8
5
.0
0
4
3
.0
0
1
1
9
.0
0
1
2
2
5
3
1
4
1
6
3
F
6
C
5
2
.7
5
1
4
.6
0
5
3
.1
5
9
6
.2
0
1
8
.4
5
1
7
0
.0
0
3
0
.8
5
7
1
.8
5
4
0
.6
5
6
7
.0
0
1
3
1
3
0
1
3
3
2
3
F
N
A
A
5
9
.6
0
2
1
.2
5
6
6
.2
0
1
1
7
.0
0
3
3
.8
5
1
5
9
.0
0
3
7
.0
5
1
0
6
.0
0
6
3
.0
0
9
2
.6
5
S
u
p
p
le
m
e
n
ta
l 
T
a
b
le
 1
: 
L
y
m
p
h
o
b
la
to
id
 C
e
ll
 L
in
e
 P
a
n
e
l 
(4
 o
f 
4
)
145
L
in
e
F
a
m
il
y
G
e
n
e
ra
ti
o
n
S
e
x
A
g
e
 (
Y
e
a
rs
)
M
e
a
n
 C
D
4
0
M
e
a
n
 C
D
8
6
L
in
e
F
a
m
il
y
G
e
n
e
ra
ti
o
n
S
e
x
A
g
e
 (
Y
e
a
rs
)
M
e
a
n
 C
D
4
0
M
e
a
n
 C
D
8
6
6
9
8
5
1
3
4
1
1
F
6
9
2
3
1
.5
0
1
6
1
.6
0
1
0
8
5
0
1
3
4
4
2
F
4
8
2
4
8
.0
0
1
2
7
.8
3
6
9
9
1
1
3
4
1
2
F
4
2
2
3
0
.1
7
1
2
0
.6
7
1
0
8
5
1
1
3
4
4
2
M
5
2
2
7
9
.5
0
1
3
3
.0
0
6
9
9
3
1
3
4
1
1
M
7
4
2
3
5
.4
0
1
7
5
.8
3
1
0
8
6
0
1
3
6
2
2
M
5
0
2
4
9
.8
0
1
2
5
.0
0
6
9
9
4
1
3
4
0
1
M
6
8
3
8
8
.1
7
1
8
6
.4
0
1
0
8
6
1
1
3
6
2
2
F
4
9
3
6
1
.0
0
1
6
0
.7
5
7
0
0
0
1
3
4
0
1
F
6
6
2
8
5
.6
0
1
2
2
.7
5
1
1
9
8
2
1
3
6
2
3
F
2
8
2
5
3
.3
3
1
2
9
.5
0
7
0
0
6
1
3
4
1
3
F
1
0
1
9
1
.6
7
1
5
1
.8
0
1
1
9
8
4
1
3
6
2
3
M
2
6
1
7
6
.0
0
1
2
8
.2
5
7
0
0
8
1
3
4
0
3
M
2
3
3
7
0
.2
5
1
8
2
.8
3
1
1
9
8
5
1
3
6
2
3
F
2
4
2
6
2
.0
0
1
5
4
.5
0
7
0
1
0
1
3
4
1
3
F
8
2
1
4
.6
7
1
0
2
.8
3
1
1
9
8
6
1
3
6
2
3
F
2
2
2
5
8
.5
0
1
4
2
.2
5
7
0
1
2
1
3
4
1
3
F
1
8
2
2
5
.0
0
1
5
5
.5
0
1
1
9
8
7
1
3
6
2
3
M
1
9
3
1
8
.1
7
1
3
0
.7
5
7
0
1
9
1
3
4
0
2
F
4
5
2
8
5
.6
7
1
2
5
.6
0
1
1
9
8
8
1
3
6
2
3
F
1
7
2
7
8
.2
0
1
4
3
.1
7
7
0
2
0
1
3
4
1
3
M
7
3
5
1
.8
3
1
5
8
.8
3
1
1
9
8
9
1
3
6
2
3
F
1
4
2
6
3
.0
0
1
0
2
.0
0
7
0
2
1
1
3
4
1
3
M
1
4
2
2
2
.4
0
1
0
1
.3
0
1
1
9
9
0
1
3
6
2
3
M
9
3
6
1
.3
3
1
6
1
.2
5
7
0
2
2
1
3
4
0
1
M
6
3
3
7
5
.0
0
1
5
1
.5
0
1
1
9
9
1
1
3
6
2
3
F
7
2
0
6
.6
7
1
2
9
.0
0
7
0
2
7
1
3
4
0
3
M
1
1
2
1
4
.6
7
1
5
1
.2
0
1
1
9
9
2
1
3
6
2
1
M
8
6
1
8
0
.7
5
1
0
5
.5
0
7
0
2
9
1
3
4
0
2
M
4
7
4
5
6
.1
7
1
6
0
.8
3
1
1
9
9
3
1
3
6
2
1
F
8
0
2
2
0
.6
0
1
6
1
.7
5
7
0
3
4
1
3
4
1
1
M
7
1
2
5
6
.3
3
1
4
1
.2
0
1
1
9
9
4
1
3
6
2
1
M
8
0
2
5
4
.6
7
9
4
.7
8
7
0
4
0
1
3
4
0
3
M
1
9
3
3
8
.7
5
2
4
4
.5
0
1
1
9
9
5
1
3
6
2
1
F
8
4
2
1
4
.3
3
1
1
0
.8
7
7
0
4
4
1
3
4
1
3
F
2
0
3
2
8
.0
0
1
9
2
.2
0
1
1
9
9
6
1
3
6
2
3
M
2
1
2
6
8
.5
0
1
4
0
.2
5
7
0
4
8
1
3
4
1
2
M
4
3
2
2
7
.5
0
1
1
8
.7
4
1
1
9
9
7
1
4
2
0
3
F
3
1
2
5
0
.2
0
1
3
4
.4
0
7
0
5
3
1
3
4
0
3
F
2
4
2
5
6
.5
0
1
1
6
.6
0
1
1
9
9
8
1
4
2
0
3
F
2
7
1
9
7
.6
0
1
3
2
.3
3
7
0
5
5
1
3
4
1
1
F
7
0
2
4
5
.0
0
1
5
4
.8
0
1
1
9
9
9
1
4
2
0
3
F
2
8
3
4
0
.7
5
2
0
5
.6
7
7
0
5
6
1
3
4
0
1
F
6
5
2
1
4
.6
0
1
0
7
.2
5
1
2
0
0
0
1
4
2
0
3
F
2
2
2
1
2
.5
0
1
6
0
.0
0
7
0
6
2
1
3
4
0
3
F
2
7
1
9
5
.4
0
9
9
.0
8
1
2
0
0
1
1
4
2
0
3
F
2
0
2
3
4
.4
0
1
1
4
.8
3
7
3
4
2
1
3
4
0
3
M
1
6
3
0
3
.5
0
9
1
.9
0
1
2
0
0
2
1
4
2
0
3
F
2
0
1
9
2
.2
0
1
2
5
.2
0
7
3
4
3
1
3
4
1
3
F
2
2
2
0
4
.6
7
1
2
1
.8
0
1
2
0
0
3
1
4
2
0
1
M
9
7
3
2
7
.4
0
1
3
8
.2
0
7
3
4
4
1
3
4
1
3
F
1
7
1
9
8
.0
0
1
2
4
.0
0
1
2
0
0
4
1
4
2
0
1
F
9
2
2
4
6
.8
0
1
3
9
.8
3
7
3
4
5
1
3
4
5
1
F
6
9
2
7
1
.7
5
1
2
2
.1
7
1
2
0
0
5
1
4
2
0
1
M
7
7
2
3
0
.2
0
1
1
7
.6
0
7
3
4
6
1
3
4
5
1
F
8
5
3
2
9
.5
0
1
5
0
.2
5
1
2
0
0
6
1
4
2
0
1
F
7
5
2
7
3
.6
7
1
2
4
.0
0
7
3
4
7
1
3
4
5
1
M
8
6
3
5
9
.2
0
1
6
3
.3
3
1
2
0
0
7
1
4
2
0
3
M
2
8
2
3
8
.5
0
1
3
1
.5
0
7
3
4
8
1
3
4
5
2
F
4
5
3
2
1
.6
0
1
6
0
.8
0
1
2
0
4
7
1
3
4
4
3
F
2
7
3
2
6
.5
0
1
4
3
.5
0
7
3
4
9
1
3
4
5
2
M
4
9
1
9
0
.2
5
1
1
0
.8
0
1
2
0
4
8
1
3
4
4
3
F
2
5
2
7
6
.2
5
1
2
4
.0
0
7
3
5
0
1
3
4
5
3
F
2
5
1
8
8
.2
5
1
3
3
.0
0
1
2
0
4
9
1
3
4
4
3
F
2
2
2
2
9
.0
0
1
3
7
.6
7
7
3
5
1
1
3
4
5
3
M
2
3
2
3
7
.6
0
1
3
1
.5
0
1
2
0
5
1
1
3
4
4
3
M
1
7
2
4
9
.2
5
1
2
6
.0
0
7
3
5
2
1
3
4
5
3
M
2
2
2
2
3
.1
7
1
5
9
.2
5
1
2
0
5
2
1
3
4
4
3
M
1
6
2
1
6
.2
5
1
0
8
.3
5
7
3
5
3
1
3
4
5
3
M
2
0
2
1
8
.2
5
1
1
9
.7
5
1
2
0
5
3
1
3
4
4
3
F
1
4
2
5
5
.7
5
1
3
1
.5
0
7
3
5
4
1
3
4
5
3
F
1
9
2
0
1
.0
0
1
4
2
.2
5
1
2
0
5
4
1
3
4
4
3
F
1
1
2
5
2
.0
0
1
0
2
.4
3
7
3
5
5
1
3
4
5
3
M
1
6
3
8
0
.3
3
1
6
2
.6
7
1
2
0
5
5
1
3
4
4
3
M
8
3
1
0
.1
7
1
3
4
.1
7
7
3
5
7
1
3
4
5
1
M
6
9
2
9
1
.5
0
2
4
0
.8
3
1
2
0
5
6
1
3
4
4
1
M
7
9
2
7
2
.5
0
1
2
3
.8
0
1
0
8
3
8
1
4
2
0
2
M
6
0
3
2
4
.0
0
1
3
5
.2
5
1
2
0
5
7
1
3
4
4
1
F
7
5
1
9
1
.5
0
1
2
0
.1
7
1
0
8
3
9
1
4
2
0
2
F
5
5
3
2
6
.0
0
1
1
5
.2
5
S
u
p
p
le
m
e
n
ta
l 
T
a
b
le
 2
: 
P
il
o
t 
L
y
m
p
h
o
b
la
to
id
 C
e
ll
 L
in
e
 P
a
n
e
l
146
